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Bacterial diseases have historically accounted for a high burden of morbidity and 
mortality worldwide. While antibiotic therapy and immunisations have significantly 
improved clinical outcomes in the last couple of centuries, the rate at which new 
treatments and vaccines are being developed has slowed down. One way to accelerate 
innovation in the field is by understanding the host-bacteria interactions that take place 
in vivo and affect the clinical outcome of the disease, the response to treatment and the 
immunological response following vaccination. Mechanistic mathematical models are 
being increasingly used to advance our understanding about unobservable, host-pathogen 
interactions in vivo. These models allow us to develop hypotheses about the underlying 
biological mechanisms responsible for an observable and measurable outcome (e.g. the 
number of bacteria in a tissue of interest) and use them to try to match what has been 
experimentally or clinically observed.  
In this thesis, I have developed mechanistic models and used them in conjunction with 
experimental data on systemic murine Salmonella Typhimurium infections to: 
1. characterise the effects of different vaccine preparations on the immune system of the 
host and its response to a secondary bacterial challenge, 
2. compare the effects of different antibiotic classes on bacterial populations residing in 
different organs, and predict whether the residual bacteria following antibiotic treatment 
differ in their proliferative capacity,  
3. develop a new, flexible methodological tool for a priori experimental design in studies 
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i. Thesis Abstract  
Bacterial diseases still remain a major threat, especially for vulnerable demographic 
groups in less privileged parts of the world. While bacterial infections are -in principle- 
treatable with antibiotics, they are becoming increasingly challenging to manage due to 
the rise of antibiotic resistance and tolerance to most available first-line antibiotics. To 
counteract this challenge, the global community is exploring ways to better understand 
the host-pathogen interactions underpinning pathogenesis, to optimise the use of 
existing antibiotics and to accelerate the development of novel therapeutics and 
vaccines.  
Historically, much of microbiological research has been centred around gaining 
knowledge about the components involved in host immunity and bacterial virulence. 
The conventional approaches used by microbiologists, such as genetic engineering, 
microscopy and culture techniques, have allowed them to obtain static snapshots of 
bacterial populations or single bacterial cells. By combining qualitative data with 
statistical analysis, microbiologists can establish correlations between interventions 
and outcomes, but not infer the biological mechanisms responsible for the observed 
relations. For example, using statistical tests combined with snapshot data on the number 
of bacteria before and after antibiotic administration, it is possible to determine whether 
an antibiotic of interest is significantly correlated with lower bacterial numbers in a 
particular tissue, but it is not possible to gain further insights as to whether the observed 
reduction in bacterial loads is due to enhanced bactericidal activity, induction of 
bacteriostatic mechanisms or a combination thereof.  
Moving a step further from the mere establishment of statistical significance, it is 
becoming increasingly feasible to combine microbiological data with more sophisticated, 
mechanistic models that can address questions regarding the dynamical changes 
underlying the snapshot data obtained through conventional observational techniques. 
Characteristic examples of such questions include:  
1) What is the relative contribution of bacterial death and division events in shaping 
bacterial numbers in in vivo experimental observations?  




3) What is the directionality of inter-tissue colonisation in an organism, e.g. given the 
presence of bacteria in organs A and B, is it possible to deduce whether bacteria from 
tissue A have seeded tissue B, or vice versa?  
Obtaining answers to these questions provides a more complete understanding of the 
within-host dynamics of bacterial infections in the naïve host, as well as in response to 
interventions; prophylactic or therapeutic. By integrating experimental data with 
mathematical modelling, it is possible to maximise the biological insight offered by 
experimental observations, without the need to expend more resources.  
 
The present thesis uses experimental data on systemic infections with Salmonella 
enterica serovar Typhimurium to showcase the benefits of integrating in vivo 
microbiological data with mechanistic mathematical models to:  
1) obtain complementary biological insights into the within-host dynamics of S. 
Typhimurium in the naïve, immunised and antibiotic-treated murine host, and 
2) optimise resource allocation during experimental design in order to obtain 
maximally informative experimental data. 
 
 
In particular, the aims of the present thesis can be summarised as follows:  
 
Bacterial dynamics in the naïve host (Chapter 3):  
• To formulate and compare a range of models corresponding to biological 
hypotheses regarding the early dynamics (0-6 hours) of systemic S. 
Typhimurium infections, especially with regards to early inter-tissue migration 
events and bactericidal activity in the blood.  
• To quantify the late-phase dynamics (6-72 hours), which have hitherto 
remained quantitatively uncharacterised in the naïve host, due to the lack of 






Bacterial dynamics in the immunised host (Chapter 4):  
• To quantitatively compare the effect of a live-attenuated and a whole-cell 
killed vaccine on the within-host dynamics of S. Typhimurium systemic 
infections over a period of 72 hours.  
 
Bacterial dynamics in the antibiotic-treated host (Chapter 5):  
• To quantitatively compare the effect of a fluoroquinolone (ciprofloxacin) and 
a beta-lactam (ampicillin) antibiotic on the within-host dynamics of S. 
Typhimurium systemic infections during treatment (time period of 3 days) and 
following antibiotic withdrawal (time period of 2 days).  
• To determine whether, when and where antibiotic-tolerant bacterial 
subpopulations arise during antibiotic treatment.  
• To characterise the dynamics of bacteria originating from previously tolerant 
populations and antibiotic-sensitive populations following antibiotic 
withdrawal. 
 
Development of a technique to optimise experimental design (Chapter 6):  
• To develop a computationally efficient tool to optimise experimental design 
with regards to inference precision using microbiological data from studies with 
isogenic tagged strains. 
• To appropriately test the performance of the novel tool. 
• To showcase the use of this tool in a range of biological scenarios of 
exponential growth, decay and “source-to-sink” bacterial migration. 
• To illustrate the use of the tool in optimising resource allocation (e.g. number 
of animal hosts, number and choice of sampling time points, inoculum size) to 
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• Bacterial diseases are still major “killers” worldwide. 
• Antibiotic resistance and tolerance render antibiotics less and less effective at 
definitively treating bacterial infections.  
• Accelerated research and development of novel prophylactic and therapeutic 
agents is urgently needed.  
• Deciphering the within-host dynamics of bacteria can help create targeted 
therapies and vaccines. 
• Coupling experimental techniques with mechanistic mathematical modelling can 
maximise insights into the unobservable biological processes that collectively 
determine the fate of a bacterial infection.  
• Computationally efficient inference tools are needed to enable the use of 
mathematical modelling in complex biological systems. 
• Murine infections with Salmonella Typhimurium are a well-established 
experimental system used as an archetype to study the within-host dynamics of 
bacterial infections. 
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1.1.  Bacterial Infections: Current Burden, Challenges and Prospects 
1.1.1. Epidemiological Background  
According to the most recent estimates by the World Health Organisation, bacterial 
diseases, including respiratory infections and diarrhoeal diseases, are classified amongst 
the top 10 leading causes of mortality, accounting for almost 6 million deaths globally 
every year worldwide (WHO, 2018)  The burden of bacterial diseases is asymmetrically 
distributed in terms of geography, age, socioeconomic and health status, mostly afflicting 
infants, elderly and immunocompromised individuals in low-resource settings in Sub-
Saharan Africa and South-East Asia (Yoshikawa, 2002).  
While, in principle, most bacterial diseases can be either treatable with antibiotics, 
preventable with immunisation or both, in practice, the efficacy of antibiotic treatment 
and the feasibility of en mass vaccination is hampered by multifactorial challenges on a 
logistical and clinical level alike. Far from complacency, a successful response to 
bacterial diseases would ideally include rational management based on a mechanistic 
understanding of their progression in vivo. 
 
1.1.2. Antimicrobial Therapy: Challenges to a Success Story 
Antimicrobial therapy has been one of the most successful examples of chemotherapy in 
the history of humankind. Although commonly associated with the 20th century 
discoveries of Paul Erlich (Ehrlich and Hata, 1910) and Alexander Fleming (Fleming, 
1929), concentrated traces of tetracycline in skeletons of prehistoric populations provide 
evidence that antibiotic agents have empirically been used long before the golden era of 
antibiotic revolution (Nelson et al., 2010). However, despite the earlier intuitive use of 
naturally-occurring compounds with low level of antimicrobial activity, it was not until 
the systematic extraction and de novo synthesis of antibiotics in the 20th century that 
communicable diseases ceased being the leading cause of death globally (CDC, 2016).  
Despite the plethoric discovery of antimicrobial compounds in the 20th century, the 
management of bacterial infections still remains precarious, largely due to the combined 
effects of antibiotic resistance (reviewed by Hofer, 2018) and tolerance (reviewed by 
Brauner et al., 2016), compounded by unresolved inequities in antimicrobial access 
across the globe (The Center for Disease Dynamics, Economics and Policy, 2019). While 




responsible for bacterial unresponsiveness to antibiotic therapy. A clonal population of 
bacteria can be wholly insensitive to one or more antibiotics; alternatively, it can be 
sensitive albeit incompletely eradicated, leaving a surviving subpopulation capable of 
establishing chronic infections with future recrudescent bouts. The former phenomenon 
is termed resistance and is attributable to heritable genetic mutations enabling bacteria to 
circumvent antimicrobial action, while the latter is known as tolerance and encompasses 
the survival of non-genetic variants in a clonal bacterial population due to -what is 
currently seen as- non-heritable metabolic adaptations that are non-specific to the 
antibiotic (Levin-Reisman et al., 2019; Van den Bergh, Fauvart and Michiels, 2017).  
To continue treating bacterial diseases effectively in the face of these challenges would 
require expedited drug research and development combined with stewardship of existing 
antibiotics (Doron and Davidson, 2011). Salient examples include efforts to optimise 
antibiotic administration regimens in terms of antibiotic class, timeframe and dose, and 
to maximise the synergistic effects between compounds in multi-therapy treatments, in 
alignment with endogenous immune control of the infection by the host. As the discovery 
and commercialisation of novel antibiotic agents is slow (Daron and Davidson, 2011; 
Silver, 2011), optimising the use of already available agents is an important mid-term 
solution. To achieve the synergistic orchestration of antibiotic activity and host immunity, 
there is a requirement for an integrated understanding of the dysfunctional host-pathogen 
interactions targeted by antimicrobial agents (Munguia and Nizet, 2017). Furthermore, 
there is a need to disentangle the complex interactions between host immunity and 
pathogen behaviour (Gjini and Brito, 2016), and to identify the determinants of successful 
disease establishment and progression (Munguia and Nizet, 2017; Casadevall and 













1.1.3. Immunisation: Designing and delivering the “ideal” vaccine 
Complementary with efforts to optimise antibiotic development and use, immunisation 
of vulnerable populations (Breiman et al., 2012) has emerged as an equally promising 
population-wide strategy which has been used to control the spread and sequelae of 
bacterial diseases caused by important human pathogens such as Mycobacterium 
tuberculosis, Haemophilus influenzae B, Streptococcus pneumoniae, Clostridium tetani 
and Salmonella enterica Typhi amongst others (Bacterial vaccines, 2020). However, as 
with antibiotics, new vaccines are not developed rapidly enough (Pronker et al., 2013) 
due to logistical and immunological challenges. Endemicity of most bacterial infections 
geographically overlaps with high prevalence of chronic viral (e.g. HIV) and parasitic 
(e.g. malaria, toxoplasmosis, schistosomiasis) immunomodulatory diseases affecting 
individuals of all ages (Levine and Farag, 2011), thus rendering the design of safe 
vaccines against bacterial agents for demographically- and immunologically- 
heterogeneous populations difficult (Crum-Cianflone and Sullivan, 2017).  
Meeting the increasing demand for safe, immunogenic, non-reactogenic vaccines (Khan 
et al., 2017) would be facilitated by a refined understanding of vaccine mode of action at 
the host-bacterial interface (Coward et al., 2014). A variety of vaccine types including 
live-attenuated, inactivated, subunit and conjugate vaccines is currently available or 
under development for a wide range of bacterial diseases, each with individual strengths 
and weaknesses (Clem, 2011). The host’s immune response elicited by each vaccine type 
differs in its immunologic potency, durability, efficacy and cross-protection from relative 
strains. Additionally, differentially sophisticated technology is required for mass-scale 
production of each vaccine type, and practical factors including ease of production, 
chemical resilience under extreme temperatures, route of delivery, cost and frequency of 
required boosters play a critical role in assessing the eligibility of any given vaccine for 
mass immunisation in low-resource settings (Duijzer, van Jaarsveld and Dekker, 2018).  
It would be ideal if we could produce the cheapest, most practical-to-store and easiest-
to-manufacture vaccine that would also confer lifelong immunity against all strains 
responsible for any particular bacterial disease. However, this is not the case for most 
available preparations. Different vaccine types have complementary strengths in terms of 
both their immunological and economic profiles (Clem, 2011), and, ultimately, choices 




Understanding how, when and for how long each vaccine type impacts on the processes 
of bacterial replication, killing and inter-organ migration could help identify the minimal 
functional requirements of an effective vaccine, and potentially inform a synthetic 
biology approach to vaccine engineering, away from the inefficiencies of empirical 
design (Diard et al., 2019; Coward et al., 2014),. However, for the majority of vaccines 
currently in use the mode of action at the level of host-pathogen interactions remains 
obscure (Oyston and Robinson, 2012). 
An understanding of the unobserved processes responsible for the establishment and 
growth of bacterial populations in different tissues can also render the process of vaccine 
research and development less wasteful and more systematic. Under the status quo, a 
vaccine candidate incapable of eliciting the desired immunological response is rejected 
instead of improved. Largely, this is because knowledge about how a vaccine exerts its 
in vivo effect at the host-bacterial interface is lacking; this knowledge gap hinders the 
scientific community from making informed modifications to its chemical structure, 
route of delivery or conjugation before iteratively re-assessing its efficacy (Six et al., 
2011).  
A good example of how this trend could be reversed is the recent interest in dissecting 
the effects of imperfect vaccine candidates on the within-host dynamics of pathogens. 
The merits of this alternative rational vaccine design approach can be demonstrated by 
the case study of an inactivated oral vaccine against S. Typhimurium currently under 
investigation in the murine host (Diard et al., 2019). Following detailed understanding of 
the bacteriostatic action of IgA as one of the main protective components of an oral 
vaccine against S. Typhimurium in the gut lumen (Moor et al., 2017), Diard et al. (Diard 
et al., 2019) showed that IgA-mediated bacterial clumping exerts a selective pressure 
against S. Typhimurium, which rapidly evolve surface structures (O-antigens) that can 
no longer be recognised by vaccine-induced IgA and can, thus, proliferate in the host 
circumventing the vaccine protection. Insights into this unexpected antibody-driven 
evolution of IgA escape variants led to iterative improvements in the formulation of the 
original vaccine, through addition of a cocktail of O-antigen variants that can induce IgA 




Finally, characterisation of bacterial migration, killing and division can lead to 
maximisation of the synergistic potential of bacteriostatic and cidal pathways in bacterial 
disease management. For example, studying the effect of different vaccine formulations 
on the early within-host Salmonella dynamics has revealed that a live-attenuated vaccine 
inactivates a large proportion of the inoculum very rapidly, while a whole-cell killed 
vaccine does not (Coward et al., 2014). This rapid inoculum inactivation observed in 
mice vaccinated with the live-attenuated vaccine is the result of the synergistic action 
between the vaccine-induced IgG response and the naturally-occurring production of 
reactive oxygen species (ROS) in the naïve host during the early phase of systemic 
Salmonella infections (Grant et al., 2008). Vaccines and antimicrobial agents that 
reinforce or complement the immunological processes already in action in the naïve host 
are likely to be more effective (Lipsitch and Siber, 2016).  
 
1.2. Deciphering the within-host dynamics of bacterial infections 
1.2.1. Insights into the within-host dynamics of bacterial disease as a propeller 
of innovation in management strategies 
Previously, it was noted that on the grounds of slow vaccine and antibiotics development, 
optimal use and repurposing of existing agents is pivotal. A major prerequisite for this 
strategy is the pursuit of a mechanistic understanding of the biological processes at the 
host-pathogen interface during infection and treatment. 
For the purposes of the current thesis I employ a functional definition of the term within-
host bacterial dynamics as the collection of the unobserved processes of bacterial 
colonization, phenotypic switch, division, death and inter-tissue migration within a host 
following inoculation. Knowledge about the comparative dominance of each process at 
different stages in the infection timeline and in different tissues can facilitate the 








1.2.2. Experimental techniques to investigate interactions at the host-
bacterial interface  
[reproduced verbatim from Vlazaki, Huber and Restif, 2019] 
From first principles, therapeutic interventions should aim to reduce or eliminate the 
pathogenic bacteria from the infected host. This outcome can be achieved by slowing 
down bacterial replication, accelerating bacterial killing, altering bacterial migration 
between tissues or employing any favourable combination thereof. Although bacterial 
growth and dissemination have been extensively studied in terms of molecular and 
cellular mechanisms (reviewed by Endesfelder, 2019; Ribet and Cossat, 2015), the efforts 
to quantify how rapidly these processes progress and change in response to therapeutic 
interventions remain limited (Levin and Antia, 2001). Quantification of these dynamics 
requires a detailed observation of within-host bacterial behaviour by means of suitable 
experimental studies and high-resolution imaging and tracking technologies, as detailed 
in the following sections. 
 
1.2.2.1. Marker-based methods 
The first marker-based methods used to measure the population-averaged rate of bacterial 
replication in vivo were additive, in the sense that they involved an accessory genetic 
element, including superinfecting bacteriophages (Hormaeche et al., 1980; Maw and 
Meynell, 1968; Meynell, 1959), temperature-sensitive plasmids (Gulig and Doyle, 1993) 
or plasmids carrying antimicrobial resistance genes (Moxon and Murphy, 1978). In these 
techniques, genetic elements that induce phenotypic changes are introduced into bacteria 
and upon division segregate to daughter cells, leading to a reduction in the concentration 
of the marker, as bacteria divide.  The growth of the bacterial population can be modelled 
with the generation time of the population, signifying the half-life of the marker. At each 
bacterial generation, we would expect to find one-half fewer bacteria in the population 
harbouring the non-genetic marker. 
Additive marker-based methods have fallen out of favour for higher-resolution 
experimental techniques, as their output, which is based on detection of phenotypic 
differences, limits the potential for mathematical inference. Because the concentration of 
the marker decays with each subsequent bacterial division, the technique is limited to a 




infection. Additionally, these methods are limited in their ability to study the within-host 
dynamics of bacteria, as they may be unable to measure inter-tissue migration. Finally, 
the small number of possible detectable phenotypes constitutes a limiting factor for the 
resolution of this technique.  
To overcome these limitations, non-phenotypic marker-based techniques based on 
genetic modification of the bacterial core genome were developed, offering the added 
advantage of unrestricted observational potential in time, as well as tracking of bacterial 
migration across different tissues. This new generation of marker-based techniques 
provides outputs that allow the quantification of replication, killing and migration of 
bacteria in vivo (Coward et al., 2014; Melton-Witt et al., 2011; Grant et al., 2008; Barnes 
et al., 2006).  In contrast to their predecessors, they introduce modifications to the core 
bacterial genome, in the form of uniquely identifiable nucleotide tags inserted in non-
coding regions of bacterial chromosomal DNA to generate a pool of iso-phenotypic, 
genetically distinguishable bacteria. This bacterial pool is then inoculated into 
experimental models. Animals are sacrificed at timepoints of interest, organs harvested, 
and bacterial composition determined by quantitative polymerase chain reaction (qPCR) 
or sequencing. Signature-tagged strains allow one to follow the course of infection in the 
infected host. Because the bacterial are uniquely marked, one can essentially take 
snapshots of the bacterial loads in different tissues and, using mathematical modelling, 
determine the rates at which bacteria replicate, migrate and die in tissues at any time 
during the course of infection.  
DNA barcoding experiments have served as an archetype of successfully pairing 
mathematical with experimental approaches. On many occasions, genetic barcodes have 
been used in the absence of mathematical models to provide a qualitative assessment of 
the within-host dynamics of bacterial infections. In a standard infection, observation of a 
change from a dissimilar to a highly similar composition of tagged populations between 
two tissue samples would indicate bacterial migration between them. Additionally, the 
sudden loss of tagged strain diversity would suggest a rapid bottleneck of some effect. 
For instance, Walters et al. (Walters et al., 2012) used isogenic tagging experiments to 





However, mathematical models further allow for a quantitative assessment of the 
dynamics of the bacterial infection, as well as model selection. For instance, the observed 
composition of isogenically-tagged populations of bacteria is the result of the convolved 
effects of replication, killing, and migration. By using a within-host model which 
explicitly represents the processes of replication, killing, and migration, it is possible to 
precisely estimate these rates by comparing model outputs to experimental data. Apart 
from quantifying the contribution of different processes on the overall bacterial numbers, 
it is also possible to assess the plausibility of different biological hypothesis by selecting 
the model with the best fit to the data. Two published studies demonstrate the biological 
insights offered by complementing the qualitative data interpretation with the quantitative 
model output. First, Grant et al. (Grant et al., 2008) demonstrated using the estimates 
provided by modelling that in the early stages of infection, replication and killing lead to 
unique subpopulations of bacteria in different infection foci. Estimation of replication 
and killing rates would not have been possible without using a mathematical model.  
 
Secondly, Coward et al. (Coward et al., 2014) introduced elements of mathematical 
modelling at various points along the experimental timeline. In the early stages of 
experimental design, simulation-based experiments were used to determine the inoculum 
dose that would yield the most informative experimental output. Then, mathematical 
modelling was used to correct the raw experimental data by accounting for the noise 
introduced due to partial sampling and the samples undergoing qPCR. Finally, 
mathematical modelling was used to maximise the biological insight by enabling the 
comparison between the mechanisms of action of the live and killed vaccine. The live 
vaccine controlled the infection more effectively by inactivating a large number of 
bacteria shortly after inoculation, and preventing migration of bacteria from the tissues 
to the blood in the first 48h of infection. In the liver and spleen, mice immunised with the 
killed vaccine killed bacteria more rapidly than those immunised with the live vaccine. 
The latter controlled the infection mainly by lowering the replication rates of bacteria in 
the same organs. Without models, net growth can be estimated from CFU counts, but 







1.2.2.2. Fluorescence Dilution-Based Techniques 
 
Fluorescence dilution techniques take the observation of the within-host bacterial 
dynamics from the population- to the single-cell level (Myhrvold et al., 2015; Claudi et 
al., 2014; Helaine et al., 2014, Helaine et al., 2010). Fluorescence reporter plasmids, in 
which dilution of a preformed pool of a fluorophore (fluorescence dilution) acts as a 
measure of bacterial replication, are introduced into a bacterial population. Flow 
cytometry is used to determine the intensity of the signal and thus the number of 
replication events that bacteria have undergone. 
By virtue of their single-cell resolution, fluorescence dilution techniques are particularly 
useful to study bacterial heterogeneity. To this day, mathematical modelling has typically 
not been used for fluorescence-dilution type experiments. Analyses have focused on 
qualitatively characterising the heterogeneity in a signal across a bacterial population, e.g. 
with regards to its spectrum of replication rates. 
However, mathematical modelling is needed to precisely quantify the extent of 
heterogeneity in the biological attribute of interest and to test hypotheses that may 
underlie this heterogeneity. In theory, because fluorescence halves at each division in 
fluorescence dilution experiments, discrete peaks should be observed on the histogram of 
fluorescence corresponding to bacteria at specific numbers of generations. Nonetheless, 
the histogram of fluorescence intensity is continuous. It is likely that this incongruence 
reflects some heterogeneity in the experimental process. Mathematical modelling can 
help distinguish the heterogeneity from the experimental process from the heterogeneity 
in the biological process. In particular, stochastic models are well-suited for this purpose, 
because they can capture different sources of variation. 
 
1.2.2.3. Peak-To-Trough Ratio 
 
One of the most recently developed technique pertinent to facilitating the observation of 
in vivo bacterial dynamics makes use of the differential genetic signatures left by 
replication cycles (Korem et al., 2015).  During DNA replication, regions that have 
already been passed by the replication fork will have two copies, while the yet 




the replication origin and that near the terminus, termed peak-to-trough ratio (PTR) 
should reflect the growth rate of the bacterial population.  
 
In 2018, Gao and Li (Gao and Li, 2018) developed an algorithm allowing the quantitative 
inference of bacterial growth rates from PTR data. First, their approach allows for 
correction of sequencing bias (GC content bias is reported in next-generation sequencing) 
using a linear mixed effect models which corrects the average coverage of contig 
according to the difference in GC content of the average GC content of all contigs. 
Quality control and exclusion of contigs is followed by a principal component analysis 
of contig coverages in multiple samples leading to more accurate inference of the distance 
between the contig and the replication origin compared to single samples. Quantification 
of parameter estimate accuracy when using experimental data of variable quality (e.g. 
different number of contig sizes, degree of contamination, contig number) is possible. 
This feature could be relevant to experimental design, as it could inform experimental 




1.3. The role of mathematical modelling in maximising insight into the 
within-host dynamics of bacterial infections 
 [reproduced verbatim from Vlazaki, Huber and Restif, 2019] 
 
1.3.1. Mathematical Models: Introduction and Classification 
 
Critical as it is to refine our understanding of bacterial disease progression down to the 
finer scale of host-bacterial interactions, it constitutes a challenge despite the increasing 
availability of new experimental techniques. With prospectively informed experimental 
design and improving bacterial tracking techniques in the lab, dynamical mathematical 
models have the power to infer the parameters governing the hitherto unobservable 
processes underlying bacterial dynamics, quantify them and characterize the uncertainty 
around them.   
In 1974, Eykhoff (Eykhoff, 1974) defined a mathematical model as “a representation of 
the essential aspects of a system, presenting knowledge of that system in a usable form”. 
These mathematical “representations” of real-life systems are equations organised under 
a range of forms including boolean models, models based on ordinary or partial 
differential equations, stochastic models based on stochastic differential equations, agent-
based models and game theory models amongst others (Cantone et al., 2017; Ciupe & 
Heffernan, 2017) in what Wolkenhauer wittily referred to as “a zoo of modelling 
approaches” (Wolkenhauer, 2014).  What makes all animals in that zoo distinctly 
powerful is their ability to address very different questions one may have about a system  
Though microbiologists are familiar with experimental models, they are traditionally less 
familiar with the versatility of mathematical modelling approaches, largely due to the 
limited interdisciplinary training in biological sciences (Levin and Antia, 2001). In this 
section, we aim to provide a convenient introduction to mathematical models by 
classifying modelling techniques according to their comparative strengths and 
applications to microbiological questions. 
 
Mathematical models can be categorised into functional classes (Figure 1.1), according 
to different criteria such as (1) whether their parameters represent biological processes, 
(2) whether they are fitted to experimental data, (3) whether molecular, cellular or other 


























Figure 1.1: Schematic representation of the relationships between different mathematical 
modelling techniques [reproduced from Vlazaki, Huber and Restif, 2019] 
 
Mathematical models can be divided into mechanistic and empirical on account of whether their 
parameters represent biological processes or simply characterise relations between variables in 
the data.  While empirical models are necessarily data-dependent, mechanistic models can either 
be system-specific and fitted to data or, generic, explorative and not related to experimental data 
(theoretical). Additionally, depending on the biological question addressed, mechanistic models 
can be deterministic when only the average behaviour of the system is of interest, or stochastic 
when unexplained variation in the behaviour of the system matters too. Mechanistic data-driven 
models can serve different purposes: they can either be solved forward in time to make a forecast 
(prospective analysis) or can be solved backwards in time to perform parameter inference and 


















THEORETICAL D A T A - D R I V E N  












3. Does the model 






1.3.1.1. Stochastic, mechanistic data-driven models  
In this thesis I use stochastic mechanistic models coupled with experimentally observed 
data. Mechanistic models incorporate the biological mechanisms by which changes in the 
system are thought to occur and require some knowledge or speculation about the 
unobserved interactions that determine the observable output (Thakur 1991; 
Baker et al., 2018). In the context of mathematical modelling, a mechanism often does 
not correspond to the molecular, cellular or genetic hierarchy that collectively constitutes 
causality from a microbiologist's viewpoint. From a modeller's point of view, a 
mechanism is a conceptual representation of the process acting to change the state of the 
system in a certain direction. Structurally, mechanistic models can be represented with 
flow diagrams, whereby the state of the biological system, i.e. an imaginary complete 
snapshot of that system at a given point in time, changes through processes measured by 
parameters in the model (Figure 1.2). Examples of biologically relevant quantities 
encoded as variables in these models (i.e. boxes in the flow diagram) can include 
concentrations of cytokines and antibodies, as well as numbers of immune cells and 
infectious agents in tissues amongst others. These quantities are at times directly 






Figure 1.2: An example of a flow diagram as a 
schematic representation of mechanistic models in 
microbiology [adapted from Kaiser et al., 2013]  
 
Boxes represent the variables of the system, in this case the 
number of bacteria in the caecum and caecal lymph node 
respectively. Mathematically these variables are shortened 
for convenience as NC and NL. The processes that change 
the state of the system are represented by arrows and, here, 
correspond to bacterial migration, replication and 
clearance. The rates at which these processes take place are 
quantified by parameters, in this case, μ, rL and cL 
corresponding to the rates of migration, replication and 
clearance, respectively. [reproduced verbatim from 
Vlazaki, Huber and Restif, 2019] 
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Mechanistic data-driven models, in particular, are usually system-specific and 
parameterized based on experimental outputs. For example, in 2014, Coward et al. 
carried out an experiment using individually tagged strains of S. Typhimurium to 
determine the effects of different vaccines on the rates of replication and killing of 
bacteria. The measurements of bacterial numbers in the differentially tagged 
subpopulations along the infection timeline were fed into a population-based 
mathematical model, which permitted estimation of the rates of replication and killing of 
bacteria under the two immunization regimens enabling the direct comparison between 
them. 
Stochastic models yield different results each time when initialized with the same 
parameters and initial conditions. While multiple realizations of stochastic models 
recapitulate the range of potential outcomes and their likelihood of occurrence, the output 
of a deterministic model corresponds to the mean outcome of these realizations. 
Stochastic models can quickly become too complex to solve analytically, and their 
exploration may, thus, be entirely simulation-based. When stochastic processes are 
simulated, the random nature of trajectories generated is due to randomly, exponentially 
distributed, picked times until the next process, with a randomly picked process executed 
during that time (Gillespie, 1977). This can become computationally expensive. 
Despite the higher computational cost of stochastic models, they often constitute the only 
reasonable modelling choice, when the behaviour of the system in question is particularly 
influenced by stochasticity. With terminology borrowed from the field of ecology, the 
uncertainty in the outcome can be decomposed as a function of two sources of 
stochasticity: demographic (e.g. Shaffer, 1981; Burgman, Ferson and Akcakaya, 1993) 
and environmental. Demographic events include births, deaths and migration of 
individuals. The mean rate at which a demographic event occurs is defined as the inverse 
of the average time it takes for the event to take place and can be quantified with 
mathematical models. These events are described by binary random variables with a 
certain probability of occurring per given unit of time. As demographic events at the 
population-level are a function of the sum of demographic events at the individual level, 





On the other hand, environmental stochasticity is independent of the individual; rather, it 
refers to unpredictable changes in the environmental conditions that the individuals 
experience. As such, its effects do not depend on the population size, but on the number, 
heterogeneity and stability of factors influencing individual behaviour (Fujiwara and 
Takada, 2017). In the context of within-host infectious dynamics, the nature of the 
pathogen determines the strength of each source of stochasticity. For infections requiring 
a small founding population, demographic stochasticity becomes important as they may 
either be successful or become extinct. At the same time, the complexity of the immune 
response, the microenvironment of the tissue(s) colonized, and the heterogeneity of 
infectious foci determines the effect of environmental stochasticity on the population. 
When prior biological knowledge indicates that either source of stochasticity may be 















1.3.2. Examples showcasing the range of biological insights gained using 
mathematical models in the field of host-pathogen interactions 
[reproduced verbatim from Vlazaki, Huber and Restif, 2019] 
 
1.3.2.1. Quantification of the relative contribution of different immune system 
components to the progression of infection 
Within-host models of parasitic, viral and bacterial infection often seek to determine the 
relative contributions of different components of the immune system in regulating the 
dynamics of infection. In the current treatment paradigm, the role of the host's immune 
response is often neglected, and therapeutic agents are administered for fixed periods of 
time usually in the form of monotherapy and regardless of the infectious load. It is now 
becoming increasingly recognized that a first step toward optimization of existing 
therapies is the induction of synergistic effects between the host immunity and the 
standalone effect of the therapy (Gjini and Brito, 2016). To thoroughly understand this 
interaction, mechanistic mathematical models can be used in two main ways. First, one 
can use a series of nested models prospectively, starting from simpler models and adding 
features of the immune response while quantifying the impact of each new addition in 
the process. Second, by enabling the segregation between unobserved processes of 
replication and killing, mathematical models begin to shed light on the black-box of host–
pathogen interactions and inform further biological experiments. For example, if rapid 
killing is identified as the main driver of an observed decline in bacterial numbers, it is 
reasonable to first look in the direction of known cidal branches of the host immunity. 
 
One such approach was taken by Grant et al. in 2008 (Grant et al., 2008) where following 
the identification of early bactericidal activity in a Salmonella mouse model, infection 
progression in wild type mice was compared to that in NADPH oxidase deficient mice to 
unravel an important role of that immunological component in inducing the inferred 
bactericidal effect. In other pathogen classes, mathematical models addressing similar 
questions were successfully used much earlier. 
 
With regards to host immune system-bacterial interactions, mathematical modelling of 
the Mycoplasma species has been ongoing. The Kirschner group have developed a series 




and chemokines of the immune system in the progression of early tuberculosis (TB) 
infection. Their compartmental model based on ordinary differential equations including 
the lung and the draining lymph node (DNL) has been used to study the dynamics of early 
infection, particularly the role of dendritic cells in T-cell priming (Marino and Kirschner, 
2004) and, later, the roles of dendritic cell trafficking to and from the DNL (Marino et 
al., 2004), cytotoxic T-cell-mediated Mycobacteria killing (Sud et al., 2006), TNF-α and 
anti-inflammatory IL-10 (Cilfone et al., 2013) in host defence. Their contributions 
identified the macrophage infection rate and T-cell-mediated immunity as the two key 
elements in determining the trajectory of an infection into one of (i) primary TB, (ii) 
primary TB with clearance, (iii) latency and (iv) reactivation (Marino and Kirschner, 
2004). 
 
1.3.2.2. Comparison of the effect of different strains on infection dynamics 
Fitting within-host models to samples of different strains of the infectious pathogen can 
also facilitate our understanding of how the within-host dynamics of infection vary across 
different strains of the same species. Different strains of pathogens are responsible for 
differences in seasonal and local outbreaks of contagious and deadly infections such as 
influenza (Du et al., 2017), cholera (Weill et al., 2019), community-acquired pneumonia 
(Zhang et al., 2019) and others. These pathogens, albeit very closely related, can show 
extreme differences in transmission rates (e.g. in Mycobacterium tuberculosis in Verma 
et al., 2019), response to therapeutic agents (e.g. in Vibrio cholerae in Weill et al., 2019) 
and virulence (e.g. in swine fever virus in Portugal et al., 2014). In this context, 
mathematical models allow for sensitivity analyses to identify which parameter(s) have 
the greatest impact on a given outcome; this can be helpful in highlighting potential 
causes that drive inter-strain differences. 
 
For instance, Hur et al. (Hur et al., 2013) fit models of influenza infection to experimental 
data on seasonal and pandemic strains of flu. They found that the only parameter that 
varied between the pandemic and seasonal strains was the viral replication rate, indicating 








1.3.2.3. Comparison of the effects of different therapeutic interventions on infection 
dynamics 
Within-host models of infection (both theoretical data-driven) can also reveal important 
insights into the effect of different drugs at the level of the host–pathogen interaction and 
identify effective treatment strategies (e.g. decide whether it is more efficient to prevent 
replication or increase killing). For example, Rong and Perelson (Rong and Perelson, 
2010) evaluated the effect of different Hepatitis C (HCV) treatment strategies. Protease 
inhibitors are being increasingly used in combination with pegylated interferon and 
ribavirin to treat HCV-1 infection, but there remain concerns of relapse after treatment. 
They developed a deterministic mathematical model to examine viral load dynamics 
before and after treatment with a protease inhibitor. Banerjee, Keval and Gakkhar 
(Banerjee, Keval and Gakkhar, 2013) considered the effect of ribavirin being used in 
combination with interferon therapy for HCV infection. Although the study was 
theoretical in nature, it found that – provided a certain threshold of drug efficacy – a 
triphasic response of viral load could be observed, leading to eradication of the virus. 
 
1.3.2.4. Comparison of the effects of different inoculum size on infection dynamics 
Infections can take off with inocula of variable sizes. However, the inoculum size affects 
the population composition of the infectious agents and how they respond to therapy. 
Formulating a deterministic mechanistic model, Meredith et al. (Meredith et al., 2015) 
reported that inoculum size determines the efficacy of β-lactam antibiotics when 
administered to bacterial populations of which at least some members harbor extended β-
lactamase activity. If β-lactam antibiotics were administered in high-density populations, 
then some members would survive and re-establish the infection. They reported that the 
population was sensitive when its initial density was sufficiently low or examined in a 
short time window. Given these properties, they reasoned that optimal antibiotic dosing 











1.3.2.5. Studying the dynamics of infection across different scales 
Mathematical models can be employed to study host–pathogen interactions at multiple 
levels, from cellular to whole-organism and even population level. A solid knowledge of 
the versatility of mathematical techniques allows the use of the same tools to study 
questions on different scales. With judicious use, mathematical models can also combine 
insight acquired at different levels e.g. the single cell and organ levels and use this to gain 
novel insights about disease progression (Gog et al., 2015). For example, a stochastic 
mathematical model generated by the Perelson lab showed that early HIV dynamics differ 
depending on whether infected target cells produce virions continuously or do so in a 
single burst (Pearson, Krapivsky and Perelson, 2011). This study shows how events at 
the single-cell level can have a profound impact on infection dynamics at the whole-
organism level ultimately affecting clinically important quantities used for diagnosis and 
as guides for therapeutic intervention. 
 
Furthermore, it is possible to use the predictions from modeling the host–pathogen 
interactions to inform models at higher scales. In 2009, Heffernan and Keeling 
(Heffernan and Keeling, 2009) took advantage of well-founded predictions about 
immunity in a measles-infected host (Heffernan and Keeling, 2008) to predict the effect 
of vaccination at the population level. 
 
1.3.2.6. Investigating the evolutionary dynamics of infectious disease within the host 
Finally, mathematical models have been used to characterize and quantify the 
evolutionary dynamics of infectious agents within a host. For instance, Chisholm and 
Tanaka (Chisholm and Tanaka, 2016) developed a mechanistic mathematical model to 
examine the evolution of M. tuberculosis within its host. M. tuberculosis is observed to 
enter a latent, dormant state, but, at first glance, a state of dormancy is not advantageous 
for the pathogen as it does not permit replication. However, the study demonstrated that 
latency can be an evolutionarily desirable state. 
 
Furthermore, Fabre et al. (Fabre et al., 2012) formulated a deterministic mechanistic 
model of competing viral populations within host plants. They parameterized it according 
to the carrying capacity of the plant, the intrinsic rate of increase of each variant and the 
competition strength each genotype exerts on the others. They determined the forms of 




intensity and temporal variation of genetic drift experienced by viruses during host plant 
colonization. Parameters were statistically inferred by model fitting to high-throughput 
sequence data of the viral counts obtained from the plants over time, and model selection 

































1.3.3. Inference frameworks 
As noted earlier, mathematical models can serve a range of purposes (Figure 1.1) from 
forecasting to inferring parameters and aiding in experimental design. In data-based 
mechanistic models the first step to achieving any of these goals is model calibration, a 
process of identifying combinations of parameter values that best align the model’s 
output with the experimentally observed biological output (Read et al., 2018). Despite its 
central role in data-based mathematical modelling, model calibration is often challenging 
for biological systems with multiple components, complex underlying biological 
mechanisms and long progression timelines due to various limitations in inference 
frameworks (Penas et al., 2017). These issues are particularly relevant to in vivo studies 
on the within-host dynamics of infection where the capacity for observations and direct 
measurements is limited.  
 
An inference framework is a validated set of mathematical tools aiming to identify a 
single set or a range of parameter values that either minimise a defined metric of 
discrepancy or maximise a metric of proximity between an experimentally observed and 
a model predicted output. In this section, I explain the motivation for my inference 
framework of choice by classifying commonly used inference frameworks into a) 
likelihood-based (statistical) and b) likelihood-free (simulation-based), and outlining the 
features, advantages and limitations of each.  
 
 
1.3.3.1. Likelihood-based inference frameworks 
Likelihood-based frameworks notably include frequentist maximum-likelihood (MLE) 
and Bayesian frameworks (Hartig et al., 2011).  Both rely on the idea that  𝑃(𝑥|𝜃), the 
probability of obtaining the observed data 𝑥 for each possible model parameterisation 𝜃 
given model 𝑀(𝜃) is proportional to the support given to a parameter set  𝜃  by the 
observed data 𝑥 (Fisher, 1922).  
 
On this premise, the frequentist MLE approach formulates a likelihood function 𝑃(𝑥|𝜃) 
and seeks to maximise that function; the 𝜃 that corresponds to the maximum likelihood 




In contrast, the Bayesian framework is interested in a compound quantity known as the 
posterior distribution 𝑃(𝜃) which is proportional to the likelihood 𝑃(𝑥|𝜃) multiplied by 
the prior distribution 𝑝(𝜃), a probability distribution reflecting one’s prior belief about 
the parameter values prior to model calibration (Equation 1).  
 





Unlike the frequentist approach which identifies a single best point estimate for the 
underlying parameters, 𝑃(𝜃) (Eq. 1) is interpreted as a distribution of parameter values 
reflecting the uncertainty around the parameter values in the Bayesian framework.  
Strictly speaking both frameworks are contingent upon the formulation and solution of a 
likelihood function 𝑃(𝑥|𝜃). While for some simple models it is indeed possible to solve 
the likelihood function analytically, most models have intractable likelihood expressions 
which require numerical approaches.  
 
1.3.3.2. Likelihood-free inference frameworks 
Although analytical solutions are the fastest and most accurate, for the vast majority of 
biologically relevant mathematical models the likelihood expression is impossible to 
evaluate due to the presence of a large number of interacting components, multiple latent 
variables, or a distribution of observed data that is modelled by a complex stochastic 
computational model. 
 
To bypass this challenge, it is possible to use a forward approach starting with parameter 
values, followed by model-based simulation and comparison of the simulation output 𝑥′ 
to the observed data 𝑥. This simulation-based, likelihood-free approach constitutes the 
basis for a range of inference frameworks (reviewed in Durham and Gallant, 2002) 
including approximate Bayesian computation (aBC), (Marin et al., 2011; Beaumont, 
2010; Csillery et al., 2010), simulated pseudo-likelihoods (Concordet and Nunez, 2002), 
indirect inference (Gourieroux et al., 1993), informal likelihoods (Beven, 2006), 
sequential neural likelihood (Papamakarios, Sterratt and Murray, 2019), divergence-
minimisation (Price et al., 2017) and Pattern-Oriented Modelling (Wiegand et al., 2003, 
Grimm et al., 2005). These tools rely on approximating the shape of the likelihood 




reducing the dimensionality of the data by comparing sufficient summary statistics 
between the observed and simulated data (Hartig et al., 2011). 
 
1.3.3.2.1. Divergence-minimisation inference framework  
In 1.3.3.2. I list only a selection of the numerous likelihood-free methods available to 
overcome the challenge of intractable likelihood expressions. The impetus for the 
development of this large number of inference tools has been the quest for computational 
efficiency as simulation-based tools have high demands in computational time and power.  
However, despite the range of available tools, three practical problems persist:  
 
1. computational efficiency remains suboptimal, often only allowing for parameter 
inference given a single model, but rarely allowing for model selection where 
multiple models need to be parameterised,  
2. the majority of tools available have been developed and applied in disciplines 
such as physics, engineering and computer science; as a result, rarely are there 
blueprints of applied case studies accessible to biologists,  
3. in microbiology, the format of the observed data output is inflexibly dependent 
on the resolution of the experimental techniques used, and any inference 
framework used needs to be adjusted and optimised for the format of data in 
question. 
As a result of these unresolved challenges, the range of suitable inference tools is, in 
reality, limited.  My methodology of choice in this thesis has been a moments-based, 
divergence-minimisation approach developed by Price et al. (Price et al., 2017), which 
has been applied to ITS-based data before and has shown to be computationally efficient 
for model comparison. Its computational efficiency results from a combination of a) 
dimensionality reduction by compressing the experimentally observed and model outputs 
into summary statistics (method of moments), and b) obtaining analytically evaluable 
expressions of the first- and second-order moments used as summary statistics for the 
linear dynamics assumed in the model. 
 
In this framework, the metric used to quantify the degree of support that observed data 




divergence between the summary statistics of the model output and those of the observed 
data. Instead of seeking to maximise the likelihood of observing the experimental data 
under a parameter set 𝜃 , here one seeks to minimise the discrepancy between the 
distribution of data generated by 𝑀(𝜃)  and that of experimentally observed data. 
Confidence intervals around the parameters point estimate are obtained by means of 
parametric bootstrap followed by parameter estimation for each of the bootstrapped 
samples, as detailed in section 2.7. 
 
Overall, the computational efficiency of this moments-based likelihood-free inference 
framework facilitates the application of mathematical models to in vivo observations from 
complex biological systems over a long time period, the comparison of the performance 
of multiple candidate models, model selection and the use mathematical modelling as a 
























1.4. Murine infections with Salmonella enterica serovar Typhimurium as an 
in vivo experimental model  
 
1.4.1. Background on the experimental system  
Experimental models are physical representations of a real-life system either in vivo or in 
vitro, commonly used by microbiologists in the lab because of their amenability to 
genetic manipulation, reproducibility of results and convenience. While in vitro work can 
reveal mechanistic insights at the molecular and genetic level in terms of pathogenicity 
and response to treatment, in vivo work with animal hosts introduces additional layers of 
biological complexity and renders findings more relevant to whole-organism biology.  
All animal models of human diseases have inherent limitations, but they also have 
important advantages over in vitro methods, including the presence of organized organ 
systems, an intact immune system, the possibility to engineer animal hosts with specific 
genetic backgrounds, and the availability of multiple methods for characterising the 
immune response to microorganisms (Bakaletz, 2004). 
Murine infections with Salmonella species have been widely used as an experimental 
model to study the bacterial pathogenesis of gastrointestinal diseases and host-pathogen 
interactions in vivo (Higginson, Simon and Tennant, 2016). This host-pathogen 
combination is popular because, on the one hand, Salmonella is an extensively 
characterised pathogen with relevance to human diseases and, on the other, because 
certain mouse strains can be readily infected by Salmonella and show symptoms within 
a relatively short timeframe. The abundance of knowledge around the pathogen and the 
susceptibility of the host to infection, alongside other logistical facilities such as 
standardised ethics protocols, low-cost housing requirements and easily accessible rodent 
handling expertise make murine Salmonella infections an attractive choice as an 
experimental model in vaccine and therapy design, as well as immunological and 
microbiological studies (Higginson, Simon and Tennant, 2016; Nilson, Kari and Steele-






1.4.2. Systemic Salmonellosis: Epidemiology, Challenges and Management 
Besides its central role as a prototypical experimental system, murine infections with S. 
Typhimurium have been extensively studied as a model system for both the enteric and 
systemic phase of salmonellosis. Systemic salmonellosis refers to a collection of human 
systemic diseases caused by different strains of the same bacterial pathogen; it 
encompasses typhoid and paratyphoid fever caused by infection with Salmonella enterica 
serovars Typhi and Paratyphi respectively, and invasive Non-Typhoidal Salmonellosis 
(iNTS) caused when non-typhoidal intestinal Salmonella strains (Enteritidis, 
Typhimurium and thousands more), which can escape the host’s immune system control 
and disseminate into the blood (Feasey et al., 2012).  
Salmonella enterica is a Gram-negative enteric bacillus, commonly transmitted through 
the faeco-oral route and less frequently directly into the blood through an open wound. 
Upon ingestion, the bacterium successfully survives the low gastric pH and moves to the 
intestine where it invades epithelial cells ultimately gaining access to the underlying 
lymphoid tissue. Abundant with macrophages, the lymph facilitates the encounter of 
phagocytes with Salmonellae, which henceforth establish an intracellular niche used for 
proliferation, immune evasion and spread. Systemic infection arises at the lymph – blood 
interface where the establishment of bacteraemia facilitates bacterial migration and 
colonisation beyond the mesenteric and caecal lymph nodes to the systemic compartment 
with the liver and spleen being the main reservoirs in the murine hots (Parry et al., 2002; 
Grant et al., 2008) 
Although largely treatable with antibiotics and preventable by improvements in water 
hygiene and general sanitation, systemic salmonellosis was still responsible for 14 
million cases of typhoid fever with 222,000 associated deaths, over 2 million cases of 
iNTS with >500,000 associated deaths (Ao et al., 2015), and unaccountable cases of 
neuropsychiatric sequelae in survivors in 2014-15. The geographical distribution of 
disease burden is uneven, with South-East Asia and Sub-Saharan Africa being regions of 
typhoid fever and iNTS endemicity (Figure 1.3) mainly due to economic inequality, 
poverty and inadequate sanitation infrastructure, coinfections and high HIV prevalence. 
To make matters worse, reports suggest that a large proportion of those outbreaks 
included cases of multidrug-resistant infections unresponsive to mainstream antibiotic 




2008), rendering antimicrobial resistance an additional, clinical obstacle in the reduction 
of worldwide mortality and morbidity of systemic salmonellosis.  
 
 
Figure 1.3: Geographic distribution of typhoidal and non-typhoidal Salmonella endemicity 






Chronic asymptomatic human carriage further complicates the landscape of transmission 
and bacterial evolution; acutely infected patients who clinically recover can remain either 
short-, longer-term or chronic carriers responsible for human-human disease transmission 
through faecal shedding. They constitute living and moving disease reservoirs facilitating 
the emergence of novel bacterial genotypes (Gunn et al., 2014) through horizontal 
transfer of antimicrobial resistance genes. Around 5% of those infected and treated for 
salmonellosis will proceed to chronic bacterial carriage (Levine, Black and Lenata, 1982) 
in the biliary tree and gallbladder through hepatobiliary bacterial transfer (Gonzalez-
Escobedo, Marshall and Gunn, 2011). Typhoidal Salmonella strains have no known 
environmental reservoirs and shedding from a chronic, asymptomatic carrier may be a 
key component in driving transmission in human populations (Gunn et al., 2014). 
Bacterial persistence is also critical to address from the viewpoint of effective 
antimicrobial stewardship: can extended antimicrobial regimes ever eradicate these 
infections and if so, in what combination and length?  
There are at least two explanations about why antibiotics, even with optimal use, may fail 
to completely clear a bacterial infection. The first is that bacterial targets are resistant to 
the antimicrobial in use, i.e. they carry inheritable and transferrable genetic elements 
allowing them to resume grow at high antibiotic concentrations (Scholar and Pratt, 2000). 
The second explanation is the phenomenon of tolerance whereby some bacteria survive 
exposure to antibiotics because of their slow metabolic state while remaining genetically 
identical to bacteria susceptible to the administered antimicrobial (Brauner et al., 2016). 
Tolerance naturally ensues from non-genetic, phenotypic heterogeneity, defined as an 
epigenetically-driven metastable variation in cellular processes (Dhar and McKinney, 
2007). In turn, heterogeneity in bacterial populations has multiple putative sources 
ranging from deterministic in origin and including cell age, cell-cycle stage and metabolic 
oscillations to stochastic events related to gene expression (Avery, 2006). Focusing on 
stochastic determinants of heterogeneity, a bidirectional causal relationship between 
heterogeneity in bacteria and heterogeneity in host cell response further amplifies the 
range of observed host-pathogen interactions (Avraham et al., 2015).  
Appreciating the reciprocal relationship between bacterially- and environmentally- 
driven population heterogeneity can contribute to antibiotic use rationalisation. For 




rates could favour the use of antibiotics in polytherapy regimes instead of standalone 
therapy or vice versa depending on their predicted synergistic or antagonistic effects. 
Furthermore, finding out when this phenotypic heterogeneity is first established in vivo, 
whether bacteria with different replication rates follow a characteristic spatial distribution 
and whether tissues with specific features preferentially act as reservoirs has the potential 
to optimise the route of antimicrobial delivery and its formulation, and to inform best 
clinical practice about whether prolonged antibiotic regimes can ever succeed in fully 
clearing the bacterial reservoirs. 
Currently, the clinical armamentarium against systemic salmonellosis is based on the 
pillars of antibiotic therapy and pre-exposure immunisation. Public health authorities in 
the U.K. recommend the use of broad-spectrum antibiotics such as fluoroquinolones (e.g. 
ciprofloxacin, orofloxacin), chloramphenicol or ampicillin as first-line treatment of 
sensitive clinical isolates of Salmonella, administered for 7-14 days. In cases of long-
term carriage, often seen in immunocompromised individuals, 28-day antibiotic courses 
are recommended, albeit with equivocal success in achieving complete bacterial 
clearance (British Medical Journal (BMJ) Best Practice, 2018). The emergence of S. 
Typhi strains resistant to all first- and second- line treatment antibiotics (including 
ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol) has increased in 
frequency worldwide since the 1980s, creating pressure to shift the management 
paradigm towards prevention rather than treatment in endemic areas (Kariuki et al., 2015). 
Alarmingly, in Malawi, 90% of iNTS isolates were multi-drug resistant in 2008 (Gordon 
et al., 2008).  
Although prevention strategies against systemic salmonellosis have been an active area 
of pharmaceutical research and development since the 1890’s, only two widely-available 
vaccines against S. Typhi have been licensed to-date (MacLennan, Martin and Micoli, 
2014), and no vaccines are available against other Salmonella serovars responsible for 
paratyphoidal and non-typhoidal salmonellosis (Coward et al., 2014; MacLennan, Martin 
and Micoli, 2014). Live (e.g. Ty21a), inactivated polysaccharide-only (Vi capsular 
polysaccharide) and conjugate protein-polysaccharide vaccines against S. Typhi are 
currently in use (Higginson, Simon and Tennant, 2016), the second confirmed as safe for 
administration to immunocompromised individuals (World Health Organisation (WHO), 




immunogenicity in young children (MacLennan, Martin and Micoli, 2014). The 
increasing paratyphoidal salmonellosis prevalence in endemic countries (Ochiai et al., 
2005; Woods et al., 2006) and the >20% fatality rate of non-typhoidal salmonellosis 
amongst children (Tapia et al., 2015) renders the need for vaccines conferring protection 
against a wider range of Salmonella serovars pressing. 
The efficacy of licensed vaccines to induce long-term immunity has been traditionally 
explored from the viewpoints of field epidemiological surveys and lab-based molecular 
immunology, and only recently have mathematical models been used to interrogate the 
within-host dynamics of infection, in what ways and how early in the infection timeline 
different vaccines influence bacterial killing, replication and inter-organ migration 
(Coward et al., 2014). Equally, persistence, chronic asymptomatic carriage and relapse 
of infection have long been studied from a clinical, microbiological and genetic point of 
view, but to decipher why these phenomena occur in vivo whilst the bacterial reservoir 
retains its in vitro susceptibility to antimicrobials requires an understanding of how the 
spatial distribution of bacteria affects antibiotic efficacy as infection progresses, how 
common antimicrobial classes affect the bacterial rates of division, killing and migration, 
and, finally, when and at what rate heterogeneous pathogen subpopulations arise in the 
tissues (Rossi et al., 2017).  
Insights into the dynamical processes that drive bacterial population fluctuations at the 
host-bacterial interface has been arising as a potential accelerator of the empirical-to-













1.4.3. Literature review on the within-host dynamics of salmonellosis 
In 1.4.1. it was noted that Salmonella infections of the murine host is a reliable and 
widespread used experimental model for the study of host-bacterial interactions in vivo. 
As such, it has formed the basis for a range of qualitative and quantitative studies with 
the aim to characterise the within-host dynamics of Salmonella behaviour in the naïve 
host, differentiate between the effects of interventions at the host-pathogen interface, 
study the behaviour of Salmonellae under antibiotic pressure in different tissues, and 
identify the salient immunological components governing each phase of the infection. 
This section provides a thematic categorisation of the existing literature based on the 
biological questions addressed by these studies with a special focus on Salmonella 
enterica serovar Typhimurium (Table 1.1). These questions range from exploratory 
research mapping out the bottlenecks, intra- and inter-tissue dynamics, identification of 
relevant host immunity control mechanisms to hypothesis-driven research comparing the 
effects of two or more interventions on the dynamics of infection, and others.  
 
1.4.3.1. Characterisation of colonisation bottlenecks, intra-organ growth and inter-
tissue migration 
In the field of population dynamics microbiology, bottlenecks refer to events that reduce 
the size of the bacterial population and typically take place when a pathogen first 
colonises a new host, upon migration to a different tissue, under immune pressure, and 
upon treatment with antibiotics (Abel et al., 2015; Rossi et al., 2020). Intra-organ growth 
is the net bacterial growth that underpins the observable number of bacteria in a tissue 
and represents the convolved effects of local bacterial replication and death, while inter-
tissue migration describes the process of bacterial movement between tissues or organs. 
Studying these processes can help to a) characterise the timeline and directionality of 
tissue colonisation during the infection and adjust the timing and target of therapeutic 
interventions accordingly, b) take advantage of the spatiotemporal dynamics of infection 
to potentiate the effects of immunisation or administered antibiotic therapy and limit the 
emergence of resistance, c) understand the complex interplay between different bacterial 
species in co-infections or at the host microbiome-pathogen interface (Abel et al., 2015; 





Studies using murine infections with S. Typhimurium have used a range of experimental 
techniques to investigate the bacterial dynamics in the naïve host in both the enteric 
(Kaiser et al., 2013) and systemic phases (Grant et al., 2008) of infection, as well as at 
the enteric-systemic interface (Lam and Monack, 2014; Gulig and Doyle, 1993). Kaiser 
et al. (Kaiser et al., 2013) used ITS-based data combined with mathematical modelling 
to show that bacterial migration from the gut to lymphoid tissue is almost entirely 
unidirectional and constitutes a major bottleneck in the progression of infection. Earlier, 
Grant et al. (2008) had shown that in the systemic phase of infection high cidal activity 
imposes a strong bottleneck with concomitant rapid bacterial replication leading to the 
establishment of independent bacterial foci in different organs.  
 
The progression of S. enterica from the enteric to the systemic phase is of particular 
clinical interest, as it is commonly associated with systemic salmonellosis in 
immunocompromised and elderly individuals. Three ITS-based studies converged to the 
conclusion that salmonellae are subject to a strong bottleneck effect in their transition 
from the enteric to the systemic phase, leading to a pronounced founder effect in the 
colonisation of the mesenteric lymph node, liver and spleen (Kaiser et al., 2013; Kaiser 
et al., 2014; Maier et al., 2014). Gulig and Doyle (Gulig and Doyle, 1993) narrowed 
down the virulence activity of the S. Typhimurium plasmid to a 6.2-kb genomic region 
and found that its presence increases the rate of intracellular bacterial replication without 
affecting bacterial death or migration. Finally, Lam and Monack (Lam and Monack, 2014) 
studied the effect of orally and intraperitoneally acquired S. Typhimurium co-infections 
and concluded that the enteric Salmonellae exert intraspecies priority effects, leading to 
the exclusion of the intraperitoneally inoculated strain from further colonisation.  
 
1.4.3.2. Identification of host immunity mechanisms responsible for infection 
control 
Once a pathogen colonises a new host, the outcome of the infection is multi-factorially 
shaped by the interaction between the pathogen’s virulence factors and the host’s immune 
responses, compounded by demographic and environmental stochastic factors including 
variation in the bacterial replication, death and migration events as well as the 
composition of the humoural and cellular microenvironment at the time (Vlazaki, Huber 
and Restif, 2019). While this stochastic environment is ever-changing, the majority of 




developing improved diagnostics, therapeutics, and prophylactics (Thakur, Mikkelsen 
and Jungersen, 2019; Maier et al., 2014; Grant et al., 2008).  
 
In the quest for conserved patterns of host-pathogen interactions, a large body of work in 
microbiology pertains to genetic and bioinformatics studies identifying virulence factors 
and host immunity mechanisms by predicting the function of genes through their genetic 
sequence, using transgenic mice and DNA microarrays (Falkow, 2004). In parallel, 
studies in the field of population dynamics microbiology have successfully identified 
such host-pathogen interactions by identifying dominant cidal or static patterns, deducing 
which immunological factors may be responsible for the observed effect, and ultimately 
verifying hypotheses by comparing the dynamics of the same infection in knockout mice 
lacking the gene encoding for the immunological component in question. Genetic and 
population dynamics studies frequently complement each other to pinpoint the gene(s) 
behind an immunological mechanism of interest. 
 
An elegant example of the intertwined relationship between the two fields is found in the 
experimental system of murine S. Typhimurium infections. Early genetic studies had 
shown that while some mouse strains are resistant to S. Tyhpimurium, others are 
susceptible (Plant and Glynn, 1976); the mechanism remained unknown. In a follow-up 
population dynamics study, Hormaeche (Hormaeche, 1980) noted that Salmonellae grew 
at almost double the rate in susceptible BALB/c compared to resistant (B10 x A/J)F1 
mice, and proceeded to show that the difference in net growth was entirely attributable to 
higher bacterial division rate in the former from the early stages of infection, possibly in 
macrophages. In a subsequent genetics study, Vidal et al. (Vidal et al., 1995) pinpointed 
the natural resistance-associated macrophage protein Nramp1 gene on the bcg locus as 
the causative agent for the difference in susceptibility between the mouse strains. 
 
Furthermore, Grant et al. (Grant et al., 2008) used an ITS-based approach in phox-/- mice, 
combined with mathematical modelling to show that while NADPH oxidase exerts a 
strong bactericidal effect in the early stages of the infection, its effect becomes mainly 
bacteriostatic after 6 hours. This change in NADPH effects could be mediated by a 
transition in the population composition of Salmonellae-harbouring host cell types from 
macrophages to neutrophils, thus opening new avenues to explore the interactions 




phase of infection Maier et al. (Maier et al., 2014) reported a transition from undetectable 
cidal activity to a strong bottleneck effect by day 2; they further suggested that the change 
could be attributable to NADPH oxidase and/or granulocyte activity. 
 
Finally, using ccr7-/- mice, Kaiser et al. (Kaiser et al., 2013) mapped bacterial migration 
to dendritic cell movement, while showing that bacterial migration from the gut to the 
caecal lymph node (cLN) is controlled by toxic reactive oxygen species using cybb-/- mice.  
 
1.4.3.3. Characterisation of bacterial dynamics following immunisation 
As highlighted in section 1.1.3, development of safe vaccines with durably protective 
immunogenicity and a cost-effective economic profile limit the repertoire of antigens, 
delivery systems and adjuvants that can be effectively used, and require the prediction of 
the immune responses elicited by the vaccine (Levine and Sztein, 2004). Alongside these 
considerations, the case of Salmonella being a facultative intracellular pathogen with a 
dual lifestyle is particularly challenging in terms of vaccine development, as protection 
against the pathogen requires both humoral and cellular immunity to eliminate both 
extracellular and intracellular bacteria respectively (Mastroeni, Villarreal-Ramos, and 
Hormaeche, 1993). To predict the immune response following immunisation, detailed 
knowledge about the host-pathogen interactions is needed (Rueckert and Guzman, 2012; 
Curtiss R. III, 2002; MacLennan, Martina and Micoli, 2014).  
 
It has long been known that both live-attenuated (LV) and whole-cell killed (KV) 
vaccines increase the rate of blood clearance following an intravenous secondary 
challenge and reduce the bacterial load in the liver and spleen in the early stages of the 
infection (Collins, Mackaness and Blanden, 1966). However, whether these vaccines 
exert cidal or static effects and how their mode of action differs was not further 
investigated until 2014, when Coward et al. (Coward et al., 2014) combined ITS-based 
data with inferential modelling to conclude that the reduction in total numbers of viable 
bacteria observed in both the KV- and LV- groups is attributable to bactericidal effects 
in the first 24 hours post-challenge. However, the two vaccines were found to exert 
differential effects on the blood bacterial dynamics prior to colonisation of systemic 
tissues; while a large proportion of the inoculum was inactivated in the first 30’ post-




Finally, the intra-organ dynamics were also predicted to be different for the two groups; 
bacteria in the LV-mice were predicted to be subject to higher bactericidal activity in the 
spleen, while bacteria in the KV-mice were subject to higher bactericidal activity in the 
liver. Unfortunately, this analysis was limited to simple models applied to the early stages 
of infection due to computational constraints when using a maximum-likelihood 
inference framework. As LVs are known to stimulate a cellular CD4+ and CD8+ T-cell 
response (Mastroeni, Villarreal-Ramos, and Hormaeche, 1992; Mastroeni, Villarreal-
Ramos, and Hormaeche, 1993), further immunisation-challenge experiments were 
carried out on mice treated anti-CD4+ and anti-CD8+ antibodies to abrogate the cellular 
component of the immune response. The dynamics in this group were estimated to be 
similar to the baseline LV-immunised group for the first 72 hours of infection, leading to 
the conclusion that the induction of cellular immunity is responsible for neither the 
enhanced blood clearance of the inoculum nor the higher bactericidal activity in the 
spleen.  
 
In the same year, Lim et al. (Lim et al., 2014) independently studied the effects of a LV 
on the colonization of enteric, lymphoid and systemic organs following a secondary oral 
challenge with S. Typhimurium. Their findings on the effects of the live-attenuated 
vaccine on the systemic organs are compatible with those by Coward et al. (Coward et 
al., 2014). Both groups observed that the spleens of LV-immunised mice were colonized 
by fewer bacteria, while the dissimilar ITS composition between the liver and spleen 
meant that the vaccine prevented free communication between the two organs. 
Furthermore, in the enteric phase of the infection, Lim et al. showed that LV-
immunisation reduces the colonization of Payers’ patches (PP) but does not eliminate it 
entirely. However, given the clear separation between the systemic and enteric phase of 
the infection, the vaccine-induced protection of the PPs does not noticeably affect the 
colonization of the spleen and liver and may, thus, be of little clinical importance.  
Finally, Diard et al. (Diard et al., 2019) evaluated the efficacy of an inactivated whole-
cell oral vaccine against S. Typhimurium to show that while it induces high IgA titres, it 
fails to provide strong protection to the entire mouse cohort. This phenomenon was 
attributed to selection pressure in favour of variants that can escape IgA recognition, and 
was addressed by complementing the original vaccine formulation with a repertoire of 




1.4.3.4. Characterisation of bacterial dynamics during and following antibiotic 
exposure 
At the level of the bacterial population, two studies have used the ITS technique to 
segregate between bacterial replication, death and migration following antibiotic 
exposure. Coupling the ITS technique with fluorescence microscopy and 
pharmacokinetic analysis, Kaiser et al. (Kaiser et al., 2014) showed that S. Typhimurium 
survive ciprofloxacin treatment in the cLN, liver and spleen, and that the surviving 
bacteria were only killed with an antibiotic concentration ≥ 50-fold upper of the minimum 
inhibitory concentration (MIC) verifying their persister status.  
Similarly, Rossi et al. (Rossi et al., 2017) showed that a proportion of wild-type bacteria 
survive both ampicillin and ciprofloxacin treatment in the mesenteric lymph node (mLN), 
liver and spleen, and that the bacterial composition in the mLN is distinct from that of 
other organs, remaining largely unchanged throughout the antibiotic treatment. 
Furthermore, by comparing the effects of ampicillin and ciprofloxacin between murine 
infections with either a slow-growing or a wild-type Salmonella strain, they verified the 
positive correlation between bacterial growth rate and antimicrobial effect. 
Other studies using fluorescence activated cell sorting (FACS) and fluorescent markers 
investigated bacterial replication and killing during antibiotic treatment in vivo, with 
single-bacterium resolution mainly in splenic homogenates. Claudi et al. (Claudi et al., 
2014) used TIMER, a fluorescent protein that changes colour over time, to quantify the 
proportions of rapidly-, moderately- and slowly-dividing bacteria in the spleens of naïve 
mice and mice exposed to ciprofloxacin. The reported a positive correlation between pre-
treatment single-bacterium replication rates and the rate of clearance during treatment. 
However, given the differential prevalence of rapidly-, moderately- and slowly-growing 
bacteria in decreasing proportions, most bacteria surviving treatment originate from 
moderately-growing progenitors, as the absolute number of slow-replicating bacteria was 
low pre-treatment.  
In contrast, in a murine model of early-onset, high-dose enrofloxacin treatment, Helaine 
et al. (Helaine et al., 2014) concluded that surviving bacteria originate from a non-
dividing bacterial subpopulation. Claudi et al. (Claudi et al., 2014) reconciled this finding 




al. the antibiotic treatment was started very early, before the inoculated bacteria adapted 
to the host, and as a result, the prevalence of non-dividing bacteria was exceptionally 
high.  
Finally, Kanvatirth et al. (Kanvatirth et al., 2020) used fluorescent-tagged antibodies 
against cell-type-specific markers to investigate the role of the difference in 
microenvironment between the range of host cell type occupied by Salmonellae during 
and after antibiotic treatment. They used ciprofloxacin, an antibiotic with good cellular 
penetration to rule out the hypothesis that surviving bacteria were not exposed to the 
antimicrobial agent. Furthermore, they reported a shift in the proportion of host cell types 
occupied by Salmonellae pre- and post-treatment, with neutrophils and dendritic cells 
being the predominant host cell type occupied by the bacteria surviving antibiotic 
treatment in the murine spleen.  
1.4.3.5. Characterisation of the within-host dynamics of in vivo adapted Salmonellae 
A large proportion of insights regarding pathogen behaviour comes from either in vitro 
studies, which are typically easier and more economical to perform, or in vivo studies in 
which animal hosts are inoculated with bacteria grown in lab cultures to ensure 
homogeneity in initial conditions and minimise the use of live hosts. However, it is 
becoming increasingly clear that even in vivo studies using in vitro grown bacteria may 
not reflect naturally acquired infections transmitted from host to host or acquired through 
a peripheral route and become systemic over time. The latter applies to Salmonella 
infections which, in human populations, are typically acquired through the faeco-oral 
route and can become systemic over time in immunocompromised individuals, young 
children and older populations; this suggests that there are two time windows when 
Salmonellae can develop host adaptations: a) between shedding from one host and uptake 
by the next, b) during the transition from the enteric to the systemic phase in orally 
acquired infections. Most in vivo studies studying the enteric phase of the infection use 
in vitro grown bacteria and those studying the systemic phase of the infection use 
intravenous inocula, bypassing the host adaptations that take place during the enteric 




In 2015, Dybowski et al. (Dybowski et al., 2015) used an ITS-based approach coupled 
with mathematical modelling to characterise the nature of in vivo adaptations that S. 
Typhimurium manifests upon systemic infection of a new host, compared to in vitro 
grown bacteria which are typically used in these studies. The distribution of ITS coupled 
with model-based inferences showed that in vivo adapted bacteria are better at surviving 
the initial bottleneck, as they enter a state of lower replication that makes them less 
sensitive to early bactericidal effects, and start their systemic spread up to 24 hours earlier 
than bacteria grown in culture. 
1.4.3.6. Characterisation of host cell-bacterial interactions  
Upon infection of the host, the progression of a bacterial infection is determined by 
bacterial virulence factors and host immune factors, as well as by the local host-pathogen 
interactions which stochastically depend on the microenvironment each bacterium 
encounters. For bacteria with both an intracellular and extracellular lifestyle, the effect of 
these stochastic host-pathogen interactions is amplified, as their proliferation or 
extinction becomes multifactorially dependent on: 1) local concentration gradients of 
humoural elements of the host’s immunity, 2) the local distribution of host cell types and 
3) the interaction of the two that often determines the phenotype of the present host cells 
(e.g. cytokine-activated versus resting macrophages). Furthermore, the intracellular life 
mode of a bacterium can range from high intracellular density to sparse host cell 
occupancy; in the latter case, bacteria continuously escape infected host cells and invade 
new, adding further layers of stochasticity.  
 
While earlier in vitro experiments with macrophage cultures had shown that S. 
Typhimurium grows to high intracellular densities (Harrington and Hormaeche, 1986), 
ex vivo fluorescence microscopy on single liver macrophages showed that the majority 
of macrophages harbour 1-2 bacteria, with few macrophages harbouring higher bacterial 
loads (4-6 bacteria), and that the increase in total bacterial population size is paralleled 
by an increase in infected macrophages (Sheppard et al., 2013). A later modelling study 
considered a range of possible biological mechanisms to explain the heterogeneity in 
bacterial numbers per macrophage, concluding that the model with the strongest support 
was one with homogeneous host cell permissiveness to bacterial proliferation, where host 




bacterial accumulation in the intracellular environment and host cell lysis (Brown et al., 
2006). 
 
While the studies by Sheppard et al. and Brown et al. focused on macrophages, it is well-
established that Salmonellae interact with a range of host cell types including dendritic 
cells and neutrophils (reviewed in Castanheira and Portillo, 2017). The relative 
abundance of these cell types fluctuates over the course of the infection, as well as during 
antibiotic treatment or in immunised hosts. Kanvatirth et al. (Kanvatirth et al., 2020) 
studied the relationship between the relative abundance of host immunity cell types and 
the numbers of viable bacteria in the spleen of mice during and post-antibiotic treatment 
with ciprofloxacin. They reported that dendritic cells, macrophages and neutrophils are 
the main host cell types associated with Salmonellae during and following ciprofloxacin 
exposure. Depleting neutrophils during treatment resulted in an increase in the number 
of viable Salmonellae at the end of antibiotic treatment, while the opposite effect was 
observed when dendritic cells and macrophages are depleted. Taken together, these 




Table 1.1: A thematic summary of the experimental studies investigating the within-host dynamics of bacterial infections, adapted and extended 
from Vlazaki, Huber and Restif, 2019 
 








Characterisation of colonisation 
bottlenecks & intra-organ growth and 
inter-tissue migration 
 
Salmonella enterica serovar 
Typhimurium 




Replication, migration and death 
Grant et al., 2008 
Kaiser et al., 2013 




Plasmid segregation Replication and death Bakardjiev et al., 2006 
ITS Replication, migration and death 
Melton-Witt et al., 2012 
Zhang et al., 2017 
Uropathogenic Eschericia coli ITS Replication, migration and death 
Schwartz et al., 2011 
Walters et al., 2012 
Eschericia coli K12 Plasmid segregation Replication and death 
Meynell, 1959 
Mow and Meynell, 1968 
Bacillus anthracis 
ITS Replication, migration and death Lowe et al., 2013 
Multiple fluorescent strains Colonisation Plaut et al., 2012 
Streptococcus pneumoniae ITS Replication, migration and death 
Maier et al., 2014 
Gerlini et al., 2014 
Borrelia burgdorferi ITS Replication, migration and death Rego et al., 2014 
Vibrio cholerae 
ITS Replication, migration and death Abel et al., 2015 
Multiple fluorescent strains Colonisation Millet et al., 2014 
Yersinia pestis ITS Replication, migration and death Gonzalez et al., 2015 
Mycobacterium tuberculosis ITS Replication, migration and death Martin et al., 2017 
Haemophilus influenzae b Plasmid segregation Replication and death Moxon and Murphy, 1978 
Identification of host immunity 
mechanisms responsible for infection 
control 
Salmonella enterica serovar 
Typhimurium 
Plasmid segregation Replication and death Hormaeche, 1980 
ITS Replication, migration and death 
Grant et al., 2008 
Kaiser et al., 2013 
Maier et al., 2014 
Vibrio cholerae Multiple fluorescent strains Colonisation Millet et al., 2014 
Characterisation of bacterial 
dynamics following immunisation 
Salmonella enterica serovar 
Typhimurium 
ITS Replication, migration and death 
Coward et al., 2014 
Lim et al., 2014 
Characterisation of bacterial 
dynamics in the gut microbiome 
Multi-species bacterial samples Fluorescent marker 
Replication 
Myhrvold et al., 2015 
Peak-to-trough ratio Korem et al., 2016 
Salmonella enterica serovar 
Typhimurium 






Characterisation of bacterial 













Characterisation of bacterial 
adaptations following colonisation 
 
Salmonella enterica serovar 
Typhimurium 
ITS Replication, migration and death 
Kaiser et al., 2014 
Rossi et al., 2017 
Vlazaki et al., 2020 
Fluorescent marker 
 
Colonisation Diard et al., 2014 
Replication 
Claudi et al., 2014 
Helaine et al., 2010 
Helaine et al., 2014 
Plasmid conjugation Bakkeren et al., 2019 
Chronic bacterial carriage Monack, Bouley and Falkow, 2004 
Eschericia coli 
Fluorescent marker Replication Roostalu et al., 2008 
Plasmid segregation Replication, death Frenoy and Bonhoeffer, 2018 
Staphylococcus aureus Plasmid segregation Replication, death McVicker et al., 2014 
Salmonella enterica serovar 
Typhimurium 
Fluorescent marker Intracellular dynamics 
Kanvatirth et al., 2020  
Sheppard et al., 2003 
Brown et al., 2006 
Staphylococcus aureus  Multiple fluorescent strains Colonisation Prajsnar et al., 2012 
Salmonella enterica serovar 
Typhimurium 
ITS Replication, death Dybowksi et al., 2015 
Dybowksi et al., 2017 






1.5. Thesis Structure and Novel Contributions 
 
1.5.1. Thesis Motivation 
 
Large-scale mechanistic modelling using population-level data in microbiology is lacking. 
Using data-driven models in the field of population dynamics microbiology has been limited 
by the lack of efficient computational methods to render complex mathematical models 
feasible. Existing data-driven modelling studies are limited to: a) short time intervals, 
usually applied to data from the early phases of a bacterial infection (Grant et al., 2008; 
Kaiser et al., 2013; Coward et al., 2014), b) using a single model without comparing the 
goodness-of-fit of rival models, c) models with simple dynamics and/or few compartments 
(Brown et al., 2006). The motivation of the present thesis has been to approach the 
modelling-data interface pleiotropically, illustrating the range of applications of 
mathematical modelling, as well as the diversity of biological questions that can be 

























dynamics in the 
immunised host 
Within-host 
dynamics in the 
naïve host 
Within-host 














In the present thesis I aim to: 
1. provide the first application of a validated, computationally-efficient tool 
developed to allow large-scale modelling of population-level data from studies in 
within-host bacterial dynamics,   
2. provide a series of case studies of large-scale, data-driven modelling studies 
covering the entire timeline of available experimental data, serving as blueprints for 
an era of more extensive and complete integration between experimental data and 
mathematical modelling,  
3. illustrate the multiple uses of mathematical modelling when integrated with 
experimental data, including: parameter inference, model selection and experimental 
design, and  
4. analyse previously published ITS-based datasets and generate biological insights 
that have helped address knowledge gaps with regards to the impact of antibiotic 
therapy and immunisation on the within-host dynamics of S. Typhimurium in the 
systemic phase of infection.  
 
 
1.5.2. Thesis Structure 
 
The present thesis includes 7 chapters, of which 4 chapters (3-6) correspond to results 
obtained during this PhD. Chapter 1 defines the methodological and current knowledge 
framework, chapter 2 details the methods used and chapter 7 provides the general discussion 
about the implications and future directions of my research. Their contents are briefly 
outlined below:  
 
▪ Chapter 3: I use two published ITS-based datasets with bacterial counts from the 
blood, liver and spleen collected over 72 hours from systemic infections with S. 
Typhimurium in naïve mice (Coward et al., 2014). I combine these data with 
stochastic compartmental models, assess their goodness-of-fit and perform model 
selection. Finally, I use the better-fitting model for parameter inference to 




▪ Chapter 4: I use a published ITS-based dataset with bacterial counts from the blood, 
liver and spleen collected over 72 hours from systemic infections with S. 
Typhimurium in 3 groups of mice: naïve mice or mice previously immunised with 
either a live-attenuated or whole-cell killed vaccine (Coward et al., 2014). I use the 
model identified in Chapter 3 for parameter inference to compare the impact of 
the two vaccine formulations on these dynamics.  
▪ Chapter 5: I use a published ITS-based dataset with bacterial counts from the blood, 
liver, spleen and mesenteric lymph nodes, collected over 14 days from a systemic 
infection with S. Typhimurium in 2 groups of antibiotic-treated mice: 
ciprofloxacin- and ampicillin-treated (Rossi et al., 2017). I formulate stochastic 
compartmental models with either a single or dual phenotype, assess their goodness-
of-fit, perform model selection and make inferences about the effect of the two 
antibiotics on the within-host dynamics of S. Typhimurium. I address questions 
relevant to the origins, migration patterns and post-treatment behaviour of 
bacterial populations that survive antibiotic treatment.  
▪ Chapter 6: I extend the likelihood-free inference approach previously developed by 
Price et al. (Price et al., 2017) to an experimental design tool that can a priori 
quantify the quality of inference precision provided by experimental designs with 
different design factors. I define the determinant of the parameter variance-
covariance matrix as a measure of global precision and use a simulation study to 
show excellent concordance with the width of 95% confidence intervals obtained by 
parametric bootstrap. I assess the effect of three design factors (number of replicates, 
choice of sampling time points, initial number of bacterial copies per ITS), and 
conclude with a series of case studies representing typical patterns of within-host 






1.5.3. Novel Contributions 
As noted in 1.5.1 and 1.5.2, the present thesis contains a mix of studies aimed at obtaining 
novel biological insights and studies oriented towards developing and validating 
computational method for use with ITS-based data. The novel contributions made can be 
summarised as follows: 
 
Chapter 3: S. Typhimurium dynamics in the naïve host  
1. In the naïve murine host, inter-tissue mixing occurs during the first 6 
hours post-inoculation, earlier than previously thought. 
2. In the naïve host, bacteria migrate asymmetrically to the liver and spleen; 
bacteria preferentially migrate to the liver during the first 6 hours post-
inoculation. 
3. With parameter estimates for inter-tissue bacterial migration and intra-
organ death and replication, the systemic phase of salmonellosis can be 
broken down to 3 distinct phases starting from inoculation: a) 6 hours of 
niche establishment in the organs and intra-organ killing, followed by b) 
18 hours of exponential growth, and c) 48 hours of stable, marginal intra-
organ growth. 
 
Chapter 4: S. Typhimurium dynamics in the immunised host  
1. The live-attenuated and whole-cell killed vaccines exert different effects 
on the within-host bacterial dynamics. While the former acts on the liver, 
the latter acts on the spleen.  
2. The inferred effects of the live-attenuated vaccine are consistent with 
earlier studies showing that it induces higher levels of IgG2 antibody 








Chapter 5: S. Typhimurium dynamics in the antibiotic-treated host  
1. The dynamics in the ciprofloxacin-treated mice can be explained by a 
single-phenotype model, while those in the ampicillin-treated mice 
require a more complex dual-phenotype model including a non-growing, 
antibiotic-recalcitrant bacterial subpopulation.  
2. In ampicillin-treated mice, the non-growing, antibiotic-recalcitrant 
subpopulations emerge after 48 hours of treatment in the spleen and 
mesenteric lymph nodes. My model also infers spleen-to-liver bacterial 
transfer. 
3. Unlike ciprofloxacin, ampicillin exerts bacteriostatic effects in the blood 
and in the late phase of treatment in the spleen and mesenteric lymph node. 
4. During relapse following antibiotic treatment, the previously non-
growing populations reconstitute the bacterial population in the 
mesenteric lymph node and spleen, where the growing population went 
extinct prior to antibiotic withdrawal, but also in the liver as they replicate 
faster than the growing population. 
 
Chapter 6: A novel tool for experimental design in ITS-based experiments  
1. The determinant of the parameter variance-covariance matrix obtained by 
parametric bootstrap represents a reliable summary statistic for inference 
precision, and can used in optimal experimental design in a likelihood-
free inference framework.  
2. In ITS-based studies, a higher number of biological replicates, a higher 
number of initial copies per ITS and a selection of sampling timepoints 
based on the pattern of observed dynamics all lead to higher-precision 
estimates.  
3. With regards to optimal resource allocation and animal welfare, using 
experimental infections with a lower number of ITS per host at higher 
number of copies per ITS yields higher-precision inference than a higher 




    2. 




• ITS-based datasets consist of observations of copies per ITS in each tissue of interest 
at different sampling timepoints. 
• ITS-based data can be combined with compartmental models, with each 
compartment representing the bacterial subpopulation residing in each tissue of 
interest at time 𝑡.  
• The master or forward Kolmogorov equation describes the probability of observing 
a given number of copies per ITS in each compartment at time 𝑡 . For complex 
biological systems, the master equation can only be numerically approximated; this 
is computationally intensive and time-consuming.  
• An alternative to solving the master equation is summarising the distribution of 
bacterial copies per ITS in each compartment by a set of summary statistics: the first- 
and second- order moments.  
• Parameter inference is performed by minimising the Kullback-Leibler divergence 
between the experimental and calculated moments for a range of parameter values.  
• Assessment of model goodness-of-fit and quantification of inference precision both 
require a parametric bootstrap approach.  
• Experimental design in terms of optimising inference precision is performed by 
minimising the determinant of the parameter estimate variance-covariance matrix 
obtained by parametric bootstrap.  
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Declaration of Originality  
This chapter includes written material that has been verbatim reproduced from a paper 
currently in press (Vlazaki, Price and Restif, 2020), for which I certify that I am the sole 
contributor in terms of study design, execution and manuscript writing. I also certify that I 
have included the relevant citations, where appropriate. 
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2.1. The ITS technique: experimental output and dataset structure  
ITS represent a large class of marker-based techniques developed over the last decade to 
study the demographic processes that collectively determine the total observable microbial 
load in a tissue of interest (Grant et al., 2008). Libraries of isogenic tagged strains are 
generated by uniquely modifying the non-coding portion of the bacterial genome with 
distinctive, short nucleotide sequences; the resulting ITS are genetically distinguishable, yet 
phenotypically identical. The ITS are typically mixed in equiproportional inocula and 
administered to the animal host. Animals are culled at predetermined time points to harvest 
or partly sample tissues of interest, and a total bacterial count is obtained per tissue (Grant 
et al., 2008; Abel et al., 2015). The samples are processed to determine the ITS composition 
in each tissue, originally by qPCR (e.g., Grant et al., 2008; Kaiser et al., 2013; Kaiser et al., 
2014) and more recently by next-generation sequencing (e.g., Rossi et al., 2017; Lim et al., 
2014). The final structure of the dataset consists of number of copies per ITS in each tissue 
of interest per time point, as summarised in Figure 2.1.  
 
By obtaining snapshots of spatiotemporal data recapitulating the changing ITS composition 
of bacteria in different tissues, it is possible to characterise the unobserved processes that 
underpin the in vivo progression of a bacterial infection. Supplementing these data with 
compartmental mechanistic models, it is possible to quantify the rates at which these 
unobserved dynamical processes progress with time. A unique feature of ITS-based studies 
is the multiplicity of infections with different tagged strains within each host organism. 
Under the assumptions of independent action for bacteria and homogeneity in dynamics both 
between ITS and between host organisms, each ITS in the inoculum can be treated as an 
independent infection, with the total number of biological replicates in a dataset being equal 
to the number of ITS per host multiplied by the number of hosts. Experiments produce 
measurements of the number of copies of each ITS in anatomical compartments of interest 
at the time that each host animal is killed, and inference about the within-host dynamics 
“fills in” the gap between the sampled timepoints. 
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Figure 2.1: Summary illustration of the ITS technique and the structure of the experimental dataset 
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2.2. Conceptual Model Structure  
Mechanistic models applied to ITS data typically have a compartmental structure, with each 
compartment representing a tissue of interest, and model parameters corresponding to the 
rates at which the unobserved biological processes change with time. Figure 2.2 illustrates 
an example of a model with three compartments, all possible transitions between them and 








Figure 2.2: Conceptual structure of a mechanistic model with three compartments 
{𝑵𝟏, 𝑵𝟐, 𝑵𝟑}, intra-organ bacterial killing (ki) and replication (ri), and inter-tissue migration 
(mij). 
Earlier experimental studies on the pathogenesis of systemic salmonellosis in the murine 
host have revealed that upon intravenous inoculation, the liver and spleen act as major 
bacterial reservoirs with bloodstream-mediated bacterial migration (Grant et al., 2008), 
while for infections obtained through the orogastric route, the mesenteric lymph node is an 
additional bacterial reservoir (Rossi et al., 2017; Grant et al., 2008; Kaiser et al., 2013). This 
biological insight motivated compartmental models encompassing the blood, liver, spleen 
and mesenteric lymph node (Grant et al., 2008; Coward et al., 2014). To enable parameter 
inference of both intra-organ (e.g. killing) and inter-organ (migration) processes, a stochastic 
model was used in which the number of bacteria per ITS in each organ was treated as a 
random variable. The first- and second- order moments were used to characterise this 
distribution and the system was modelled as a multivariate Markov process involving 










r3 r2 k2 k3 
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2.3. Mathematical Model Structure  
[reproduced verbatim from Vlazaki, Price and Restif, 2020; Supplementary Methods] 
Multivariate Markov processes are defined as processes involving a number of independent 
stochastic variables, whose future state only depends on the present state and not the past 
(Markov, 1906). The dynamics of such processes collectively determine the probability that 
the system is at a given state at any particular time point; this probability can be summarised 
by the master equation (2.3.1). In bacterial dynamics, the state of the system refers to a 
vector consisting of the number of bacteria residing in the tissues of interest.  
For a multivariate process, the master equation becomes impossible to solve analytically. 
Numerical approximations of the master equation are inaccurate and time-consuming to 
obtain. To address this challenge, Coward et al. (Coward et al., 2014) and Price et al. (Price 
et al., 2017) showed that under the assumption of constant rates for the within-host dynamics 
in each time interval (first-order dynamics) and the simplification that ITS are normally 
distributed in each tissue, first- and second- moments can be used as sufficient summary 
statistics to describe the state that the system is in. It is, then, possible to derive mathematical 
equations for the first- (2.3.2) and second-order moments (2.3.3) of the experimentally 
observed states by adapting a moment-closure method for stochastic models in population 
biology described by Singh and Hespanha (Singh and Hespanha, 2006). Given the initial 
first- (means) and second-order moments (variances, covariances) per organ per time point 
and values for the parameters governing the dynamics of the system, the equations 
describing the evolution of the moments can be solved to obtain the moments at a later 
timepoint, thus bypassing the need to numerically evaluate the master equation.  
 
Let 𝑀1(𝑡) be a vector of the first-order moments for the three-compartment system in Figure 
2.1, and 𝑀2(𝑡) be the vector of second-order moments (variances, covariances) in the same 
system. 𝑀1(0) and 𝑀2(0) refer to the first- and second- moments at 𝑡=0 respectively. To 
calculate the moments at time 𝑡, 𝑀1(𝑡) and 𝑀2(𝑡), it is possible to solve equations 2.3.4 and 
2.3.5 numerically in R using the SPEEDI.R package (Price et al., 2017). 
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?̇?(𝑛1, 𝑛2, 𝑛3) = 𝑚12𝑃(𝑛1 + 1, 𝑛2 − 1, 𝑛3)(𝑛1 + 1) + 𝑚13𝑃(𝑛1 + 1, 𝑛2, 𝑛3 − 1)(𝑛1 + 1) + 𝑚21𝑃(𝑛1 − 1, 𝑛2 + 1, 𝑛3)(𝑛2 + 1)
+ 𝑚31𝑃(𝑛1 − 1, 𝑛2, 𝑛3 + 1)(𝑛3 + 1) + 𝑚23𝑃(𝑛1, 𝑛2 + 1, 𝑛3 − 1)(𝑛2 + 1)
+ 𝑚32𝑃(𝑛1, 𝑛2 − 1, 𝑛3 + 1)(𝑛3 + 1) + 𝑟1𝑃(𝑛1 − 1, 𝑛2, 𝑛3)(𝑛1 − 1) + 𝑟2𝑃(𝑛1, 𝑛2 − 1, 𝑛3)(𝑛2 − 1)
+ 𝑟3𝑃(𝑛1, 𝑛2, 𝑛3 − 1)(𝑛3 − 1) + 𝑘1𝑃(𝑛1 + 1, 𝑛2, 𝑛3)(𝑛1 + 1) + 𝑘2𝑃(𝑛1, 𝑛2 + 1, 𝑛3)(𝑛2 + 1) + 𝑘3𝑃(𝑛1, 𝑛2, 𝑛3 + 1)(𝑛3 + 1)
− [(𝑟1 + 𝑘1 +𝑚12 +𝑚13)𝑛1 + (𝑟2 + 𝑘2 +𝑚21 +𝑚23)𝑛2 + (𝑟3 + 𝑘3 +𝑚31 +𝑚32)𝑛3]𝑃(𝑛1, 𝑛2, 𝑛3) 
 
It is possible to approximate the dynamics of multivariate Markovian processes using moment-closure methods to derive a system of ODEs for 
the moments of the state variables from the master equation (2.3.1) of any stochastic model (Price et al., 2017). By considering the first- and 
second-order moments as sufficient summary statistics, it is possible to derive a closed, small-dimension system allowing fast numerical solution 
of these moments at any time point.  From the general equation for the 𝑗𝑡ℎ moment of a distribution described by Singh and Hespanha (Singh and 
Hespanha, 2006), it is possible to obtain a set of differential equations for the first-order (Equation 2.3.2) and second-order (Equation 2.3.3) 
moments as a function of time.  
𝜕𝑀1(𝑡)
𝜕𝑡




= 𝐶 ×𝑀2(𝑡) + 𝐵 × exp⁡(𝑡𝐴) × 𝑀1(0) 
Interpreted as the instantaneous probability that at time t there 
are n1 bacteria in the 1
st compartment, n2 bacteria in the 2
nd 
compartment and n3 bacteria in the 3
rd compartment 
The rate m21 is multiplied by the probability of a migration event from the 
2nd to the 1st compartment. Each bacterium in the population has the same 
probability of migrating, hence the multiplication with the total number of 
bacteria (n2 + 1) in the 2
nd compartment, prior to the migration event 
where ?̇?(𝑛1, 𝑛2, 𝑛3) is an abbreviated notation for ?̇?(𝑛1(𝑡), 𝑛2(𝑡), 𝑛3(𝑡)) and represents a system of ODEs tracking the probabilities 𝑃(𝑛1(𝑡), 𝑛2(𝑡), 𝑛3(𝑡)). 
(2.3.2) 
(2.3.3) 
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Price et al. (Price et al., 2017) provides the matrix form solution to this set of differential equations, shown in 2.3.4 and 2.3.5 for the first- and 
second-order moments respectively.  
𝑀1(𝑡) = exp⁡(𝐴𝑡) × 𝑀1(0) 
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The matrices 𝐴, 𝐵⁡and 𝐶 appearing in equations 2.3.2 – 2.3.5 are populated with the model parameters. For a three-compartment model with all 
allowed transitions between compartments illustrated as an example in 2.2, matrices 𝐴, 𝐵 and 𝐶 take the form below (2.3.8 – 2.3.11). 
⁡⁡𝐴 = (
𝑟1 − 𝑘1 −𝑚12 −𝑚13 𝑚21 𝑚31
𝑚12 𝑟2 − 𝑘2 −𝑚21 −𝑚23 𝑚32








𝑟1 + 𝑘1 +𝑚12 +𝑚13 𝑚21 𝑚31
𝑚12 𝑟2 + 𝑘2 +𝑚21 +𝑚23 𝑚32
𝑚13 𝑚23 𝑟3 + 𝑘3 +𝑚31 +𝑚32
−𝑚12 −𝑚21 0
−𝑚13 0 −𝑚31












2(𝑟1 − 𝑘1 −𝑚12 −𝑚13) 0 0
0 2(𝑟2 − 𝑘2 −𝑚21 −𝑚23) 0
0 0 2(𝑟3 − 𝑘3 −𝑚31 −𝑚32)
−𝑚12 −𝑚21 0
−𝑚13 0 −𝑚31




















(𝑟1 + 𝑟2 − 𝑘1 − 𝑘2 −𝑚12 −𝑚13 −𝑚21 −𝑚23) 𝑚21 +𝑚23 𝑚31 +𝑚32
𝑚12 +𝑚13 (𝑟1 + 𝑟3 − 𝑘1 − 𝑘3 −𝑚12 −𝑚13 −𝑚31 −𝑚32) 𝑚32 +𝑚31
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2.4. The Kullback-Leibler divergence as a cost function  
In all inference frameworks used in data-driven mathematical models, parameter inference 
is achieved by comparing the output of a mathematical model with the available 
experimental observations, and choosing the parameter set that makes the two as identical 
as possible. Cost or utility functions are used to measure how different or similar these 
quantities are; optimising these functions identifies the estimates for the unknown 
parameters. Figure 2.3 illustrates the example of ITS-based experiment to showcase the 















Figure 2.3: Schematic representation of the inference process and the role of the cost/utility 




7 copies per ITS 
 
Candidate mathematical model 
𝒕 = 𝟎 
Distribution of ITS in each tissue 
𝑀𝑜𝑏𝑠 = {𝐸1, 𝐸2, 𝐸3, 𝑉1, 𝑉2, 𝑉3, 𝑉1,2, 𝑉1,3, 𝑉2,3} 
Tissue #1 Tissue #2 Tissue #3 
𝒕 = 𝒕𝟏 
First- and second- order 
moments as summary 
statistics 
𝑀𝑝𝑟𝑒𝑑 = {𝐸1, 𝐸2, 𝐸3, 𝑉1, 𝑉2, 𝑉3, 𝑉1,2, 𝑉1,3, 𝑉2,3} 




Calculation of first- 
and second- order 
moments as 
summary statistics 
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To quantify the difference between the experimentally observed and model-predicted 
moments in the likelihood-free inference framework, it is possible to use a range of 
divergence measures including the Chi-squared distance, the Mahalanobis distance, the 
Hellinger distance, the Kullback-Leibler (KL) divergence and others. Price et al. (Price et 
al., 2017) compared their performance by evaluating the mean absolute relative error of 
parameter estimates in a three-compartment model. As shown in Figure 2.4, the performance 
of the Kullback-Leibler divergence is superior, with mean absolute relative errors 
consistently at ~ 0.15 (15%) across 30 simulated scenarios.  
 
 
Figure 2.4: Comparative performance of different cost functions 
Plot of mean absolute relative errors of parameter estimates for a three-compartment model, for a 
range of divergence measures across 30 scenarios, averaged across each of the 100 simulations at 
each observation time. The horizontal lines correspond to the average mean absolute relative error 
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In this thesis, I used a simplified expression for the KL-divergence as the preferred cost 
function. Assuming a true distribution 𝑃 for a continuous random variable and an artificial 
distribution 𝑄 for the same random variable, the KL-divergence measures the information 
lost when using an artificial probability distribution 𝑄  (model-predicted distribution) to 
describe the true probability distribution 𝑃  (experimentally observed distribution). For 
distributions P and Q of a continuous random variable, the KL divergence is defined by 2.4.1:  
 







To facilitate the numerical evaluation of this expression using only the first- and second- 
order moments of the distributions P and Q, Price et al. (Price et al., 2017) made the 
simplifying assumption that for 𝑛 ITS in the initial inoculum, the distribution of ITS copies 
in each compartment is a multivariate normal distribution with means 𝜇 = {𝜇1, 𝜇2, 𝜇3… , 𝜇𝑛} 
and variances 𝑉 = {𝑉1, 𝑉2, 𝑉3… , 𝑉𝑛}, transforming equation 2.4.1 into 2.4.2, which performs 
well as a cost function in this moments-based inference framework (Vlazaki, Price and 







−1 ⁡⁡𝑉𝑝𝑟𝑒𝑑) − 𝑛 + 𝜇
𝛵𝑉𝑜𝑏𝑠
−1 ⁡𝜇 + 𝑙𝑜𝑔
|𝑉𝑜𝑏𝑠|
|𝑉𝑝𝑟𝑒𝑑|
] , 𝑤ℎ𝑒𝑟𝑒⁡ 




2.5. Linear regressions to correct experimental data for noise  
In ITS-based experiments, raw experimental data consist of: 1) the total number of bacteria 
per tissue per time point and 2) the proportions at which each ITS is represented in the total 
bacterial count, as determined by either qPCR or next-generation sequencing. Accounting 
for the proportion of tissue sampled, it is possible to calculate the number of copies per ITS 
per tissue at each time point. However, the raw data are subject to at least two sources of 
error. First, there is sampling error due to incomplete tissue sampling which is typically 
secondary to technical constraints during the experimental procedure (e.g. it is impossible 
to obtain 100% of the blood). Second, noise is introduced by the ITS detection technique 
when quantifying the true proportions of tagged strains in a minute sample used for detection. 
(2.4.1) 
(2.4.2) 
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As inference relies on the comparison of experimental data with noise-free simulated data, 
the two known sources of noise should be accounted for in the experimental data prior to 
inference.   
Since the generating processes of both sources of noise are well-understood, both errors can 
be modelled accordingly, and any “perfect” observation can be converted to noisy through 
appropriate transformations using the model(s) for the source(s) of noise. The sampling error 
due to partial sampling of the tissue can be modelled as a binomial process (2.5.1). In terms 
of ITS-detection, the qPCR detection noise has been empirically modelled as a log-normal 
process by plating known numbers of colonies of each ITS, putting them through qPCR and 
fitting a family of models to characterise the relationship between qPCR reads and ITS 
colonies in the sample. Using a maximum likelihood approach, Coward et al. (Coward et 
al., 2014) identified the best-fitting model as shown in 2.5.2.   
 
𝝂~𝑩𝒊𝒏𝒐𝒎(𝒏,𝝋), where:  
𝜈: the number of copies per ITS in the sample 
𝑛: the number of copies per ITS in the whole tissue 
𝜑: the proportion of tissue sampled 
 
 
𝐥𝐨𝐠(𝜴𝝂)~𝑵(𝐥𝐨𝐠(𝒗) , 𝟎. 𝟐𝟔𝟕𝟒𝒆
−𝟎.𝟎𝟏𝟒𝟖𝝂),⁡ where: 
𝛺𝜈:⁡number of qPCR reads per ITS 
𝜈: the true number of copies per ITS in the sample 
 
For ITS data analysed using next-generation sequencing, it is possible to obtain a low count 
of reads even in the absence of ITS (yellow curve in Figure 2.5). To account for this, Rossi 
et al. (Rossi et al., 2017) established a technical noise cut-off (green line in Figure 2.5) below 




























Figure 2.5: Technical cut-off to account for ITS detection noise when using next-generation 
sequencing [reproduced from Rossi et al., 2017] 
 
Having characterised the noise processes, I used a reverse engineering approach to convert 
the observed noisy moments back to their true “perfect” state. To achieve this, I simulated 
large numbers of “perfect” datasets, transformed them into noisy data by applying the noise 
models, calculated the corresponding “perfect” and “noisy” moments, and used linear 
regression models weighted by the distance of the simulated data value to the experimental 
value to find an expression that describes their relationship. An example of this algorithm 
applied to simulated “perfect” and simulated noisy data from a three-compartment model is 
illustrated in Figure 2.6. I use this expression obtained from the linear regression model to 







































Figure 2.6: Linear regression models to quantify the relationship between noisy and “perfect” 
simulated data  
 
These are plots generated by simulating “perfect” datasets and transforming them to “noisy” by 
applying the noise models by Equations 2.5.1 and 2.5.2, calculating the first- and second-order 
moments and plotting the “perfect” against the “noisy” moments. To capture the relationship 
between the noisy and “perfect” data for values close to the observed moments, a weighted linear 
regression model is fitted (red line), with points weighted proportionately to their proximity to the 
observed noisy moment in the experimental dataset. Using weighted linear regression models, it is 
possible to find the “perfect” moment (purple line) that corresponds to the observed “noisy” moment 
in the experimental dataset. For variances and covariances the values have been log-transformed. 
Negative covariance values were transformed into their absolute value prior to log-transformation; 
the sign of the covariance in the experimental data was then re-assigned to the “perfect” covariance 
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2.6. Parameter Inference  
Given a set of initial moments and a set of moments observed at a later timepoint, it is 
possible to find, a set of predicted moments that closely matches the observed moments at 
the later time point by minimizing the cost function that measures the distance between them; 
in this case, the KL-divergence (Section 2.4). The parameter set generating these well-
matched predicted moments is selected as the best estimate of the unobserved processes 
which I aim to characterise and quantify.  
To perform parameter inference, I used the dedicated SPEEDI.R package (Price et al., 2017), 
which offers a range of optimisation algorithms to minimise the cost function. In the absence 
of prior knowledge about the behaviour of the function to be optimised, I used the gradient-
free Nelder and Mead optimisation routine  (optim function in the stats package R) which is 
appropriate for non-smooth functions where derivative values are not available (Nelder and 
Mead, 1965). To abrogate the influence of the algorithm search starting point, I ran the 
optimisation routine 200 times on the same set of initial and endpoint moments with different 
starting points, and chose the parameter set with the lowest divergence value as the best.  
 
2.7. Parametric bootstrap to assess model goodness-of-fit to the data 
Goodness-of-fit is a measure of how well a given model captures the experimental data. 
Here, I used a parametric bootstrap approach to assess model goodness-of-fit. Using 
minimum-divergence moments-based inference, I identified the set of parameters that 
correspond to first- and second- order moments which yield the smallest divergence from 
the observed moments (detailed in 2.5). I refer to this set of moments as predicted moments 
and the corresponding parameter set as predicted parameters.  
 
To evaluate the relative goodness-of-fit for the models, I used three metrics. The first metric 
was the pairwise comparison of the KL divergences; a lower divergence indicates a smaller 
discrepancy between the model-predicted moments and the experimentally observed 
moments. This metric is used to compare model performance overall, but is not informative 
about the model’s ability to capture each individual moment. For example, it is possible for 
two models to have similar KL divergence values, which may, at first sight, suggest that the 
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two models perform similarly. However, upon examining the discrepancy between each 
individual experimental and model-predicted moment, it is possible to observe that one 
model captures a few individual moments very well, while completely misestimating the 
others, while the second model has a more homogeneous behaviour across all moments. In 
this case, I take the latter to be a better-performing model, as it captures the summary 
statistics adequately.  
To assess the performance of the model at the level of the individual moments, I used two 
other metrics. For each model, I plotted the 95% confidence interval for each of the nine 
bootstrapped moments and overlaid the experimentally observed moments, which should 
fall within that confidence interval for a model with good fit, as explained in section 2.6. 
This metric assesses whether the model adequately captures all first- and second-order 
moments, which I have used as my summary statistics of choice. Figure 2.7 shows examples 
of models with poor (A), adequate (B) and good (C) fit. 
 
The third metric was the pairwise comparison of the similarity between each synthetic 
dataset and its bootstrapped samples for the six models considered. Given the best parameter 
estimates after fitting each model to the experimental data, I used the parametric bootstrap 
approach to simulate 500 bootstrapped samples for each. I obtained the mean value and 
standard deviation of each moment for the 500 bootstrapped samples and calculated the 
number of standard deviations between each experimentally observed moment and the mean 
of each bootstrapped sample moment. This metric provides quantitative information about 
how close the experimentally observed moments are to the mean behaviour of the model 
considered. 
For models with similar performance across the three metrics, I chose the one with the 










Figure 2.7: Bar plots of 95% confidence intervals for simulated moments from models with 
poor, adequate and good fit 
The experimentally observed moments are represented by red dots, superimposed on bar plots of 95% 
confidence intervals for moments calculated from simulated datasets (N=200) using parametric 
bootstrap when three models are considered (A-C). Panel (A) represents a model with a poor fit to 
the data, as the 95% confidence intervals for the simulated moments differ significantly from the 
experimentally observed moments (red arrows). Panel (B) represents a model with adequate fit, with 
all experimentally observed moments captured only by very few simulations of the model (orange 
arrows), while Panel (C) represents a model with a good fit, with observed moments approximating 
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S. Typhimurium dynamics 
in the naïve host  
 
Summary Points: 
• In this chapter, I formulate and apply a series of nested compartmental models to two 
ITS-based datasets from intravenous S. Typhimurium infections in the naïve murine 
host with the aim of quantitatively characterising the unobserved demographic 
processes that shape bacterial dynamics in the naïve hots. 
• In the naïve murine host, inter-tissue mixing is predicted to occur during the first 6 
hours post-inoculation, which is earlier than previously thought. 
• With parameter estimates for inter-tissue bacterial migration and intra-organ death 
and replication, the systemic phase of salmonellosis can be broken down to 3 distinct 
phases starting from inoculation: a) 6 hours of niche establishment in the organs and 
intra-organ killing, followed by b) 18 hours of exponential growth, and c) 48 hours 
of stable, marginal intra-organ growth. 
• It is possible to identify the changes in demographic processes that underpin the 
transitions between the phases. 
• In the early phase of infection, bacteria migrate asymmetrically to the liver and 
spleen, with higher migration to the former, where they are met with high 
bactericidal activity. 
• In the second phase of infection, cidal activity in the liver and blood-to-organ 
migration decrease.  
• In the third phase of infection, intra-organ bacterial dynamics remain stable, with 
bacterial replication higher than killing in both the liver and the spleen.  
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3.0. Abstract  
In the 21st century, bacterial infections still constitute a major cause of morbidity and 
mortality disproportionately afflicting children and immunocompromised individuals in 
low-resource settings. Of bacterial diseases, systemic salmonellosis remains a leading cause 
of community-acquired bloodstream infections in sub-Saharan Africa. Salmonella 
Typhimurium infections of the murine host have long served as an experimental model for 
human systemic salmonellosis to investigate virulence determinants, host immune responses 
and within-host bacterial population dynamics amongst others. Despite the continuous 
improvement of experimental techniques, in vivo observation of bacterial replication, killing 
and inter-tissue migration remains imperfect. Combining experimental data with 
mathematical modelling can address this challenge by enabling inferencing about 
experimentally unobserved processes. Here, a mechanistic, stochastic mathematical model 
is fitted to data obtained from experiments with isogenic tagged Salmonella strains to reveal 
that, in the early stages of infection, bacteria freely migrate out of the liver and spleen and 
are redistributed via the bloodstream. Estimation of the replication, killing and migration 
rates shows differential Salmonella uptake in the organs until 24 hours post-infection, before 
the rates stabilise and converge to similar levels.  
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3.1. Introduction  
Infections of genetically susceptible mice with S. Typhimurium constitute one of most 
extensively studied host-pathogen system since the 1980’s, leading to insights in the fields 
of Salmonella pathogenesis, immunity and vaccinology, while also serving as an accelerator 
for the development of new methods in microbiology (reviewed in Tsolis et al., 2011). The 
wealth of information about the genes and systemic mediators that affect the course of 
Salmonella infections in mice is a valuable resource that has allowed incremental discoveries 
to be made. Examples include the discovery that aroA Salmonella mutants are attenuated 
and immunogenic in mice (Hoiseth and Stocker, 1981), which was later used by Rossi et al. 
(Rossi et al., 2017) to compare the effect of antibiotics in rapid-growing and slow-growing 
(aroA mutant) strains. Similarly, the finding that Salmonella infection control requires both 
antibodies and CD4+ T-cells inspired the comparison between the mechanisms of action of 
live-attenuated and killed whole-cell vaccines (Coward et al., 2014). 
In contrast to the rich literature around the host immunological and bacterial virulence 
factors and their effect on Salmonella colonisation, pathogenesis and response to vaccination, 
little is known about the events that occur in vivo in terms of when, where and how quickly 
bacteria replicate, die and migrate between tissues in the naïve murine host (Sheppard et al., 
2003). Studies using confocal microscopy (Richter-Dahlfors, Buchan and Finlay, 1997; 
Sheppard et al., 2003) and ITS (Grant et al., 2006; Kaiser et al., 2013) have provided a series 
of static snapshots regarding the intracellular distribution of Salmonellae, the host cell types 
Salmonellae associate with, the tissues/organs colonised and the bacterial burden in each.  
However, insights into the mechanisms underpinning these static observations are lacking. 
One way of completing the picture is to integrate mechanistic mathematical models with 
experimental snapshot data in order to make inferences about the unobserved biological 
processes of bacterial replication, death and migration that collectively shape the 
fluctuations in the size of the bacterial subpopulations in different tissues. A study by Brown 
et al. (Brown et al., 2006) using mechanistic models to re-analyse in vivo data on 
intracellular Salmonella counts in liver macrophages (Sheppard et al., 2003) is a 
characteristic success story of using this approach, by developing a series of models to 
address the question: which modes of intracellular replication and host cell lysis are 
compatible with the observed numbers of bacteria in liver macrophages?   
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Similarly, it is possible to use this integrated mathematical and experimental approach to 
address questions about the dynamics of systemic S. Typhimurium infections in the naïve 
host at the level of the bacterial population. For example, the role of both humoural and cell-
mediated immunity in the early control of Salmonella proliferation in the blood of the murine 
host remains contested (Mittrücker and Kauffman, 2000), especially for systemic infections 
acquired intravenously, in which bacteria do not go through the immunologically active gut 
microenvironment, thus having a lower probability of encountering circulating phagocytes 
and becoming internalised. Previous modelling attempts using ITS-based data from systemic 
S. Typhimurium infections in the naïve murine host have a priori ignored the possibility 
bacterial killing in the blood (Dybowski et al., 2015; Coward et al., 2014; Grant et al., 2008). 
Another uncertainty concerns the ways in which Salmonellae colonise the systemic tissues.  
Previous studies have posited that bacteria colonise the liver and spleen, forming local foci 
which remain segregated until later in the infection process (Grant et al., 2008; Dybowski 
et al., 2015); however, these studies only used simplified models with as few parameters as 
possible for feasibility purposes, and did not comparatively assess the goodness-of-fit of 
rival more complex models.  
Other unknowns include the ways in which different tissues control infection locally, e.g. 
whether they rely on bactericidal or bacteriostatic mechanisms and the extent of disparities 
between the different tissues. Finally, there is a knowledge gap around the later phases of 
systemic salmonellosis, where bacterial subpopulations grow exponentially in both the liver 
and the spleen: is this phenomenon the result of a higher average bacterial replication rate, 
or lower cidal activity in the organs?   
Deciphering these questions is important not only to gain a more complete understanding 
around the pathogenesis and host-bacterial interactions in systemic salmonellosis, but also 
to provide a quantitative reference which will enable the characterisation of the therapeutic 
or prophylactic effects of interventions such as antibiotic treatment or immunisation.  In this 
chapter, I use ITS-based datasets from two experiments combined with data-driven 
mechanistic models to address the questions outlined earlier with regards to the within-host 
dynamics of S. Typhimurium in the naïve host. First, I formulate a series of mechanistic 
models that reflect rival biological hypotheses regarding the early inter-organ bacterial 
mixing, and killing and replication of Salmonellae, as well as the host-bacteria interactions 
in the later phases of systemic salmonellosis. Then, I evaluate their performance by assessing 
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their goodness-of-fit to the ITS-based data, and reject those that do not capture the patterns 
in the experimental data. Finally, following model selection, I perform parameter estimation 
and provide confidence intervals for the inferred parameters.  
 
  





3.2.1. Experimental Data Background  
 
Coward et al. (Coward et al., 2014) collected two datasets on bacterial counts of isogenic-
tagged S. Typhimurium SL3261 strains in C57BL/6 mice. Mice were infected with a ~240 
CFU S. Typhimurium equiproportionate inoculum comprising 8 ITS at ~30 CFU per strain. 
At 0.5, 6, 24, 48 and 78 hours post-inoculation, 9-10 mice were killed, their livers and 
spleens harvested, blood was sampled from their tail vein, bacteria isolated and segregated 
by strain using qPCR. By studying the changes in ITS composition in the tissues with time 
and comparing strain distributions between tissues it is possible to make some preliminary 
inferences about the within-host dynamics of S. Typhimurium in the naïve murine host. 
Figure 3.1 illustrates the number of bacteria per ITS in each of the biological replicates (9 
or 10 mice x 8 ITS/mouse = 72 or 80 total biological replicates) for each sampling time point.  
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Figure 3.1: ITS composition of 
bacterial loads in different organs 
at various timepoints post-
infection.  
 
This is a boxplot representation of the 
two datasets collected from 
infections of naïve mice with an 
inoculum comprising 8 ITS at ~30 
CFU per ITS. Each boxplot 
represents the distribution of copies 
per ITS in the tissues sampled, the 
blood, liver and spleen for five 
sampling time points over the span of 
72 hours. Comparing datasets 1 and 
2, there is concordance in the 
observed bacterial loads. In the 
blood, bacterial loads diminish 
between 6 and 48 hours before 
increasing again by 72 hours. In the 
liver, bacteria decline between 0.5 
and 6 hours but thereafter increase 
steadily. In the spleen, the bacterial 
load remains static for the first 6 
hours and increases from 6 to 72 








In this section, I present a series of nested mechanistic mathematical models considered and 
their correspondence to biological hypotheses suggested by previous experimental studies 
or patterns observed in the datasets (Figure 3.1).  
 
 
• M1: No early inter-organ bacterial mixing with no bacterial death or replication 

















Figure 3.2: Conceptual structure of early compartmental model M1 for systemic salmonellosis 
in the murine host  
 
 


























An ITS-based study by Grant et al. (2008) recovered 
bacteria from the blood, liver and spleen, and negligible 
numbers in other organs (kidneys, lymph nodes, heart and 
lungs. An original mathematical model for systemic 
salmonellosis was formulated including 3 compartments 
(blood, liver and spleen).  Bacteria migrated from the 
blood to the liver and spleen, with bacterial replication and 
death in the same organs, as shown in Figure 3.2. The same 
model was later used by Coward et al., 2014. This 
simplified model does not include bacterial replication and 












For an infection acquired intravenously, it is unclear how 
soon Salmonella enters host cells and whether it circulates 
as a free bacterium, attached to or phagocytosed by 
circulating host cells. This model includes bactericidal 
activity in the blood in the early stages of systemic 
infection, reflecting either humoural or cellular responses 
(Figure 3.3). Possible improvement in the model fit 
between M1 and M2 would provide support for an early 
cidal activity in the blood.  
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Figure 3.3: Conceptual structure of early compartmental model M2 for systemic salmonellosis 






















Figure 3.4: Conceptual structure of early compartmental model M3 for systemic salmonellosis 






















Figure 3.5: Conceptual structure of early compartmental model M4 for systemic salmonellosis 





























The presence of low-level bacteraemia at 6h in the 
datasets by Coward et al. (2014) (Figure 3.1) led me to 
the  hypothesis that there is free inter-organ mixing 
between the liver and spleen, as bacteria may escape in 
the bloodstream earlier than previously thought (Figure 
3.4), and in contrast to suggestions made by Grant et 
al., 2008.  
 
In M4, I consider a biological scenario with both free 
inter-organ bacterial mixing, and early bactericidal 
activity in the blood (Figure 3.5).  
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• M5: Early inter-organ bacterial mixing in systemic circulation and the liver-




















Figure 3.6: Conceptual structure of early compartmental model M5 for systemic salmonellosis 





• M6: Early inter-organ bacterial mixing in systemic circulation and the liver-

















Figure 3.7: Conceptual structure of early compartmental model M6 for systemic salmonellosis 
in the murine host  
 
 
M5 represents an extension of M4 taking into 
account more than one possible routes for 
bacterial migration between the liver and 
spleen (Figure 3.6). In the datasets used, 
blood was fractionally sampled from the tail 
vein, which represents a distal location and 
may not be representative of fast and direct 
inter-organ haematogenous spread via shorter 
routes, like the liver-spleen axis which forms 














In M6, I consider a biological scenario with 
free inter-organ bacterial mixing both 
through the systemic and portal circulation, 
but no bactericidal activity in the blood 
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3.2.3. Model Selection 
Each of the six candidate models for the early S. Typhimurium dynamics (outlined in 3.2.2) 
was fitted to the experimental data using the first two sampling time points at 0.5 and 6 hours 
after inoculation. 
To evaluate the relative goodness-of-fit for the models, I used the three metrics described in 
section 2.7. In summary, the first metric is the pairwise comparison of the KL divergences 
and is an index of the overall model performance, without providing information about how 
well the model captures the individual experimental moments. For the second metric, I 
plotted the 95% confidence interval for each of the nine bootstrapped moments and overlaid 
the experimentally observed moments. This metric assesses whether the model adequately 
captures all moments; a model with a good fit should adequately capture all individual 
moments. Finally, for the third metric I calculate the standard deviation and mean for each 
of the nine moments in the bootstrapped samples, and calculate how many standard 
deviations each experimentally observed moment differs from the mean value of each 
bootstrapped moment. The smaller the number of standard deviations, the closer the 
experimentally observed moments are to the mean behaviour of the model. 
For models with similar performance across the three metrics, I chose the one with the 
smallest number of parameters in line with the principle of parsimony.  
 
3.2.4. Parameter Inference  
Parameter inference for each model was performed by minimisation of the KL divergence 
between the set of experimentally observed moments and predicted moments given a 
parameter set 𝜃, as described in section 2.5. 
3.2.5. Quantification of uncertainty around parameter estimates  
To quantify the uncertainty around the parameter estimates, I used a parametric bootstrap 
approach (outlined in 2.5 and 2.6) to generate 500 bootstrapped datasets from the best-
performing model. For each bootstrapped dataset, I calculated the moments and performed 
inference by fitting the model and obtaining a set of best parameter estimates. For each 
parameter, I plotted the 95% confidence interval.  
 





3.3.1. Model Selection for the early phase dynamics (0 to 6 hours) 
 
In section 3.2.2, I formulated a series of mechanistic models inspired by insights from 
previous biological studies and/or patterns observed in experimental data. Here, I compare 
the performance of the six models (M1-M6) based on the three criteria described in section 
3.2.3. Table 3.1 shows the KL divergence values for models M1 to M6, with a large drop 
seen for M3, which introduces bacterial migration from the liver (m21) and spleen (m31) to 
the blood. Early cidal activity in the blood (k1) does not substantially improve the 
congruence between the model prediction and the experimental observations (M2). Models 
more complex than M3 do not improve the model fit, as shown by the near-identical KL 
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m12 Bacterial migration from the blood to the liver 
m13 Bacterial migration from the blood to the spleen 
m21 Bacterial migration from the liver to the blood 
m31 Bacterial migration from the spleen to the blood 
m23 Bacterial migration from the liver to the spleen 





k1 Bacterial death in the blood 
k2 Bacterial death in the liver 
k3 Bacterial death in the spleen 
r1 Bacterial replication in the blood 
r2 Bacterial replication in the liver 
r3 Bacterial replication in the spleen 
 
Table 3.2: Description of the model parameters  
 
In terms of the model predictions for individual moment values, models M1 and M2 both 
underestimate the variance in the blood when applied to the two experimental datasets, while 
models with organ-to-blood bacterial migration (m21, m31) address this mismatch (Figure 
3.8).  In Figure 3.8, I plot the 95% confidence intervals for the moment values, as estimated 
from 500 bootstrap samples generated from each of the models M1-M6 originally fitted to 
two experimental datasets (Panels A and B). Consistent with the pattern in the KL 
divergence values in Table 3.1, Figure 3.8 shows that M3 adequately captures all 
experimentally observed moments, while models with higher complexity (M4-M6) also 
converge to the same pattern.  
To further quantify the alignment between the model-generated predictions and the 
experimental observations for each moment individually, I assess the proximity of each 
experimental model to the mean model prediction for each moment. To quantify this 
distance, I use first calculate the mean value and standard deviation for each moment using 
the bootstrapped samples across the six models, and report the difference between each 
experimental and model-predicted moment as the number of standard deviations away from 
the mean. A decrease in the number of standard deviations reflects a model whose mean 
behaviour is closer to the experimental observations. In Figure 3.9, I plot the log10 of 
standard deviations away from the mean for each moment across the six models and two 
experimental datasets. The results are consistent with the patterns noted earlier (Table 3.1 
and Figure 3.8), with M3 providing a significant improvement, but subsequent models of 
higher complexity providing only marginal further improvements.  





Figure 3.8: Bar plots of the 95% confidence intervals for the moment values, as estimated by 
parametric bootstrap (𝒏 = 𝟓𝟎𝟎) using models M1-M6 
 
Panels A and B correspond to two experimental datasets. For each moment, the 95% confidence 
interval obtained by parametric boostrapping is shown as a bar plot. The red dots represent the 
experimentally observed moments. In both (A) and (B), M1 and M2 consistently underestimate 
V(Blood), while M3 improves the fit. M4-M6 follow the same pattern as M3.  





Figure 3.9: The difference between the experimentally observed and model-predicted moment 
values expressed as the log10 of the number of standard deviations away from the mean (𝒏 =
𝟓𝟎𝟎) 
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3.3.2.  Quantification of within-host dynamics in the naive host  
 
To discriminate the processes of within-host bacterial replication, killing and migration, I fit 
M3 to the two experimental datasets by Coward et al. (2014) for a course of 72 hours in the 
blood, liver and spleen of naive mice. I inferred the rates at which these processes occur by 
identifying the parameters, whose corresponding first- and second-order moments have the 
smallest distance from the moments characterising the distribution of observed bacterial 
counts per ITS. I obtained confidence intervals by using a parametric bootstrap approach, as 
outlined in section 2.5. In the naive host, independent model fitting for the two experimental 
datasets revealed very similar patterns of infection dynamics throughout the first 3 days post-
inoculation, both in terms of temporal evolution and in terms of the relative contribution of 
bacterial killing, migration and replication to the observed bacterial numbers. This 
congruence provides a degree of external validation to the inference conclusions.  
 
 
• 0-6 hours  
In the early stages of infection there is a marked preferential migration of bacteria from the 
blood to the liver (high predicted m12). At this stage, the liver is seeded at a higher rate than 
the spleen (m12 > m13). Bacteria escape back to the blood at a lower rate (non-zero, but 
small m21, m31 values). In terms of intra-organ activity, the bactericidal activity of the liver 
is high and exceeds the rate at which bacterial replicate (k2>r2), resulting in net bacterial 
death locally. In contrast, the bactericidal activity is much lower in the spleen (k3<k2) 
allowing low-level bacterial proliferation (k3 < r3) in that organ (Figure 3.10).  
 
• 6 to 24 hours 
In the second phase of the infection, the migration of bacteria from the blood to both the 
liver and spleen slows down (low rates of m12 and m13). No bacteria are detected in the 
blood at 24 hours, as bacterial subpopulations remain segregated in the liver and spleen (m21, 
m31 close to zero). Hepatic bactericidal activity drops, while that of the spleen remains 
stable. Bacterial replication accelerates in the liver, matching the sustained pattern observed 
in the spleen post-inoculation, resulting in replication rates marginally higher than killing 
rates and overall net intra-organ growth of the bacterial in both organs (Figure 3.11).  
 






Figure 3.10: Bar plots of the 95% confidence intervals for the parameter values during the 
acute phase of infection (0 to 6 hours), as estimated by parametric bootstrap (𝒏 = 𝟓𝟎𝟎) using 
model M3 
 
The red bar plots represent the 95% confidence intervals for the parameter estimates obtained by 
fitting M3 to the first experimental dataset, while the blue bar plots represent the parameter estimates 
obtained by model fitting to the second experimental dataset. The estimates obtained from the two 
datasets show congruent patterns in the bacterial dynamics, as shown by the overlapping bar plots. 
Overall, the majority of bacteria migrate to the liver, where they are subject to intra-organ cidal 
activity, with a small population escaping back to the blood. The minority of bacteria that migrate to 















0 to 6 hours 









Figure 3.11: Bar plots of the 95% confidence intervals for the parameter values during the 
second phase of infection (6 to 24 hours), as estimated by parametric bootstrap (𝒏 = 𝟓𝟎𝟎) using 
model M3 
 
The red bar plots represent the 95% confidence intervals for the parameter estimates obtained by 
fitting M3 to the first experimental dataset, while the blue bar plots represent the parameter estimates 
obtained by model fitting to the second experimental dataset. The rate of bacterial killing (k2) in the 
liver drops, creating an environment permissive to bacterial proliferation. The large confidence for 
the replication and killing rates (k2, r2) for the second experimental dataset reflect highly imprecise 
estimates attributable to high data variance. Dynamics in the spleen remain similar to earlier (0-6 













6 to 24 hours 
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• 24 to 72 hours 
In the third phase of the infection (24-72 hours), there is sustained bacteraemia with 
increasing bidirectional bacterial migration from and to the blood (m12, m13, m21, m31 
rates are higher compared to the second phase in Figure 3.11). Bacterial replication (r2, r3) 
and death (k2, k3) remain at similar levels as before in the liver and spleen, while bacteria 






Figure 3.12: Bar plots of the 95% confidence intervals for the parameter values during the late 
phase of infection (24 to 72 hours), as estimated by parametric bootstrap (𝒏 = 𝟓𝟎𝟎) using 
model M3 with bacterial replication in the blood (r1) 
24 to 72 hours 





In this chapter, I applied a newly described inference framework to published experimental 
datasets by Coward et al., 2014 to quantitatively characterise the within-host dynamics of 
intravenously acquired S. Typhimurium infections in the naive murine host. My modelling 
work suggests that the early infection phase is characterised by rapid migration of bacteria 
from the blood to the liver and spleen, with early inter-organ bacterial mixing. The intra-
organ microenvironments differ between the liver and spleen; while bacteria migrating to 
the liver are subject to high levels of cidal activity, bacteria lodging in the spleen are allowed 
to proliferate. In the second phase of infection (6 to 24 hours), the hepatic bactericidal 
activity drops, creating a more permissive environment for bacterial growth, which 
continues in the later phase of infection (24-72 hours) in both the liver and spleen. 
 
The modelling work presented here is, to the best of my knowledge, the first attempt in the 
field of population dynamics microbiology that successfully integrates mathematical models 
with experimental data for the entire course of an experimental infection process (72 hours). 
Although there is a wealth of experimental studies investigating the effect of virulence 
and/or immunological factors on the early colonisation, dissemination and proliferation 
process that collectively shape the infection dynamics in the naïve host, insights into the 
unobserved temporal dynamics resulting from host-bacterial interactions have been hitherto 
lacking, due to three factors: 1) technological limitations not allowing the direct observation 
and tracking of replication, killing and migration events at the level of the entire bacterial 
population, 2) the previous absence of computationally efficient mathematical tools to 
perform inference, and 3) a focus on systemic infections acquired via haematogenous spread 
of orally-acquired S. Typhimurium infections, as opposed to blood-acquired infections.  
 
Earlier studies have partially shed light on the early-phase dynamics, identifying the spleen 
and liver as major bacterial reservoirs (Grant et al., 2008), where bacteria reside 
intracellularly, replicate, lyse their host cell and generate new infectious foci by infecting 
adjacent cells (Sheppard et al., 2003; Brown et al., 2006). My inference suggests that the 
liver plays an important role in the Salmonella dynamics during the acute phase of infection, 
with the rate of blood-to-liver bacterial migration estimated to be three times higher than the 
rate of blood-to-spleen migration. For the early stages of intravenously acquired infections, 
it is unknown whether bacteria are free or reside intracellularly. Although it has been 
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suggested that immediately after gaining access to the blood, Salmonella swiftly invades 
macrophages of the reticuloendothelial system (Mastroeni, 2002), it is unclear whether this 
applies only to bacteria acquired through the orogastric route prior to haematogenous spread. 
Furthermore, it remains unknown whether bacterial movement at this stage is chemotaxis- 
or blood-flow dependent. The liver and spleen harbour different proportions of the host cell 
types that Salmonellae typically reside in (e.g. macrophages and dendritic cells) (Johansson 
and Wick, 2004), rendering chemotaxis-dependent bacterial migration a possible 
explanation for the asymmetric bacterial migration estimated during the first few hours post-
inoculation. A cellular makeup exerting stronger chemotaxis in the liver may underpin the 
high blood-to-liver migration rates in the early stages of infection. An alternative 
explanation would be the differential blood perfusion of the two organs. Gjedde and Gjeode 
(Gjedde and Gjeode, 1980) report that in BALB/c mice, the liver is one of the most profusely 
perfused organs with allocated heart output of 945mL/min, as opposed to the poorly perfused 
spleen with 46mL/min. 
 
In terms of model selection for the early phase of infection (0-6 hours), I showed that 
previously used models omitting the organ-to-blood bacterial migration (m12, m13) provide 
a poor fit to the experimental data (Grant et al., 2008; Coward et al., 2014); addition of a 
parameter for early bacterial killing (k1) in the blood does not improve the model fit either. 
On the basis of early modelling attempts in a maximum likelihood inference framework with 
a simplified model, Grant et al. (2008) argued that once bacteria migrate to the liver and 
spleen, they remain trapped in their respective microenvironments until much later in the 
infection process. My analysis in 3.1 suggests the opposite, i.e. that early inter-organ mixing 
is necessary to reproduce the distribution of copies per ITS in the experimental datasets. At 
this stage and in the presence of a large population of uninfected monocytes and 
macrophages in the liver and spleen, it is likely that Salmonellae become internalised by 
host cells. Once internalised, Salmonellae have been reported to alter the surface electrical 
properties of host phagocytes in the gut (Sun et al., 2019; Worley et al., 2006), which in 
combination with the electrochemical properties of their microenvironment can lead to 
directional movement of Salmonella-infected macrophages. A similar mechanism may 
underpin the early inter-organ migration which occurs in tandem with intra-organ expansion 
of infection foci in the systemic phase of infection (Brown et al., 2006).  
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Furthermore, my analysis in 3.3.1 shows that including a parameter for early bactericidal 
activity in the blood does not substantially improve the model fit. This result is consistent 
with the finding that upon infection with Salmonella, mouse serum deposits only a small 
amount of C3 complement onto the bacteria and, as a result, exerts no bactericidal activity 
(Siggins et al., 2011).  
 
Finally, the results presented in 3.3 pinpoint and quantify the changes that signpost the 
transition between the three phases of infection in the 72-hour period. A drop in bactericidal 
activity in the liver, as well as relative quiescence in the blood-organ communication, both 
signal the transition from the first (0-6 hours) to the second (6-24 hours) phase of the 
infection. Between the second (6 to 24 hours) and third (24-72 hours), the intra-organ 
dynamics remain fairly stable, with bacteria migrating out of the organs into the blood. The 
inferred dynamics in the blood also present an interesting pattern; from a neutral 
microenvironment in the first phase (k1, r1 = 0), to a degree of cidal activity in the second, 
and bacterial replication in the third. These dynamics are likely to reflect the changing 
patterns in host cell-bacterial interactions, as the bacteria are likely to be extracellular in the 
first phase, and occupy different types of host cells between the second and third phases.  
 
Although the modelling approach proposed by Coward et al. (2014), and extended here has 
enriched our insight and provided evidence in favour or against long-standing speculations, 
it is, nonetheless, subject to assumptions, whose acknowledgement can guide future 
experimental and modelling work. As each ITS is assumed to represent a single independent 
infection, the case of 10 mice each infected with 8 ITS represents 8 × 10 = 80 stochastic 
trajectories of a single infection, an interpretation underpinned by 3 assumptions outlined 
below: 
 
1. that all 8 WITS are phenotypically identical and exhibit identical within-host 
dynamics, 
2. that bacteria behave independently of each other, 
3. that host-bacterial dynamics are uniform across all mice, with no inter-mouse 
heterogeneity, 
4. that the rates at which demographic events take place are constant for the modelled 
time interval. 
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Of course, there is a wealth of studies showing that bacterial dynamics in vivo systems are 
complex and heterogeneous. For example, Helaine et al. (Helaine et al., 2010) and Claudi 
et al. (Claudi et al., 2014) argue that the composition of a bacterial population is not uniform 
and is characterised by diversity in both division rates and susceptibility to killing possibly 
due to bacteria residing in different microenvironments and acquiring of epigenetic marks 
during the infection process, while Balaban et al. (Balaban et al., 2004) suggest that bacterial 
heterogeneity is present in the bacterial culture even prior to inoculation of the host. 
 
Regarding heterogeneity in host-pathogen interactions, data from Coward et al. (Coward et 
al., 2014), showed that at 6 hours post-infection, 2 out of 10 mice harbour 20 and 35 CFU 
respectively in their blood, while no bacteria were detected in the blood samples collected 
from the remaining 8 mice. This bimodality in bacterial numbers, which is not necessarily 
adequately captured in the respective first- and second- order moments when all 10 mice are 
considered as a group, may reflect heterogeneity in host responses to infection. While 
acknowledging the presence of these additional layers of complexity is important to 
critically appraise the inferences made when using mathematical models, it is equally 
important to remember that the complexity of models is limited by data resolution and 
availability, and that the law of parsimony should be obeyed once a model adequately 
captures the patterns in the experimental observations. 
 
Overall, in this chapter I used a likelihood-free inference framework to quantify the within-
host dynamics of intravenously-acquired S. Typhimurium in naive murine host over a period 
of 72 hours. My analysis rejects the earlier conjecture that upon inoculation bacteria remain 
trapped in the liver and spleen during the early stages of infection, and suggests that there is 
early mixing between the two populations with the liver acting as a net recipient. 
Furthermore, my inferences show that after 6 hours, bacterial replication and killing rates in 
the liver and spleen do not change significantly, while maintaining a marginally positive net 
growth rate, which allows bacteria to grow exponentially. The rates reported in this analysis 
represent population averages and do not take into account inter-host or inter-bacteria 
phenotypic heterogeneity. To assess the effect of inter-host heterogeneity, one would need 
to obtain time series data from different animal hosts; this could be achieved by visualising 
bacteria during the infection timeline instead of culling and sampling different animals at 
each time point. Hierarchical models could be used to capture inter-host heterogeneity too. 
Finally, to address the issue of bacterial heterogeneity, observations of demographic events 
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at the level of the single bacterium with technologies like confocal/fluorescence microscopy 










S. Typhimurium dynamics 
in the immunised host  
 
Summary Points: 
• Following from Chapter 3, I apply a compartmental model to ITS-based datasets 
from groups of mice previously immunised with either a live-attenuated (LV) or a 
whole-cell killed vaccine (KV), and challenged intravenously with S. Typhimurium. 
• The LV group rapidly inactivates 1/3 of the inoculum within 30 minutes post-
inoculation, while such effect is not observed for the KV and naïve groups.  
• In the first 6 hours post-inoculation, both the KV and LV groups exert bacteriostatic 
effects in the liver with enhanced bactericidal activity in the spleen, compared to the 
naïve group. 
• In the second phase of infection (6-24 hours), the bacteriostatic effect persists in the 
livers of both KV and LV mice. In the spleen, the bactericidal activity of the naïve 
group increases.  
• In the third phase of infection (24-72 hours), the LV group controls intra-organ 
proliferation for the longest time, while in the KV group positive net bacterial growth 








With the rise of antibiotic resistance and tolerance, relapsing bacterial infections and co-
infections, immunisation against bacterial diseases is emerging as a promising management 
strategy in areas of high endemicity. Systemic infections with typhoidal and non-typhoidal 
Salmonella enterica rank among the most common bloodborne infections in Sub-Saharan 
Africa. Designing affordable, safe vaccines that elicit durable responses against a range of 
S. enterica serovars is challenging and would benefit from a detailed understanding of the 
effects that different vaccine candidates exert on the within-host dynamics of Salmonella. 
In this study, I use mechanistic mathematical models applied to ITS-based data comparing 
the effects of a live- and killed- S. Typhimurium vaccine on the in-host bacterial dynamics 
following a secondary challenge. Inferences show that the superior performance of the live 
vaccine in controlling both bacteraemia and intra-organ bacterial proliferation over a longer 
time period is attributable to an early inoculum inactivation, early bacteriostatic effects in 
the liver and cidal in the spleen, followed by a later period of bacterial trapping in the organs 
and control of intra-organ growth. These effects all align with the predicted effects of a 
significant IgG2 response which is induced in mice immunised with the live but not the 
killed vaccine.  
  




In the 21st century, bacterial diseases persist as leading causes of death and disability 
worldwide, particularly in low-resource settings, disproportionately affecting the 
immunocompromised, elderly and under five population (Gordon et al., 2008). Both 
typhoidal and non-typhoidal Salmonella are major causative agents of bloodstream 
infections and large contributors to morbidity and mortality in Sub-Saharan Africa (Feasey 
et al., 2015; Marks et al., 2017), accounting for almost 40% of community-acquired 
bloodstream infections in the region (Uche, MacLennan and Saul, 2017).  
 
With multidrug-resistant Salmonella infections on the rise worldwide (Yan et al., 2016; 
Feasey et al., 2015), the WHO has advised the mass immunisation of individuals living in 
areas of invasive salmonellosis endemicity (Breiman et al., 2012). Although prevention 
strategies have been an active area of pharmaceutical research and development since the 
1890’s, three vaccines against S. Typhi have been licensed to-date (Guzman et al., 2006), 
and no vaccines are available against other Salmonella serovars responsible for 
paratyphoidal and non-typhoidal salmonellosis (Coward et al., 2014). The increasing rates 
paratyphoidal and non-typhoidal invasive salmonellosis prevalence in endemic countries 
(Ochiai et al., 2005), combined with the >20% fatality rate of non-typhoidal salmonellosis 
amongst children (Tapia et al., 2015) renders the need for vaccines conferring protection 
against a wider range of Salmonella serovars pressing. 
 
With vaccination emerging as a promising solution to the aggravating problem of 
antimicrobial resistance, efforts are being made to accelerate the research and development 
(R&D) of new vaccines. High-throughput screening of large libraries of vaccine candidate 
targets (Davies et al., 2012; Guo et al., 2015; Itoh et al., 2019), and a detailed understanding 
of how pathogens interact with their host to colonise tissues, disperse and proliferate 
(Hadjichrysanthou et al., 2016; Coward et al., 2014; Orwa, Mbogo and Luboobi, 2018; 
Handel et al., 2018; Davies et al., 2019) are gradually being recognised as major accelerators 
of R&D.  
 
While the en masse screening of vaccine candidates has been enabled by biomolecular 
technological advances and immunological research (Broach and Thorner, 1996), novel 
insights into how pathogens replicate, move and die in their hosts are being generated 
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through the increasing use of mathematical modelling as an adjunct to conventional data 
analysis (Restif, Thakar and Harvill, 2009). Studies using sophisticated experimental 
techniques are revealing finer and finer details at the host-pathogen interface (Grant et al., 
2008; Helaine et al., 2010; Walters et al., 2012; Claudi et al., 2014; Korem et al., 2016). 
However, without the application of mathematical models, the output of such studies 
remains conventionally limited to measurements of net changes in pathogen numbers 
(Walters et al., 2012) or, at best, bacterial replication events (Helaine et al., 2010; Claudi et 
al., 2012).  
 
Mechanistic insights into the within-host dynamics of pathogens benefits vaccine R&D in 
three ways. First, it has been historically recognised that the most effective vaccines are 
those that induce an immune response closely mimicking that of a natural infection. A 
detailed understanding of how, when and where natural immunity controls an infection can 
inspire the design of vaccines that either mimic or act in synergy with natural host defences 
(Garon and Orenstein, 2015). Second, by characterising the mode of action of candidate 
vaccines prior to clinical trials, it is possible to predict potential shortcomings in terms of 
their performance and safety profile in populations with immunodeficiencies, co-infections 
or profiles that correlate with an altered immunological status (e.g. elderly individuals, 
young children or pregnant women). Third, given that vaccines exert pleiotropic effects on 
the host’s immune system, the quantitative characterisation of each of these effects on the 
demographic events that shape the size of bacterial subpopulations in the tissues can help 
determine the predominant effect(s) of any given vaccine candidate. For example, if a 
vaccine induces mainly bactericidal effects, it is possible to investigate this mechanism 
further and pinpoint the component(s) of the host immune response that is responsible for 
this effect. This host immunity response can then be combined with other favourable 
responses to create a potent and safe vaccine.  
 
In this thesis, I already addressed the first point in Chapter 3, showing differences between 
the liver and spleen microenvironments in terms of their ability to control the proliferation 
of S. Typhimurium over time; these differences are attributable to specific host immunity 
factors which need to be further investigated. In Chapter 4, I aim to address the second point 
by quantitatively characterising the effect of two vaccine formulations, a live-attenuated (LV) 
and an inactivated, whole-cell vaccine (KV) on the within-host dynamics of a secondary 
intravenous challenge with S. Typhimurium.  
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A live-attenuated S. Typhimurium vaccine was first constructed by Hoiseth and Stocker 
(Hoiseth and Stocker, 1981) by using deletion mutations in the aroA locus, thus rendering 
Salmonella growth strictly conditional on the presence of aromatic compounds, which are 
not found in mammalian tissues. It has remained one of the most promising candidates since 
(Table 4.1), the only caveat being that the safety profile of live vaccines amongst 
immunocompromised individuals remains a long-standing challenge, as on the one hand, 
knowledge about their effects in these populations is lacking (Pirofski and Casadevall, 1998), 
and on the other, a large proportion of individuals living in Salmonella-endemic areas are 
infected with one or more immunomodulatory diseases. In a study by Izhar et al. (Izhar et 
al., 1990) it was reported that moderately immunocompromised mice infected with the 
ΔaroA Salmonella vaccine strain showed no greater susceptibility to infection than 
immunocompetent mice; this finding validates that the virulence attenuation in aroA mutants 
is not attributable to effect(s) at the host immunity-pathogen interface, and makes further 
exploration of the effects of this vaccine worth pursuing.  
 
Live-attenuated vaccines have represented an effective alternative to killed vaccines, which 
were among the first to be tested in vivo due to their perceived good safety profile (Cronly-
Dillon, 1972). Evidence collected over the years (Cronly-Dillon, 1972; Angerman and 
Esenstein, 1980; Coward et al., 2014) showed that any protection conferred by killed-































1. Heat-killed S.Tm 
Intraperitoneal 
At 0.5 months post-immunisation, no 
protection was offered in oral challenges, 
and equal protection in intraperitoneal 
challenges for preparations 1 and 2. 





1. Low-dose live S.Tm 
Intraperitoneal 
At ~3 months post-immunisation, the 
percentage of mice surviving a secondary 
challenge are 50%, 0%, 20% and 0% for 
preparations 1-4 respectively. 
2. Acetone-killed S.Tm 
3. Ribosomal extract 







At ~2 months post-immunisation, live 
ΔAroA S.Tm induced a Th1 cellular 
response with higher anti-LPS IgG2a 
levels than both killed vaccines. The live 
ΔAroA S.Tm protection was equally 
durable across all immunisation routes. 




Coward et al., 
2014 
SL3261 
1. Acetone-killed S.Tm 
Subcutaneous 
At ~1.5 months post-immunisation live 
ΔAroA S.Tm vaccine rapidly inactivated 
~40% of challenge inoculum, induced 
bacteriostasis and a delayed bactericidal 
T-cell response. 
2. Live ΔAroA S.Tm 
Lim et al., 
2014 
SL1344 Live ΔAroA S.Tm Oral 
At ~1.5 months post-immunisation, 
invasion of the secondary challenge to the 
Payer’s patches was reduced, but not 
abolished. 
Erova et al., 
2016 
14028 
1. Live ΔlppAB S.Tm 
Oral 
At ~1 month post-immunisation, both 
preparations provide complete protection 
against a secondary challenge. Live 
ΔlppAB ΔmsbB S.Tm-immunised mice 
produced higher levels of faecal IgA and 
IL-6, while live ΔlppAB S.Tm-
immunised mice produced higher levels 
of IL-17A and TNF-α. 
2. Live ΔlppAB ΔmsbB 
S.Tm  
Diard et al., 
2019 
SB300 
Peracitic acid killed 
S.Tm 
Oral 
At ~1 month post-immunisation, 
immunised mice were incompletely 
protectected due to the emergence of 
S.Tm mutants with short O-antigens, 
which were not bound by vaccine-
induced IgA.  
 
Table 4.1: Review of in vivo studies on the effects of immunisation preparations on S. 
Typhimurium dynamics.  
 
In this chapter, I show how using data from experiments using ITS of S. Typhimurium in 
immunised mice, in conjunction with bespoke mechanistic models can suggest novel 
biological insights on the effect of different vaccines (Coward et al., 2014). I focus on data 
from an ITS-based study by Coward et al., (2014), to study the effects of a live-attenuated 
and an acetone-killed vaccine on the within-host dynamics of S. Typhimurium post-
immunisation. Based on previous work on the course of systemic Salmonella infections in 
the naïve host (Chapter 3), I develop a mechanistic mathematical model which assumes free 
bacterial movement between the blood and the two main reservoirs of infection: the liver 
and spleen (Grant et al., 2008), with concomitant bacterial replication and killing occurring 
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in the latter. In the differentially immunised groups, I quantify the differential bacteriostatic 
and cidal effects of the two vaccine formulations and their ability to control bacterial spill-
over from the organs to the blood. This work builds on preliminary modelling work in 
Coward et al. (Coward et al. 2014) who only used a simple model with no organ-to-blood 
migration and did not analyse data from the later phase of the infection due to computational 
constraints in the maximum-likelihood inference framework. My suggested model corrects 
the poor fit of the original model, also highlighted by Price et al. (2017), and extends the 
inferencing into the later time points to provide a complete picture of the mechanisms by 
which the two vaccines differentially influence the within-host dynamics of infection in a 
secondary S. Typhimurium challenge.  
 
  




4.2.1. Experimental data background  
Coward et al. (2014) collected datasets on bacterial counts of isogenic-tagged S. 
Typhimurium SL3261 strains in two groups of differentially immunised mice C57BL/6 mice 
intravenously challenged with S. Typhimurium 30 days post-immunisation. Mice used as 
control were not immunised (Naïve). Of the immunised groups, the first received a live-
attenuated ΔAroA vaccine (LV), while the second received an acetone-killed vaccine (KV) 
subcutaneously. Mice were challenged with a ~240 CFU S. Typhimurium equiproportionate 
inoculum comprising 8 ITS at ~30 CFU per strain. At 0.5, 6, 24, 48 and 72 hours post-
inoculation, 9 or 10 mice were killed, their livers and spleens harvested, blood was sampled 
from their tail vein, bacteria isolated and segregated by strain using qPCR. By studying the 
changes in ITS composition in the tissues with time and comparing strain distributions 
between tissues it is possible to make some preliminary inferences about the within-host 
dynamics of S. Typhimurium in the immunised murine host. Figure 4.1 illustrates the 
number of bacteria per ITS in each of the biological replicates (9 or 10 mice x 8 ITS/mouse 
= 72 or 80 total biological replicates) for each sampling time point.  
 
Figure 4.1: Bacterial copies per ITS in different tissues at various timepoints post-infection in 
the naïve, KV and LV groups of mice  
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Figure 4.1 shows the bacterial copies per ITS, as recovered by qPCR in the blood, liver and 
spleen of the naïve, KV and LV groups of mice. Across the three groups, there is negligible 
bacteraemia until 48 hours post-infection; in the 48-72 hour interval, the LV-group exert 
superior control, while the KV-group do not control bacterial migration to the blood equally 
well. The liver is the organ where bacteria preferentially migrate to in the first 0.5 hour post-
inoculation in both the naïve and immunised groups. Both the KV and LV groups restrain 
bacterial numbers in the liver during the first 24 hours, with the LV group exerting a longer-
lasting effect (until 72 hours). A similar trend is observed in the spleen, with the LV group 
controlling bacterial numbers much more effectively across the infection period, while in 




4.2.2. Model structure 
 
In this chapter, I used a general model structure, including bacterial killing and replication 
in the blood, liver and spleen, as well as bacterial migration between blood and the organs. 
The model structure can be summarised as follows (Figure 4.2), with the parameter names 












Figure 4.2: Schematic representation of the model structure applied to ITS-based data from 























m1.2 Bacterial migration from the blood to the liver 
m1.3 Bacterial migration from the blood to the spleen 
m2.1 Bacterial migration from the liver to the blood 






k1 Bacterial death in the blood 
k2 Bacterial death in the liver 
k3 Bacterial death in the spleen 
r1 Bacterial replication in the blood 
r2 Bacterial replication in the liver 
r3 Bacterial replication in the spleen 
 
Table 4.2: Description of parameters and parameter names  
 
4.2.3. Parameter Inference  
Parameter inference for each model was performed by minimisation of the KL divergence 
between the set of experimentally observed moments and predicted moments given a 
parameter set 𝜃, as described in section 2.5. 
 
4.2.4. Quantification of uncertainty around parameter estimates  
To quantify the uncertainty around the parameter estimates, I used a parametric bootstrap 
approach (outlined in 2.5 and 2.6) to generate 500 bootstrapped datasets from the best-
performing model according to 3.2.3. For each bootstrapped dataset, I calculated the 
moments and performed inference by fitting the model and obtaining a set of best parameter 
estimates. For each parameter, I sorted the parameter estimates in ascending order and 








4.3.1. Early inoculum inactivation 
 
As shown by the raw data in Figure 4.1, a large proportion of bacteria is killed or inactivated 
in the blood of the LV mice during the first 30 minutes post-inoculation Using the data from 
the early sampling time point (0.5 hours post-inoculation), it is possible to estimate the 
number of bacteria that actively migrate to and die/replicate in the organs, and only consider 
those bacteria seeding the tissues as the active inoculum dose. My inference suggests that in 
the LV group, over 1/3 of the inoculum is inactivated (Figure 4.3) in the first 30 minutes of 
infection, unlike the KV and naïve group where the inferred inoculum size post-inoculation 





Figure 4.3: Bar plots of 95% confidence intervals for the active inoculum estimate in naïve, 
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4.3.2. Comparison of intra-organ dynamics between KV- and LV- immunised mice 
 
This section compares the bacterial killing and replication rates in the liver and spleen of 
naïve, KV- and LV- immunised mice. Inferences have been made using the model presented 
in 4.2.2, and results are presented following the phases of infection, in alignment with my 
previous analysis in Chapter 3.  
 
 
•   0 to 6 hours 
Mice immunised with either the whole cell or the live-attenuated vaccines show no signs of 
bacteraemia within the first 6 hours of infection, unlike the naïve group as shown in Figure 
4.1. In line with Coward et al. (Coward et al., 2014), my modelling work estimates that upon 
inoculation, a fraction of the original bacterial population is rapidly inactivated in the blood 
(Figure 4.3), while the remaining bacteria are asymmetrically distributed between the liver 
and spleen (Figure 4.4). Of the active inoculum, the majority of bacteria colonise the liver 
in both the KV- and LV- immunised groups in the first 30 minutes post-inoculation, similar 
to the naïve group (Figure 4.4).  
 
 
Figure 4.4: Boxplots showing the experimentally observed number of bacteria per ITS in the 
blood, liver and spleen for the naïve, KV- and LV- groups of mice. 
0.5 hours post-inoculation 
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Following organ colonisation, bacterial numbers decline sharply within the first few hours.  
In the liver, bacterial numbers decline due to high bactericidal activity in the naïve mice, 
while in the LV and KV groups the rates of bacterial death and replication are lower, 
suggesting that the vaccines elicit a bacteriostatic effect (lower r2) which, in turn, renders 
bacteria more recalcitrant to killing (Figure 4.5).  
 
In the spleen, the numbers of bacteria in the naïve group increase during the first 6 hours 
post-inoculation (positive net growth), while in both the KV and LV mice bacterial numbers 
decline (ellipses in dashed lines in Figure 4.6) due to the higher bactericidal activity in both 
immunised groups (Figure 4.5). For the two immunised groups, bacterial killing and 
replication rates in the spleen do not differ substantially.  
 
 
Figure 4.5: Bar plots of 95% confidence intervals for the rates of bacterial replication and 
death in naïve, KV and LV mice from 0 to 6 hours after inoculation, estimated using 





0 to 6 hours 





























Figure 4.6: Bivariate 95% confidence regions for the rates of bacterial replication and death 
in naïve, KV and LV mice from 0 to 6 hours after inoculation, estimated using parametric 
bootstrap (𝒏 = 𝟓𝟎𝟎) 
 
The black, blue and red ellipses illustrate the bivariate 95% confidence region for replication and 
killing rate in naïve, KV and LV groups of mice respectively, with the solid lines representing the 
liver and the dashed lines the spleen. The large length of the major axis of the ellipse represents the 
high correlation between replication and killing parameter estimates, which accounts for the large 
confidence intervals seen in figure 4.5. Diagonal grid lines indicate net growth rates (replication rate-
killing rate). While bacteria proliferate in the spleens of naïve mice, there is net bacterial death in the 
spleens of both the KV and LV mice, secondary to enhanced bactericidal activity, as shown in Figure 















0 to 6 hours 
(net bacterial growth) 
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• 6 to 24 hours 
 
During the second phase of infection, no signs of bacteraemia are present in the immunised 
groups. Inference suggests that the patterns of intra-organ dynamics remain similar to the 
first phase, with estimates of bacterial replication and killing in the liver lower for both 
immunised groups; this reflects a persisting bacteriostatic effect (Figure 4.7). In the spleen, 
the rates of bacterial replication and death remain similar for the immunised groups, while 
the bactericidal action in the spleen of naïve mice increases leading to a reduction in the net 





Figure 4.7: Bar plots of 95% confidence intervals for the rates of bacterial replication and 
death in naïve, KV and LV mice from 6 to 24 hours after inoculation, estimated using 
parametric bootstrap (𝒏 = 𝟓𝟎𝟎). The dots represent the estimated value for each parameter.  
 
6 to 24 hours 
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Bacterial numbers increase in the liver and spleen of both immunised groups, albeit at a 
slower rate compared to the naïve group; intra-organ net growth rate in immunised mice is 
lower than the net growth rate in naïve mice (Figure 4.8). 
 
 
Figure 4.8: Bivariate 95% confidence regions for the rates of bacterial replication and death 
in naïve, KV and LV mice from 6 to 24 hours after inoculation, estimated using parametric 
bootstrap (𝒏 = 𝟓𝟎𝟎). 
 
The black, blue and red ellipses illustrate the bivariate 95% confidence region for replication and 
killing rate in naïve, KV and LV groups of mice respectively, with the solid line representing the 
liver and the dashed line the spleen. The large length of the major axis of the ellipse represents the 
high correlation between replication and killing parameter estimates, which accounts for the large 
confidence intervals seen in figure 4.7. Diagonal grid lines indicate net growth rates (replication rate-
killing rate). The ellipsoid confidence regions for all groups are congregated at the bottom left-hand 
side of the graph, indicating marginal net growth for all groups, with the highest values 




6 to 24 hours 
(net bacterial growth) 
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• 24 to 72 hours 
During the third phase of infection, signs of bacteraemia first appear in the naïve and KV 
group (by 48 hours), while bacteraemia is delayed in the LV group with bacteria detected in 
the blood only after the 48-hour mark. In terms of intra-organ dynamics, it appears that in 
the spleen the rates of replication and death are similar across the three groups, as indicated 
by the overlapping confidence intervals between 24 and 48 hours. In the 48-72 hour interval, 
bacterial replication accelerates in the immunised groups, but not in the naïve group. In the 

























Figure 4.9: Bar plots of 95% confidence 
intervals for the rates of bacterial replication 
and death in naïve, KV and LV mice from 24 
to 74 hours after inoculation, estimated using 
parametric bootstrap ( 𝒏 = 𝟓𝟎𝟎 ). The dots 
represent the estimated value for each 
parameter.      dsdfsdf 
 
 
Panels A and B offer a refined account of the intra-
organ dynamics during the third phase of 
infection, as the dynamics in the immunised 
groups change more readily than in the naïve 
group, as evidenced by the differentially timed 
appearance of bacteraemia in the KV and LV 
groups.  
 
In the liver, the live- and killed- vaccine both 
induce bacteriostatic effects, with concomitant 
lower bacterial death (panels A and B). In the 
spleen, there is evidence of bacteriostasis in the 
KV, but not the LV group (panels A and B). These 
conclusions are not definitive and only suggested 
by the point estimates (dots), as the 95% 
confidence intervals for the parameter 
estimates for bacterial death and replication in 
the spleen are overlapping across the three 
groups.  
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In the LV group net bacterial growth in both the liver and the spleen is the lowest between 
24 to 48 hours, indicating a better control of the infection both in terms of bacteraemia and 
in terms of intra-organ proliferation (Figure 4.10 (A)). However, between 48 and 72 hours, 
the LV group no longer retains its ability to control intra-organ bacterial growth, as shown 
in Figure 4.10 (B). In contrast, in the KV group positive net bacterial growth starts earlier in 
both the liver and the spleen (Figure 4.10 (A)) and remains at the same level throughout the 



































Intra-organ net bacterial growth 
Figure 4.10: Bivariate 95% 
confidence regions for the rates 
of bacterial replication and 
death in naïve, KV and LV mice 
from 0 to 6 hours after 
inoculation, estimated using 
parametric bootstrap (𝒏 = 𝟓𝟎𝟎) 
 
The black, blue and red ellipses 
illustrate the bivariate 95% 
confidence regions for replication 
and killing rate in naïve, KV and 
LV groups of mice respectively, 
with the solid line representing the 
liver and the dashed line the 
spleen. The large length of the 
major axis of the ellipse represents 
the high correlation between 
replication and killing parameter 
estimates, which accounts for the 
large confidence intervals seen in 
figure 4.7. Diagonal grid lines 
indicate net growth rates 
(replication rate - killing rate).  
 
Panels A and B illustrate the 
comparative net growth in the 
three groups between 24-48 hours, 
and 48-72 hours post- infection 
respectively.  While positive net 
growth starts from 24 hours post-
infection in both the KV and naïve 
group, in the LV group it only 
starts after 48 hours, suggesting 
that the live-attenuated vaccine 
induces longer-term control of 
bacterial proliferation in both the 
liver and spleen. 




Following my analysis in Chapter 3, in this chapter I applied a likelihood-free inference 
framework to published experimental datasets by Coward et al., 2014 to quantify and 
compare the within-host dynamics of intravenously-acquired S. Typhimurium infections in 
mice immunised with either an live-attenuated or an acetone-killed vaccine. Qualitative 
patterns in the data suggest that between the two vaccine formulations, the live-attenuated 
vaccine exerts superior control both in terms of lower intra-organ bacterial proliferation and 
delay of bacteraemia. Combining the data with mathematical inference, I showed that a 
combination of mechanisms underpin the performance of the live-attenuated vaccine in 
controlling intra-organ bacterial growth and bacteraemia; in particular: 1) a quick early 
inactivation of 1/3 of the administered inoculum, 2) bacterial trapping in the liver and spleen, 
3) early bacteriostatic effects in the liver and bactericidal effects in the spleen, 4) longer-
term control of intra-organ bacterial proliferation in the late phase (24-72 hours), 5) long-
term trapping of bacteria in the organs until 72 hours post-infection. On the contrary, the 
whole-cell killed vaccine exerts more moderate control both in terms of intra-organ bacterial 
proliferation and bacteraemia. In the early phase of the infection, bacteriostatic mechanisms 
prevail in the liver, combined with moderate cidal activity in the spleen. Similar to the LV 
group, bacteraemia is initially well-controlled, but by 48 hours post-infection bacteria are 
detectable in the blood. Finally, in the last phase of the infection, unlike the LV group, 
positive net bacterial growth occurs in both the liver and spleen of the KV group.   
 
The experimental observations by Coward et al. (2014) recapitulate patterns from an earlier 
study by Izhar et al. (Izhar et al., 1990), who previously compared the in vivo effects of live-
attenuated and whole-cell killed vaccines by relying on quantifying the inoculum size 
required to kill 50% of the animal host cohort (LD50), a much less granular approach 
compared to the integrated data-based model approach followed here. In this early study, 
immunisation with an aroA mutant strain (live-attenuated vaccine) conferred the most robust 
protective response, with an LD50 of 3 logs higher than that for the killed vaccine. However, 
the immunological mechanisms underpinning this effect and the time frame of their action 
has so far remained unclear largely due to a lack of tools to investigate the dynamic 
components of the host-pathogen interactions: where are the cidal hotspots? where is 
bacterial replication slowed down? when do bacteria die and when does replication take off? 
do inter-organ bacterial populations mix, and if so, when and where?   
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In this modelling study, I have addressed these questions for the 72-hour interval following 
the secondary intravenous challenge. To contextualise these findings and evaluate their 
impact, it is important to consider the different pathways of immunity that underpin the 
effects of the two vaccine formulations, and relate them to the patterns of intra-organ control 
inferenced from the data. Live vaccines based on mutations in the aromatic pathway have 
been shown to elicit both humoural and cellular immunity, both of which are recognised as 
important in the control of S. Typhimurium infections in the murine host (Mastroeni, 
Villarreal-Ramos and Hormaeche; 1993). Despite the ability of live-vaccines to induce a 
cellular response, a comparison of bacterial loads between T-cell positive and T-cell 
negative mice showed that the T-cell response elicited by the live-vaccine only became 
important after the 72-hour mark; as a result, the differential effects elicited by the two 
vaccine preparations in the 72-hour interval examined here are attributable to differences in 
humoural responses.  
 
Intravenous vaccination with a live S. Typhimurium vaccine has been found to elicit a a 
greater IgG2a and IgG2b antibody responses against a secondary S. Typhimurium  challenge, 
compared to the killed vaccine (Harrison et al., 1997). Later studies in the murine host 
showed that IgG2a antibodies bind FcγRI receptors and play a key role in enhancing the 
antimicrobial action of reactive oxygen intermediates (Goh et al., 2011; Uppington et al., 
2006). Furthermore, previous mechanistic modelling studies based on in vitro data on 
antibody treatment and infection of murine phagocytic cells showed that bacterial 
opsonisation with IgG2 may elicit a non-replicating bacterial phenotype, which is observed 
as initially low, but subsequently rising intracellular bacterial counts, given that bacteria are 
predicted to regain their proliferative capacities in these permissive host cells (Restif et al., 
2013). IgG2a has been pinpointed as the main antibody subclass whose levels appear to be 
significantly higher in the LV, as opposed to the KV and naïve groups. Indeed, the inferred 
early inoculum inactivation in the LV group agrees with the findings by Restif et al. (Restif 
et al., 2013). 
 
Between 0 and 6 hours, my estimates for the intra-organ dynamics differ from those reported 
by Coward et al. (Coward et al., 2014), who used a simplified model without organ-to-blood 
bacterial migration for inference in the naïve group. As shown in Chapter 3, the fit of this 
simplified model to the data is poor, and it is greatly improved by adding non-zero 
parameters for organ-to-blood migration (m21, m31) in the early stages of infection; the new 
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extended model leads to higher estimates for bactericidal activity in the liver of naïve mice 
(Chapter 3). By comparison to the naïve group, both the KV- and LV- groups exert 
bacteriostatic effects in the liver during the first 6 hours of infection, and bactericidal effects 
in the spleen, which can be explained by the fact that LV-enhance IgG-opsonization 
of Salmonella enhances the capacity of dendritic cells to deploy lysosomal-dependent 
degradation of the internalised bacteria, and to present antigenic peptide–MHC complexes 
in the spleen (Riquelme, Bueno and Kalergis, 2012). The relative abundance of dendritic 
cell populations in the spleen could explain the bactericidal activity inferred in the splenic 
compartment during the early phase of the infection.  
 
In the late phase of infection (24-48 hours) the dynamics in the vaccinated groups differ, 
with the LV-group exerting superior control on bacterial proliferation than the KV-group 
during the 24-48 hour interval in both the liver and the spleen (Figure 4.10(A)). As bacteria 
are mostly intracellular at this stage, it is possible that the differences in bacterial 
proliferation permissiveness between the two groups of immunised mice are attributable to 
differences in the interactions between the host cells and differentially-coated bacteria. 
Indeed, the main difference in antibody expression between the two vaccine preparations is 
the significantly higher levels of IgG2 in the LV group (Harrison et al., 1997). A later in 
vitro study used infections with S. Typhimurium coated with humanised antibody on human 
phagocytes and reported that IgG2-mediated phagocytosis was preferentially dependent on 
FcγRIIA than FcγRI receptors, while for all IgG subclasses (IgG1, IgG3, IgG4) bacterial 
internalisation depended more on FcγRI (Goh et al., 2011). Given the well-established 
heterogeneity in expression of FcγR receptor subtypes on the surface of different leukocyte 
types (Rosales, 2017; Patel, Roberts and Barb, 2019), it is possible that Salmonellae in the 
two immunised groups are preferentially phagocytosed by host cells with different 
permissiveness to intracellular proliferation. 
 
Overall, in this chapter I comparatively characterised the effects of a live-attenuated and an 
acetone-killed S. Typhimurium vaccine on the demographic events that underlie bacterial 
proliferation in the tissues during a 72-hour time interval following a secondary intravenous 
challenge. The early inoculum inactivation and superior control of intra-organ bacterial 
proliferation elicited by the LV-vaccine are both compatible with previously studied roles 
of IgG2, the IgG isotype whose expression is significantly higher in mice vaccinated with a 
live vaccine. Further in vivo research at the level of the single bacterium is needed to study 
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the effects of different vaccines on the association between different host cell types and 
bacteria. A blueprint for this kind of studies was recently provided by Kanvatirth et al. 
(Kanvatirth et al., 2020) who studied the host cell types that S. Typhimurium preferentially 
associates with before and after antibiotic treatment. Combining the insight from such 
studies can help determine whether basis of the differential vaccine success in infection 
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• The well-documented phenotypic heterogeneity of in vivo bacterial populations 
influences the impact different antibiotic therapies have on the within-host dynamics 
of bacteria.  
• Comparisons between different antibiotic classes can reveal whether bacterial 
phenotypic switch in response to antibiotics is universal or antibiotic specific, and 
whether these effects persist after antibiotic withdrawal.  
• I address this question by combining mathematical models with a single or a dual 
phenotype with ITS-based data using ciprofloxacin and ampicillin. 
• Inferences made regarding the rates at which the dynamics of S. Typhimurium 
change over time indicate that while ciprofloxacin acts via cidal mechanisms, 
ampicillin has mixed static and cidal effects. 
• Bacterial subpopulations surviving ampicillin treatment in the mesenteric lymph 
node (MLN) and spleen have adopted a non-replicating, antibiotic-recalcitrant 
phenotype. 
• Surviving bacteria in the ciprofloxacin-treated group are of the growing, antibiotic-
sensitive phenotype.  
• Following antibiotic withdrawal in ciprofloxacin-treated mice, growth rate in the 
blood, liver and spleen is higher on day 1 post-antibiotic withdrawal and, 
subsequently decreases. In ampicillin-treated mice, the liver, spleen and MLN are 
repopulated by progenitors of the non-growing antibiotic-recalcitrant bacteria. 
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• Declaration of Originality  
This chapter has been reproduced verbatim from a published research paper (Vlazaki et al., 
2020), for which I certify that I am the sole contributor in terms of study design, execution, 
and manuscript writing. I also certify that I have included the relevant citations, where 
appropriate. 
  





Antibiotic therapy has drastically reduced the mortality and sequelae of bacterial infections. 
From naturally-occurring to chemically-synthesised, different classes of antibiotics have 
been successfully used without detailed knowledge of how they affect bacterial dynamics in 
vivo. However, a proportion of patients receiving antimicrobial therapy develop 
recrudescent infections post-treatment. Relapsing infections are attributable to incomplete 
clearance of bacterial populations following antibiotic administration; the metabolic profile 
of this antibiotic-recalcitrant bacterial subpopulation, the spatiotemporal context of its 
emergence and the variance of antibiotic-bacterial interactions in vivo remain unclear. Here, 
we develop and apply a mechanistic mathematical model to data from a study comparing 
the effects of ciprofloxacin and ampicillin on the within-host dynamics of Salmonella 
enterica serovar Typhimurium in murine infections. Using the inferential capacity of our 
model, we show that the antibiotic-recalcitrant bacteria following ampicillin, but not 
ciprofloxacin, treatment belong to a non-replicating phenotype. Aligning with previous 
studies, we independently estimate that the lymphoid tissues and spleen are important 
reservoirs of non-replicating bacteria. Finally, we predict that post-treatment the progenitors 
of the non-growing and growing bacterial populations replicate and die at different rates. 
Ultimately, the liver, spleen and mesenteric lymph nodes are all repopulated by progenitors 
of the previously non-growing phenotype in ampicillin-treated mice. 
 
Relevant published output:  
1. Vlazaki M, Rossi O, Price DJ, McLean C, Grant AJ, Mastroeni P, Restif O. 2020 A 
data-based mathematical modelling study to quantify the effects of ciprofloxacin and 
ampicillin on the within-host dynamics of Salmonella enterica during treatment and 
relapse. J. R. Soc. Interface 20200299. 
  




In the modern era, antibiotics are the cornerstone of therapeutics in bacterial disease 
treatment (Center for Disease Control, 2019). The term “antibiotics” refers to a 
heterogeneous collection of naturally-derived or chemically synthesised compounds which 
clear bacterial infections through various biochemical mechanisms, including inhibition of 
cell wall synthesis, bacterial lysis, nucleic acid and protein synthesis inhibition (reviewed in 
Kohanski, Dwyer and Collins, 2010). Antibiotics are traditionally classified as either 
bactericidal reducing bacterial load by killing bacteria, bacteriostatic acting to limit bacterial 
loads by keeping bacteria in a stationary growth phase, or both (Wilson and Miles, 1964; 
Bernatová et al., 2013).  
 
The effect of different antibiotics on bacterial dynamics has been studied extensively in vitro, 
in optimally and homogeneously growing bacterial populations harvested from 
exponentially growing cultures (McCall et al., 2019). Conclusions drawn from these studies 
provide insights into the mode of action of different antibiotic agents on their bacterial 
targets; however, their clinical relevance remains unknown, as in vivo bacterial populations 
are characterised by heterogeneity in their growth and dissemination dynamics (Claudi et 
al., 2014; Bumann and Cunrath, 2017; Dewachter, Fauvart and Michiels, 2019; Haugan et 
al., 2018). Upon successful colonisation, in vivo bacterial behaviour is multifactorially 
shaped by nutrient availability (Claudi et al., 2014; Shehata and Marr, 1971), host immunity 
(Grant et al., 2008; Gjini and Brito, 2016, Duneau et al., 2017) spatial arrangement of the 
infectious foci (Bottery et al., 2019), and host cell composition in the immediate bacterial 
vicinity (Kolter, Siegele and Tormo, A. 1993; Kanvatirth et al., 2020). The landscape of 
within-host bacterial dynamics is further complicated by the induction of stress responses in 
bacterial populations exposed to antibiotics, which alter the bacterial metabolic and 
transcriptional profile, slow down or stop replication, and ultimately affect the pathogen’s 
susceptibility to the antibiotic (Kaldalu, Hauryliuk and Tenson, 2016). These adaptations 
may lead to incomplete clearance of the bacterial load as a result of the emergence of an 
antibiotic-recalcitrant, yet genetically non-resistant, bacterial subpopulation, termed 
“persister” (Kim and Wood, 2016; Bigger, 1944).  
 
An important caveat of in vitro studies using optimally growing bacteria from exponential 
phase cultures is disregarding the influence of the bacterial growth rate on the therapeutic 
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effect of some classes of antibiotics. All clinically-used antibiotic classes exert their 
maximum therapeutic effect when applied to optimally growing bacteria, where cidal agents 
clear 99.9% of the bacterial load under clinically relevant regimens (Ferro et al., 2015; 
Nielsen, Cars and Friberg, 2011; Regoes et al., 2004). However, in vitro studies with 
Escherichia coli and Staphylococcus aureus have revealed that even though different 
antibiotic classes are homogeneously effective on exponential phase bacteria, they exert 
heterogeneous effects on slowly-replicating and non-replicating bacterial populations. 
Depending on which bacterial functions they target, different antibiotic classes are more or 
less active against slow- or non-replicating bacteria (Zeiler and Voigt, 1987; Fantin et al., 
1991; McCall et al., 2019; Haugan, Løbner-Olesen, and Frimodt-Møller, 2018). 
 
For example, beta-lactam antibiotics (natural and synthetic penicillin-like compounds), like 
ampicillin, have a range of pharmacological targets including bacterial cell wall synthesis 
and bacterial autolysis pathways amongst others (Ghooi and Thatte, 1995), resulting in both 
bacteriostatic and bactericidal properties respectively. However, bacteriostatic effects 
attributable to bacterial cell wall disruption may act antagonistically to the bactericidal 
effects due to bacterial lysis (Ghooi and Thatte, 1995). This antagonistic relationship has 
been experimentally observed in vitro as a positive correlation between the cidal effect of 
beta-lactams and the growth status of the targeted bacteria (Lee et al., 2018; Tuomanen et 
al., 1986) This class of antibiotics induces structural changes in the bacterial peptidoglycan 
cell wall leading to cell lysis via a bulge-mediated process (Yao, Kahne and Kishony, 2012) 
whether these morphological changes modulate bacterial replication rates and to what extent 
this phenotypically static effect antagonises the cidal action of the drug requires further 
investigation (Ocampo et al., 2014). 
 
In contrast, quinolones, like ciprofloxacin, predominantly target the transcriptional 
machinery of the bacteria, and thus do not slow down bacterial growth at clinically relevant 
concentrations (Cui et al., 2018). They act as DNA gyrase inhibitors, stalling bacterial 
chromosome replication through the formation of double-strand DNA breaks, thus 
preventing the replication forks from accessing the terminus (Drlica et al., 2007). Unlike 
beta-lactams whose efficacy has been linearly correlated with bacterial growth rate (Lee et 
al., 2018; Tuomanen et al., 1986), quinolones act on heterogeneously growing bacteria so 
long as they remain transcriptionally active (Sanders, 1988). Unlike other antibiotics the 
bactericidal activity of ciprofloxacin is not affected by the bacterial growth rate, both in in 
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vitro optimally-growing bacterial populations and in in vivo bacterial populations displaying 
heterogeneity in replication rates (Haugan, Løbner-Olesen and Frimodt-Møller, 2018). 
 
Unlike bacteria in cultures, the heterogeneity of bacterial growth dynamics in vivo is far 
greater. A substantial body of literature has been dedicated to studying the in vivo effects of 
antimicrobial therapy on murine infections with Salmonella enterica serovar Typhimurium, 
especially focusing on slow- or non-replicating bacterial cells during antibiotic exposure. 
Despite the fundamental in vitro differences in the modes of action of different antibiotic 
classes, a large proportion of in vivo experimental studies involving naturally-occurring 
heterogeneously-replicating bacterial populations have been conducted using second-
generation fluoroquinolone agents (either enrofloxacin or ciprofloxacin) in murine 
infections with S. Typhimurium (Claudi et al., 2014; Helaine et al., 2014; Kaiser et al., 2014). 
Using fluorescent-based techniques for observation of bacterial dynamics at the single-cell 
level, these studies have identified the lymphoid tissues and the spleen as sites of highest 
persister concentration (Helaine et al., 2014) have tried to address the replication dynamics 
of persisters’ progenitors (Claudi et al., 2014; Helaine et al., 2014) have provided insights 
in the inter-organ bacterial exchange during the gastrointestinal phase of infection (Kaiser 
et al., 2014) and have studied antibiotic-driven persistence in the context of cooperative 
virulence (Diard et al., 2014) and promotion of antibiotic resistance (Bakkeren et al., 2019).  
A later study by Rossi et al. (Rossi et al., 2017) used clinically-relevant concentrations of 
both a beta-lactam and a second-generation fluoroquinolone antibiotic later in the infection 
process (72 hours post-inoculation) to qualitatively characterise and compare the effect of 
the antibiotics on the within-host Salmonella dynamics, thus providing a blueprint for using 
murine infections with Isogenic Tagged Strains (ITS) to address questions on the effects of 
antibiotic therapy on bacterial dynamics in vivo.  
 
Differences in the experimental design of these studies, including timing, dose, route of 
antibiotic administration, tissues examined and experimental techniques have unravelled 
different facets of the effects of antibiotic therapy on different tissues, as summarised in 
table 5.1.  
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Table 5.1: Review of in vivo studies on the effects of antibiotic treatment on S. Typhimurium 
dynamics.  
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Despite the growing interest in characterising the effect of antibiotic treatment on different 
tissues, quantitative approaches to infer and separately quantify unobserved processes such 
as bacterial replication, death, migration and phenotypic switch remain underrepresented. 
Additionally, it is now commonly accepted that non-replicating bacterial subpopulations 
emerge as a result of antibiotic-exposure. However, the effect of different antibiotic classes, 
the tissues of origin of phenotypic variants, and the time point of emergence of these non-
growing subpopulations still remain ambiguous. Finally, how bacterial populations recover 
in different tissues following antimicrobial withdrawal and how non-growing antibiotic-
recalcitrant bacteria regain their replicative capacity during the relapse phase of an infection 
are both questions directly relevant to our understanding of bacterial disease recrudescence 
underpinning chronic infections. 
 
An important first step to address these knowledge gaps was taken by Rossi et al. in their 
ITS-based study of the comparative effects of ampicillin and ciprofloxacin on S. 
Typhimurium in vivo (Rossi et al., 2017). The novel contributions of the study included the 
use of both a beta-lactam and a fluoroquinolone antibiotic to directly compare their effects 
in the same experimental setup, the study of both the treatment and the relapse phase, the 
use of clinically relevant doses of antibiotics after the appearance of symptoms in line with 
the anticipated clinical response, instead of supramaximal early therapy, and data collection 
on 4 different organs involved in the systemic phase of infection, addressing not only intra- 
but also inter-organ dynamics. Finally, unlike previous studies carried at the single bacterial 
level, Rossi et al. used a bacterial population-level experimental technique (ITS) in a 
biological system with well-established heterogeneity in its dynamics (Claudi et al., 2014; 
Helaine et al., 2014; Kaiser et al., 2014).  
 
In this follow-up study, we complement the bacterial population-level outputs of this study 
by developing a family of mechanistic mathematical models to identify and quantify the 
experimentally unobserved processes of bacterial replication, death, inter-organ migration 
and phenotypic switch that collectively underpin the qualitative changes in the net bacterial 
number in different organs documented in Rossi et al. (Rossi et al., 2017). We perform a 
simulation-based study to show that heterogeneities in bacterial phenotypes can be 
detectable from data collected at the level of the whole bacterial population. This 
methodological finding expands the scope of questions that can be addressed using well-
established techniques such as ITS. Motivated by the well-documented emergence of a 
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persister, antibiotic-recalcitrant bacterial subpopulation upon antibiotic administration, we 
consider two models: (1) the single-phenotype model (SP) assumes a bacterial population 
with uniform dynamics, with each biological process described by a single parameter 
representing the average rate at which the process occurs, and (2) the dual-phenotype model 
(DP) assumes that the observed output of changing bacterial load in tissues is shaped by two 
bacterial subpopulations with different dynamics in vivo: one is a replicating, antibiotic-
sensitive subpopulation, and the other is a non-replicating, antibiotic-recalcitrant 
subpopulation (Balaban, 2004). By comparing how well the best model within each of these 
two classes of models can recapitulate the experimentally observed dynamics, we infer that 
at clinically-relevant doses ampicillin, but not ciprofloxacin, induces a non-growing 
antibiotic-recalcitrant bacterial subpopulation.  
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5.2. Methods  
 
5.2.1. Experimental Dataset Structure  
This is a mathematical modelling study using experimental data by Rossi et al. (Rossi et al., 
2017) on the effect of ampicillin and ciprofloxacin on the within-host dynamics of wild-type 
S. Typhimurium in the murine host. Two groups of C57BL/6 mice were inoculated 
intravenously with an equiproportionate mix of 8 Isogenic Tagged Strains (ITS) of S. 
Typhimurium amounting a total of 1000 colony-forming units (CFU). The infections were 
allowed to develop for 72 hours, at which time a proportion of the mice from each group 
was culled, their organs harvested (either partially or in totality), homogenised and plated to 
determine the number of CFUs per organ/sample. Furthermore, genomic DNA was prepared 
from the recovered bacteria and these DNA samples were subjected to next generation 
sequencing (NGS) in order to determine the proportion at which each of the 8 ITS was 
present.  
 
Of the remaining mice, group A was started with 300 mg/kg ampicillin and group C was put 
on a 40 mg/kg ciprofloxacin regimen intraperitoneally (i.p.) per day (maximum 
recommended dosage for veterinary treatment of small rodents) (Carpenter, 2012; Hawk, 
Leary and Morris, 2005). Antibiotic treatment was maintained for 96 hours; a proportion of 
mice was killed at 24-hour intervals to determine the per organ total CFU count and ITS 
composition. In total, data were collected at 4 equally spaced time points during the 
antibiotic treatment.  
 
For the last phase of the study, the antibiotics were stopped, and the infection was allowed 
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5.2.2. Conceptual Model Structure  
The liver, spleen and mesenteric lymph nodes (MLN) are well-established reservoirs for 
Salmonellae (Grant et al., 2008; Kaiser et al., 2015) while bacteraemia is also a hallmark of 
systemic salmonellosis. On the basis of previous biological insight and prior modelling 
attempts, and acknowledging that the enteric-systemic interface has not been extensively 
studied in tandem, we first considered a general compartmental model allowing all possible 
connections between the key organs for which data were available, and with a single-
phenotype bacterial population characterised by homogeneous dynamics (Figure 5.1). The 
parameters governing the transitions in the model, and mapping to the biological processes 
in vivo are described in table 5.2.  
 
 
Figure 5.1: Generalised single-phenotype model with free inter-organ bacterial 
migration between the blood, liver, MLN and spleen, and with intra-organ bacterial 
death and replication in the all organs.  
 
As an extension to the single-phenotype model and given the prolonged exposure to 
antibiotic-induced stressed, we proceeded to formulate a dual-phenotype model (Figure 5.2). 
This model assumes the emergence of a bacterial subpopulation which is non-replicating 
and survives antibiotic treatment (Figure 5.2). 
 




Figure 5.2: The dual-phenotype (DP) model encompasses a phenotypic switch from replicating 
bacteria susceptible to killing to non-growing, antibiotic-recalcitrant subpopulations in the 



























m1.2 Bacterial migration from the blood to the liver 
m1.3 Bacterial migration from the blood to the MLN 
m1.4 Bacterial migration from the blood to the spleen 
m2.1 Bacterial migration from the liver to the blood 
m3.1 Bacterial migration from the MLN to the blood 
m4.1 Bacterial migration from the spleen to the blood 
m2.3 Bacterial migration from the liver to the MLN 
m2.4 Bacterial migration from the liver to the spleen 
m3.2 Bacterial migration from the MLN to the liver 
m4.2 Bacterial migration from the spleen to the liver 
m3.4 Bacterial migration from the MLN to the spleen 






m5.6 Bacterial migration from the blood to the liver 
m5.7 Bacterial migration from the blood to the MLN 
m5.8 Bacterial migration from the blood to the spleen 
m6.5 Bacterial migration from the liver to the blood 
m7.5 Bacterial migration from the MLN to the blood 
m8.5 Bacterial migration from the spleen to the blood 
m6.7 Bacterial migration from the liver to the MLN 
m6.8 Bacterial migration from the liver to the spleen 
m7.6 Bacterial migration from the MLN to the liver 
m8.6 Bacterial migration from the spleen to the liver 
m7.8 Bacterial migration from the MLN to the spleen 





k1 Bacterial death in the blood 
k2 Bacterial death in the liver 
k3 Bacterial death in the MLN 
k4 Bacterial death in the spleen 
r1 Bacterial replication in the blood 
r2 Bacterial replication in the liver 
r3 Bacterial replication in the MLN 






s2.6 Switch from P1 to P2 in the liver 
s6.2 Switch from P2 to P1 in the liver 
s3.7 Switch from P1 to P2 in the MLN 
s7.3 Switch from P2 to P1 in the MLN 
s4.8 Switch from P1 to P2 in the spleen 
s8.4 Switch from P2 to P1 in the spleen 
s1.5 Switch from P1 to P2 in the blood 
s5.1 Switch from P2 to P1 in the blood 
 
Table 5.2: Description of parameters used in the mechanistic models 
P1 refers to the growing, antibiotic-sensitive bacteria and P2 refers to the non-growing, antibiotic-
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5.2.3. The modelling framework  
Mathematically, these models (Figures 5.1 and 5.2) are translated into multivariate 
continuous-time Markovian processes (Markov, 1906), with stochastic variables each 
representing the number of bacteria in the blood, liver, spleen and MLNs (observed 
experimental output). The dynamics of such processes, in particular the probability that the 
system is at a given state at any particular time point, can be summarised by the forward 
Kolmogorov equation, which describes this probability in terms of the contribution of each 
of the biological processes included in the mechanistic model (bacterial replication, killing, 
migration and phenotypic switch). In this case, the state refers to a vector consisting of the 
number of bacteria in all 4 locations at the time point of interest. Transitions between 
different states, i.e. any change in the number of bacteria in any of the tissues of interest over 
time, are driven by dynamical processes quantified by parameters, reflecting the rate of 
development of unobserved bacterial dynamics in time.  
 
5.2.3.1. Summary statistics for cross-distribution comparison 
For a multivariate stochastic system, the overarching forward Kolmogorov equation 
becomes analytically intractable for multi-compartmental systems with numerous 
parameters. To avoid the step of solving the probability density function characterising the 
multivariate bacterial distribution, we use summary statistics to capture the necessary 
features of interest. Our models only incorporate zero-order dynamics, thus the first- (mean 
numbers of bacteria in each organ) and second-order (variance-covariance matrix of 
bacterial numbers in all organs) moments suffice to describe the distribution (Price et al., 
2017). 
5.2.3.2. Divergence minimisation parameter inference framework 
Here, we solve the mathematical models retrospectively using experimentally measured 
outputs (numbers of bacteria per organ) with the aim to estimate the values of unobserved 
processes, which correspond to parameters characterising bacterial replication, death, 
migration and switching to a non-growing phenotype. To achieve this, we use a likelihood-
free inference framework, which overrides the problem of intractability. As the multivariate 
distribution is characterised by a set of first- and second- order moments, it is possible to 
explore parameter value combinations with the aim of reaching a distribution that 
approximates the experimentally observed bacterial distribution as closely as possible. This 
is achieved by minimising a quantity (cost function) that cumulatively expresses the 
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divergences between each experimentally-observed and predicted pair of moments (Price et 
al., 2017). In this case we choose the Kullback-Leibler divergence as the cost function to be 
minimised.  
Parameter inference was performed using the freely available SPEEDI.R package (Price and 
Restif, 2017) and the Nelder & Mead (Nelder and Mead, 1965) optimisation algorithm.  
 
5.2.3.3. Parametric bootstrap for quantification of inference precision and 
assessment of model goodness-of-fit 
 
Goodness-of-fit is a measure of how well a given model captures the experimental data. 
Here, we use a parametric bootstrap approach to assess model goodness-of-fit. Using 
minimum-divergence moments-based inference, we identify the set of parameters that 
correspond to first- and second- order moments and yield the smallest divergence from the 
observed moments. This set of moments is referred to as the predicted moments and the 
corresponding parameter set as the predicted parameters. 
 
Using the predicted parameters, we simulate 500 samples of size emulating the number of 
observations (10 mice x 8 ITS = 80 or 5 mice x 8 ITS = 40) per time point in the experimental 
dataset. For each simulated sample, we calculate the corresponding moments and compare 
each set of moments with the predicted moments to obtain a divergence value. We refer to 
those moments as simulated moments. If each of the experimental moments fall into their 
respective distribution of simulated moments, the goodness-of-fit is adequate and the model 
can be accepted as plausible.  
 
We, then, use the simulated moments to anew infer the range of parameter values, which 
provide the confidence intervals for our original parameter estimates, and thus serve as a 
measure of the inference precision.   
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5.3. Results  
5.3.1. Simulation study for the detection of heterogeneity in ITS data  
Using infections with mixed inocula comprising ITS it is possible to infer the rates at which 
inter- and intra-organ dynamics of infection change over time. However, it has not hitherto 
been shown whether data from ITS-based studies can be used to address questions about 
heterogeneity in within-host dynamics. Here, we are interested in comparing the 
performance of a SP model assuming a single bacterial population with uniform dynamics, 
and that of a DP model assuming two bacterial subpopulations with different dynamics, 
described in section 5.2.2.  
 
We performed a simulation-based study to investigate whether bacterial populations with 
uniform replication and death dynamics could be reliably distinguished from bacterial 
populations composed of both a growing, antibiotic-sensitive subpopulation and a non-
growing, antibiotic-recalcitrant subpopulation, by applying mechanistic models to simulated 
data from synthetic ITS-based “experiments”. 
 
We simulated 10 synthetic datasets with different parameter sets from the dual phenotype 
DP-model. We then applied both the SP- and DP-models to the 10 synthetic datasets to 
obtain a best parameter estimate, and as per 5.2.2.3, we used a parametric bootstrap approach 
to generate 500 bootstrapped samples for each of the 10 synthetic datasets under the two 
models. We finally performed a pairwise comparison of their goodness-of-fit. 
 
We used two tools to evaluate the goodness-of-fit of the SP- and DP- models to the synthetic 
datasets. The first was the pairwise comparison of the KL divergences; a lower divergence 
indicates a better fit between the model and the synthetic data. The second tool was the 
pairwise comparison of the similarity between each synthetic dataset and its bootstrapped 
samples when the DP- or SP- model was used respectively. To this end, for each of the two 
models we obtained the mean value and standard deviation of each moment for the 500 
bootstrapped samples and calculated the number of standard deviations between each true 
moment value and the mean value from the bootstrapped samples. 
 
For all 10 synthetic datasets simulated from the DP-model, the DP-model gave consistently 
lower Kullback-Leibler (KL) divergence values by two orders of magnitude, compared to 
the SP-model (shown in Table 5.3). When applied to DP-data, the bootstrapped samples 
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from the DP-model were more similar to the original synthetic data than bootstrapped 
samples from the SP-model (Figure 5.3). 
 
Overall, this simulation study shows that phenotypic heterogeneity at the level of two 
subpopulations is detectable from ITS-based data collected at the level of the entire bacterial 




KL divergence from DP- 
model 
KL divergence from SP- 
model 
1 0.0031 0.55 
2 0.0053 1.38 
3 0.0041 0.88 
4 0.0013 0.20 
5 0.0026 1.17 
6 0.0045 0.47 
7 0.0017 0.46 
8 0.0045 0.45 
9 0.0012 0.92 
10 0.0046 1.16 
 
 
Table 5.3: Pairwise comparison of KL-divergence values from DP- and SP- model fitting to 
synthetic datasets simulated from the DP-model. 
 





Figure 5.3: Comparison of SP- and DP- model performance on synthetic data simulated from 
the DP-model. 
 
Each of the horizontal panels (1-10) represents the fit between one synthetic dataset and the SP- and 
DP-models in blue and red respectively. The blue and red dots represent the number of standard 
deviations between the moments of the virtual dataset and the mean value of 500 bootstrapped 
datasets generated from the best parameter set in the SP and DP model respectively. The moment 
indices in the x-axis refer to the 14 means, variances and covariances used as summary statistics of 
the ITS distributions in the 4 organs. The number of standard deviations is always near-zero when 
the DP-model is applied (red), while consistently higher when the SP- model is applied (blue).  
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5.3.2. Model Selection  
First, we identified the best-fitting, most parsimonious model from the family of single-
phenotype (SP) models, whose structure is shown in Figure 5.1. Starting from a fully 
parameterised model (12 parameters), we fitted sequentially simpler models (nested models) 
to data from ampicillin- and ciprofloxacin treated mice day-by-day for 4 days of total 
treatment and 2 days post-treatment. For each treatment group, we used the ITS counts per 
organ at 72 hours post-inoculation as the starting point and the respective ITS counts at 24 
hours post-treatment to mark the end of the first day of the antibiotic regimen, and inferred 
the best parameter estimate set, as detailed in 5.2.5.1. We repeated the same inference 
process to estimate the parameter values for each time interval separately, totalling four time 
intervals during antibiotic treatment and 2 during the relapse phase. 
 
We repeated the same process for the family of DP models, whose structure is shown in 
Figure 5.2. The best-fitting models for the SP and DP family of models are comparatively 
summarised for each time interval, in the ampicillin- and ciprofloxacin-treated groups. Note 
that where the DP model offers no improvement in fitting the experimental data, the best DP 




































SP Ampicillin 1 k1,k2,k3,k4,r2,r3,r4,m4.2 8 0.66 
DP Ampicillin 1 k1,k2,k3,k4,r2,r3,r4,m4.2 8 0.63 
SP Ampicillin 2 k1,k2,k3,k4,r2,r3, r4 7 0.98 
DP Ampicillin 2 k1,k2,k3,k4,r2,r3, r4 7 0.93 
SP Ampicillin 3 k1,k2,k3,k4,r2r3,r4 7 1.60 
DP Ampicillin 3 k1,k2,k3,k4,r2,r3,r4,m4.8,m8.6 10 0.56 
SP Ampicillin 4 k1,k2,k3,k4,r3,r4, m1.4 7 0.50 
DP Ampicillin 4 k1,k2,k3,k4,r1,r2,r3,r4,m3.7,m4.8 10 0.49 
SP Ampicillin 5 k2,k3,k4,r1,r2,r3,r4 8 0.58 
DP Ampicillin 5 k2,k6,k7,k8,r1,r2,r6,r7,r8 9 0.12 
SP Ampicillin 6 k1,k2,k3,k4,r1,r2,r3,r4 8 0.73 
DP Ampicillin 6 k1,k2,k6,k7,k8,r1,r2,r6,r7,r8 10 0.39 
 
Table 5.4: Comparative summary of best-fitting SP- and DP- models in the ampicillin-






























SP Ciprofloxacin 0-24 k1,k2,k3,k4,r1,r2,r3,r4 8 0.06 
DP Ciprofloxacin 0-24 k2,k4, r2,r4,m3.7,m1.2 6 0.40 
SP Ciprofloxacin 24-48 k1,k2,k3,k4,r1,r2,r3,r4,m2.4 8 2.91 
DP Ciprofloxacin 24-48 k1,k2,k4,r2,r4,m2.4,m3.7,m4.8, 
m8.6 
8 3.40 
SP Ciprofloxacin 48-72 k1,k2,k3,k4,r1,r2,r3,r4,m2.4 9 0.25 
DP Ciprofloxacin 48-72 k1,k2,k3,k4,r1,r2,r3,r4,m1.4,m4.8, 
m2.6,m8.4,m6.2,m7.3 
14 0.33 
SP Ciprofloxacin 72-96 k2,k3,k4,r1,r2,r3,r4 7 0.14 
DP Ciprofloxacin 72-96 k2,k3,k4, r1,r2,r3,r4,m4.8,m8.4, 
m6.2 
10 0.19 
SP Ciprofloxacin 96-126 k2,k3,k4,r1,r2,r3,r4 7 0.54 
DP Ciprofloxacin 96-126 k2,k3,k4,k5,k7,k8,r2,r3,r4,r5,r7,r8, 
m6.8 
13 0.85 
SP Ciprofloxacin 126-140 k1,k2,k3,k4,r1,r2,r3,r4,m2.4 9 0.38 
DP Ciprofloxacin 126-140 k1,k2,k3,k4,r1,r2,r3,r4,m2.4 9 0.38 
Table 5.5: Comparative summary of best-fitting SP- and DP- models in the ciprofloxacin-
treated mice  
 
Having identified the best-fitting model from each model family for each of the 6 time 
intervals considered in each of the 2 treatment groups, we then assessed whether the 
divergence of the best predicted model from the experimental data can be recapitulated by 
bootstrapped datasets simulated from the best parameter set corresponding to the best fitting 
models. Given that the DP model family is more complex than the SP model family, we 
chose the best-fitting DP model as superior to the best-fitting SP model only if bootstrapped 
data from the former were consistently more similar to the experimentally observed data 
than synthetic data from the SP model.  
 
S. Typhimurium dynamics in the antibiotic-treated host    Results 
154 
 
To quantify the similarity between the experimentally observed and bootstrapped data 
produced from either the best-fitting SP or the best-fitting DP models, we calculated the 
first- and second-order moments for each of the 500 bootstrapped datasets produced from 
each of the best-fitting models per time interval per treatment group, followed by the mean 
and standard deviation for each of those moments. As illustrated in Figure 5.4, we then 
calculated in standard deviations the distance between the moments from the experimentally 
observed data and the mean values for the moments of the bootstrapped samples, similarly 
to 5.3.1.  
 
 
Figure 5.4: Comparison of SP and DP model performance assessing the relationship between 
model-based simulations and observed experimental values 
The blue and red dots represent the number of standard deviations between the experimentally 
observed moments and the mean value of 500 bootstrapped datasets generated from the best 
parameter set in the SP and DP model respectively, for each time point. The indices in the x-axis 
refer to the 14 means, variances and covariances used as summary statistics of the ITS distributions 
in the 4 organs. The enumeration of the horizontal panels (1-6) refers to the number of days after the 
start of antibiotic treatment. In ampicillin-treated mice, improvement in the model fit with the DP 
model is shown by an overall reduction of the number of standard deviations between the 
experimentally observed moments and the mean value of 500 parametric datasets, especially during 
days 2, 3 and 5. In ciprofloxacin-treated mice, there is no consistent improvement when the DP 
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5.3.3. SP and DP model comparison in ampicillin-treated mice  
We applied the SP model, described in section 5.2.2., to the dataset from the ampicillin-
treated group. Upon obtaining the best parameter estimates for each time interval, we 
simulated 500 bootstrapped datasets to obtain a distribution of values for each of the 
moments. We expected that in a well-fitting model, the experimentally observed moments 
would fall within the distribution of bootstrapped moments. Figure 5.5 summarises the 
results of the fit of the DP- and SP- model to the experimental data, showing that the DP-




Figure 5.5: Comparison between the fit of the SP- and DP- models to the experimental data. 
Each of the boxplots captures the distribution of 500 bootstrapped values for each of the 14 first- and 
second-order moments, while each red dot represents the value of the same moment from the 
experimentally observed data. Improvements can be seen in moments with indices 8, 9, 10, 11 and 
14 on day 3, moments with indices 1, 6, 8, 9, 10, 11 and 13 on day 4, and moments with indices 6, 
8, 12 and 14 on day 5. The improvement mostly concerns the variances (indices 4-8) and covariances 
(indices 8-14).  
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5.3.4. SP model-fit in ciprofloxacin-treated mice 
We then applied the SP-model, described in section 5.2.2., to the dataset from the 
ciprofloxacin-treated group and obtained a distribution of values for each of the moments, 
as in 5.3.2. Here, we show that throughout the treatment and relapse phase, the 
experimentally observed moments can be recapitulated by simulations from the SP-model 




Figure 5.6: Experimental moments in relation to moments from synthetic data using the best-
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5.3.5. Intra-organ dynamics during the treatment phase  
Our models predict that ampicillin and ciprofloxacin exert different effects on intra-organ 
bacterial dynamics in terms of their bactericidal and bacteriostatic effects (Figure 5.7). While 
in ciprofloxacin-treated mice, bacterial replication occurs throughout the duration of 
treatment in all four organs, ampicillin suppresses bacterial replication, particularly in the 
blood and in the late phase of treatment in the spleen and MLN. The occasionally wide 
confidence intervals in our estimates are explained by the correlation between replication 






Figure 5.7: 95% confidence 
intervals of intra-organ 
replication and killing rates 
estimated from 500 
parametric bootstrapped 
samples from the best 
parameter estimates. 
 
Panel A comparatively shows 
the replication rates for 
ampicillin-treated and 
ciprofloxacin-treated groups, 
while panel B shows the killing 
rates for the two groups. The 
dots represent the mean values 
across 500 parametric 
bootstrapped samples from the 
best parameter estimates, while 
the bars represent the lower 
and upper boundaries of the 
95% confidence intervals. The 
cidal activity in ciprofloxacin-
treated mice culminates after 3 
days of treatment, while the 
static effects of ampicillin peak 
after 4 days of treatment.  
 




Figure 5.8: Bivariate 95% confidence regions of intra-organ replication and killing rates (500 
bootstrapped samples) for ciprofloxacin-treated mice 1 day after treatment. 
The black, blue and red ellipses illustrate the bivariate 95% confidence regions for replication and 
killing rate in the liver, spleen and MLN respectively during day 3 after the start of ciprofloxacin 
treatment. The large length of the major axis of the ellipse represents the high correlation between 
replication and killing parameter estimates, which accounts for the large confidence intervals seen 
in Figure 5.7. Diagonal grid lines indicate net growth rates (replication rate-killing rate). In the liver 
and spleen, cidal effects are stronger leading to a negative net growth rate, while net growth in the 
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5.3.6. Non-growing subpopulations recalcitrant to antibiotic therapy in ampicillin-
treated mice 
In ampicillin-treated mice, the best-fitting DP-model predicts the emergence of a non-
growing, antibiotic-recalcitrant bacterial subpopulation. Our inference shows that this 
bacterial subpopulation emerges 48 hours after treatment with ampicillin at varying 
proportions in different organs and over time. By 72 hours of treatment, non-growing 
antibiotic-recalcitrant bacteria originating from the spleen have migrated to the liver. By 96 
hours, the entirety of the bacterial population in the MLN and spleen have switched to the 
non-growing, antibiotic-insensitive phenotype, as summarised in Figure 5.9.  
 
 
Figure 5.9: Proportion of persister bacteria in the blood, liver, MLN and spleen during 
ampicillin-treatment. 
The confidence intervals for the proportion of persister bacteria are expressed as a fraction of total 
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5.3.7. Dynamics in the relapse phase  
Following withdrawal of the 4-days of antibiotic treatment, bacterial infection relapses in 
both ampicillin- and ciprofloxacin-treated groups, with positive net growth rates in the first 
30 hours post-withdrawal. In the ampicillin-treated group, the progeny of the growing 
subpopulation has a different net growth to that of the non-growing, antibiotic-recalcitrant 
one in the liver (Liver (P)), MLN (MLN (P)) and spleen (Spleen (P)), shown in figure 5.10. 
 
 
Figure 5.10: 95% confidence intervals of net growth rates (replication - killing rate) during 
relapse, estimated from parametric bootstrapped samples based on the best set of parameter 
estimates. 
In the ciprofloxacin-treated group with the predicted single bacterial phenotype, the relapse phase is 
characterised by positive net growth across all organs, with small fluctuations during the 2 days post 
ciprofloxacin withdrawal. In the ampicillin-treated group, the comparison between the net growth 
rates for the progenitors of the previously non-growing subpopulation with those of their previously 
growing counterparts in the liver shows that the former are consistently higher than the latter. 
Following bacterial relapse, all organs are repopulated by progenitors of the previously non-growing, 
antibiotic-recalcitrant subpopulation.  
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To understand what drives the extinction of the previously growing antibiotic-sensitive 
population in the liver of ampicillin-treated mice, we compare the killing and replication 
rates between the progeny of the previously growing and the persister population (Figure 
5.11).  
 
Figure 5.11: 95% confidence 
intervals of intra-organ 
replication and killing rates 
estimated from 500 parametric 
bootstrapped samples from the 
best parameter estimates during 
the relapse phase. 
Panel A comparatively shows the 
replication rates for ampicillin-
treated and ciprofloxacin-treated 
groups, while panel B shows the 
killing rates for the two groups. 
The dots represent the mean values 
across 500 parametric bootstrapped 
samples from the best parameter 
estimates, while the bars represent 
the lower and upper boundaries of 
the 95% confidence intervals. In 
the ampicillin-treated mice, 
progeny of the non-growing 
antibiotic-recalcitrant bacterial 
reservoir in the liver (Liver (P)) 
replicate at a higher rate on average 
compared to the progenitors of 
their previously growing 
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5.4.  Discussion 
In the present data-based modelling study, we set out to quantify the effects of ciprofloxacin 
and ampicillin on the in vivo dynamics of S. Typhimurium in the murine host. 
Complementing previous studies, this is a mathematical modelling study based on data 
collected at the level of the bacterial population, using a virulent SL1344 Salmonella strain 
in C57BL/6 immunocompetent mice that have not been pre-treated with antibiotics. We used 
data from mouse infections with two different classes of antibiotics, one beta-lactam and 
one fluoroquinolone to directly compare their in vivo effects on the bacterial dynamics in an 
intravenous infection of wild-type mice, closely mimicking the systemic phase of non-
typhoidal salmonellosis (Rossi et al., 2017).  
 
The inferential capacity of our mechanistic models is dependent on quantitative signals 
present in the experimental data collected by Rossi et al. (Rossi et al., 2017) i.e. changes in 
the mean number of ITS copies per organ during time, their variance and their joint 
variability across all organs (covariance). Mathematical models can make use of the 
direction, magnitude and collective effect of these changes to maximise the insight provided 
by experimental data, especially if the changes in the mean numbers, which constitute the 
primary tool for qualitative inference, are not strikingly dissimilar. Our simulation study 
shows that when a single-phenotype model is applied to data from a dual-phenotype system, 
there is consistent misestimation of the variances across all 10 synthetic datasets. In our 
experimental data, the ill fit of the SP-model during days 3 and 4 of treatment mainly 
concerns variances and covariances. It, thus, appears that the quantitative signal allowing us 
to carry out this inference lies in the second-order moments (variances, covariances) of the 
ITS distribution in the organs. 
 
As a proof-of-concept, we first conducted a simulation-based study to show that mechanistic 
models applied to ITS-based data can distinguish between bacterial populations with 
uniform and heterogeneous dynamics. Then, we fit a both a SP- and a DP- model to data 
from ampicillin- and ciprofloxacin-treated mice. Our best-fitting models suggest that a SP 
population can explain the dynamics in ciprofloxacin-treated mice, while the dynamics in 
ampicillin-treated mice are further complicated by bacterial phenotypic heterogeneity, best 
captured by the DP model with a non-growing, antibiotic-recalcitrant bacterial 
subpopulation. Inferences made regarding the rates at which these dynamics develop over 
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time indicate that while ciprofloxacin acts predominantly via cidal mechanisms, ampicillin 
has mixed bacteriostatic and bactericidal effects (Landman, 1997) At the end of ampicillin 
treatment, surviving bacteria in the MLN and spleen have adopted a non-replicating, 
antibiotic-recalcitrant phenotype; in contrast, the vast majority of surviving bacteria in the 
ciprofloxacin-treated group are of the growing, antibiotic-sensitive phenotype. Following 
antibiotic withdrawal, bacteria relapse in both the ampicillin- and ciprofloxacin-treated 
groups of mice. In ciprofloxacin-treated mice, growth rate in the blood, liver and spleen is 
higher on day 1 post- antibiotic withdrawal and, subsequently decreases. In ampicillin-
treated mice, the liver, spleen and MLN are repopulated by progeny of the non-growing 
antibiotic-recalcitrant bacteria. 
 
These results can be discussed in the context of previous experimental studies using 
alternative observational techniques, including non-phenotypic marker-based techniques e.g. 
Kaiser et al., 2014; Diard et al., 2014) fluorescence dilution (Helaine et al., 2014) and peak-
to-trough ratio (Haugan, Løbner-Olesen and Frimodt-Møller, 2018). An in vitro study by 
Ghooi and Thatte (Ghooi and Thatte, 1995) showed that beta-lactam antibiotics, such as 
ampicillin, act as both bacteriostatic and bactericidal agents, due to their concomitant action 
on bacterial cell wall synthesis inhibition preventing bacterial replication, and their action 
on autolysins inducing bacterial death respectively. McCall et al. (McCall et al., 2019) 
introduced the phenomenon of antibiotic-induced stasis to explain the emergence of a slow- 
or non-growing bacterial population as a result of exposure to antibiotics with bacteriostatic 
effects and proceeded to show that this population cannot be killed by the same antibiotic 
class. The inferences made by our best-fitting DP model based on data from ampicillin-
treated mice aligns with these documented in vitro effects of ampicillin on bacterial growth, 
as we estimated both strong bacteriostatic effects in the blood and the organs after 48 hours 
of treatment, and the emergence of a non-growing, antibiotic-recalcitrant subpopulation in 
organs where persisters have previously been reported in vivo (Lewis, 2010). 
 
In vivo studies using quinolones such as enrofloxacin and ciprofloxacin have highlighted the 
emergence of non-growing bacteria that survive treatment in the mesenteric and caecal 
lymph nodes, often termed persister cells (Claudi et al., 2014; Kaiser et al., 2014; Helaine 
et al., 2014; Griffin et al., 2011). In these studies, fluoroquinolones were used very soon 
after inoculation, and at high doses (8mg/mouse enrofloxacin oral in Kaiser et al. (Kaiser et 
al., 2014); 2.4 mg/mouse ciprofloxacin intraperitoneal in Helaine et al. (Helaine et al., 2014). 
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Fluoroquinolones are known to retain their cidal activity against non-replicating bacteria in 
vitro, hence additional factors such as the high antibiotic concentration or low oxygen 
tension in vivo could be responsible for the emergence of persister bacteria in the gut-
associated lymphatic tissues (Lewin, Morrissey and Smith, 1991). 
 
Helaine et al. (Helaine et al., 2014) used a fluorescence dilution (FD) technique to explore 
the replication history of individual bacteria during exposure to early, high-dose 
enrofloxacin in different tissues. They identified persister bacterial populations in the lymph 
nodes and spleen. Our modelling study indicates that the spleen and MLN are indeed the 
main sites of interest regarding the emergence of persisters, when mice were treated with 
ampicillin. However, our model did not predict this persisting subpopulation in 
ciprofloxacin-treated mice. This discrepancy could either be due to the low levels of 
persisters in this group, which would not affect the ITS distributions significantly enough to 
be detected by our model, or due to the differences in the experimental design of the studies, 
especially the timing and dose of the fluoroquinolone therapy, which is known to affect its 
pharmacokinetic properties (Lewin, Morrissey and Smith, 1991). Our findings suggest that 
at clinically relevant doses, non-growing “persisters” may not be a universal sequela of 
antibiotic treatment, but may be antibiotic-specific, as our SP-model was still adequate to 
capture the dynamics in the ciprofloxacin-treated group. Alternatively, the vast majority of 
persister bacteria following quinolone exposure may originate from growing instead of non-
replicating bacteria (Claudi et al., 2014). Finally, an important determinant in the apparent 
lack of consensus in this field is the significant inherent stochasticity in extinction time and 
dynamics in vivo during antibiotic treatment even for large bacterial populations, 
compounded by host variability (Coates et al., 2018). 
 
As noted, the lymph nodes and spleen have been previously identified as organs that harbour 
non-replicating bacteria recalcitrant to antibiotic activity of beta-lactam antibiotics. Our 
best-fitting DP model for the ampicillin-treated group further suggests that while this group 
of persister bacteria originate from bacterial populations originally residing in the spleen and 
MLN, they have migratory potential. In particular, these non-growing bacteria migrate from 
the spleen to the liver later during the treatment, and interestingly, once in the liver they 
convert back to the original phenotype, regaining their replicative capacity, but also their 
sensitivity to antibiotic killing. While the trigger of the switch is unknown at this stage, one 
candidate mechanism could be the change in bacterial microenvironment due to inter-tissue 
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migration, particularly the change in occupied host cell type. In a recent in vivo study of 
splenocytes infected with S. Typhimurium at the single cell level, Kanvatirth et al. 
(Kanvatirth et al., 2020) showed that different host cell types affect not only how easily 
Salmonellae can replicate or become a target for killing intracellularly, but also how readily 
they enter a low metabolic, persister state. In contrast to the intimate relationship between 
the liver and the spleen, recalcitrant bacteria arising in the MLN do not appear to migrate 
either in the liver or spleen, similar to their growing, antibiotic-sensitive counterparts in that 
regard. As a result, the MLN stands in isolation, showing distinct dynamics, while the liver 
and spleen form a network supporting continuous inter-organ migration.  
 
During the relapse phase, following withdrawal of antibiotic therapy, bacteria resume 
growth and repopulate the liver, spleen and MLN. In the livers of ampicillin-treated mice 
where the antibiotic-sensitive and antibiotic-recalcitrant subpopulations co-exit, the former 
is killed at higher rates despite replicating at lower rates than the latter, collectively leading 
to its extinction. As a result, all three tissues are repopulated by progeny of the antibiotic-
recalcitrant subpopulation.  
 
Nevertheless, inferences made by our model are subject to three levels of limitations, which 
we describe here. Limitations at the level of the experimental data include the absence of 
markers of bacterial metabolic activity and uniquely identifiable persister subpopulations. 
In terms of our modelling approach, we assumed the simplest case of linear rates describing 
the underlying dynamics of the experimental system; although simplifying, our assumption 
is justified by dividing the infection timeline into shorter time intervals and making 
independent inferences for each, and the fact that we only estimated average rates. We 
developed and applied a single- and a dual-phenotype model but did not increase the model 
complexity further to include more than two bacterial phenotypes.  Our decision was based 
on the law of parsimony, whereby the simplest possible model structure that adequately 
captures the observed data is preferred; this reduces the risk of overfitting and model 
unidentifiability. Additionally, we pooled the ITS distributions from multiple mice per 
treatment group per time point, effectively assuming homogeneous host immune responses. 
Finally, at the level of interpreting our results, we have attributed cidal activity to antibiotic 
effects, ignoring any baseline immune responses. For the purposes of comparing the effects 
of the two antibiotics, and if the assumption that the average baseline immune response 
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between the two groups is similar, then the differences in the dynamics of two groups are 
still largely rightly attributable to the action of the antibiotic in question.  
 
In summary, in this paper we present an integrated approach between experimental data and 
mechanistic mathematical models in a case of immunologically intact, previously untreated 
mice infected with S. Typhimurium, treated with either ampicillin or ciprofloxacin, and 
finally allowed to relapse. Our study showcases the value of mechanistic mathematical 
models in maximising biological insight from experimental data, where previous qualitative 
inference only provides limited information. The additional benefit of our data-driven 
modelling approach is making inferences about processes that cannot be or remain 
challenging to observe experimentally in a living organism. External validation of our 
inferential insights would require in vivo experimental setups that involve groups 
independently treated with different antibiotics at clinically relevant regimens, and a reliable 
marker to discern non-growing, antibiotic-recalcitrant bacteria at all time points. Ideally, 
fine-scale data on drug penetration in different tissues, local drug concentration gradients 
and host cell uptake would be needed to determine the exact microenvironment to which 
bacteria are exposed. Serial sampling of the bacterial load from the same host would 










An experimental design tool to optimise 
inference precision in data-driven 
mathematical models of bacterial infections in 
vivo 
Summary Points: 
• With early integration of mathematical modelling in the experimental design process, 
it is possible to identify experimental designs which maximise the information 
content per experimental resource unit.  
• Optimal experimental designs aid the decision-making process around optimal 
resource allocation.  
• Precise inference through integrating experimental data with mathematical models 
enables the clear-cut comparison between competing biological hypotheses and the 
generation of meaningful predictions.  
• Tools to quantify the information of alternative experimental designs have been 
lacking in microbiology due to the long-standing lack of computationally efficient 
inference methods.  
• Inspired by the canonical D-optimality criterion, I choose the determinant of the 
parameter estimate variance-covariance matrix as a metric for global variance in the 
inferred parameters in a likelihood-free inference framework applied to ITS data.  
• Prediction of high-precision experimental designs is more consistent in biological 
systems with low variance due to low bacterial replication and killing rates. 
• A higher number of biological replicates yields higher-precision inference.  
• A lower number of ITS per animal host, leading to higher number of copies per ITS 
yields higher-precision inference.  
• Given a constraint on the total number of animal hosts used, a lower number of 
biological replicates with a low number of ITS per host leads to higher-precision 
inference than a higher number of biological replicates with a high number of ITS 
per host.  
Mathematical Modelling in Optimal Experimental Design           Summary 
168 
 
Declaration of Originality  
This chapter has been reproduced verbatim from a published research paper (Vlazaki. Price 
and Restif, 2020), for which I certify that I am the sole contributor in terms of study design, 
execution, and manuscript writing. I also certify that I have included the relevant citations, 
where appropriate. 
  




The management of bacterial diseases calls for a detailed knowledge about the dynamic 
changes in host-bacteria interactions. Biological insights are gained by integrating 
experimental data with mechanistic mathematical models to infer experimentally 
unobservable quantities. This inter-disciplinary field would benefit from experiments with 
maximal information content yielding high-precision inference. Here, we present a 
computationally efficient tool for optimising experimental design in terms of parameter 
inference in studies using isogenic tagged strains. We study the effect of three experimental 
design factors: number of biological replicates, sampling timepoint selection and number of 
copies per tagged strain. We conduct a simulation study to establish the relationship between 
our optimality criterion and the size of parameter estimate confidence intervals, and 
showcase its application in a range of biological scenarios reflecting different dynamics 
patterns observed in experimental infections. We show that in low-variance systems with 
low killing and replication rates, predicting high-precision experimental designs is 
consistently achieved; higher replicate sizes and strategic timepoint selection yield more 
precise estimates. Finally, we address the question of resource allocation under constraints; 
given a fixed number of host animals and a constraint on total inoculum size per host, 
infections with fewer strains at higher copies per strain lead to higher-precision inference. 
 
Relevant published output:  
• Vlazaki M, Price DJ, Restif O. 2020 An experimental design tool to optimise 
inference precision in data-driven mathematical models of bacterial infections in 
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6.1.  Introduction 
Bacterial infections remain leading causes of mortality and morbidity worldwide, 
accounting for > 50% of annual deaths in vulnerable demographic groups such as the elderly, 
young children and immunocompromised individuals, and disproportionately afflicting 
resource-constrained regions (World Health Organisation, 2019). At the same time, the rapid 
emergence of antibiotic resistance (Hofer, 2018) and tolerance (Brauner et al., 2016) are 
swiftly incapacitating an increasing number of clinically licenced antibiotic agents. Research 
and development of both novel antibiotics and vaccines is slow, leaving us exposed to 
untreatable, chronic and recrudescent bacterial infections.  
 
The establishment, progression and outcome of a bacterial infection in a host is shaped by 
the dynamics of bacterial transmission, colonisation, within-host replication, death, inter-
tissue migration, and the interaction of bacteria with the immune system or administered 
therapeutic agents. Deciphering each of these factors individually can accelerate the 
transition from empirical to targeted engineered approaches in bacterial treatment and 
prophylaxis (Coward et al., 2014). To aid the characterisation of these dynamics, we often 
combine high-resolution experimental techniques with inferential mathematical models that 
fill in the gaps with regards to processes that remain experimentally unobservable (Restif, 
Thakar and Harvill, 2009).  
 
In the field of bacterial dynamics, isogenic-tagged strains (ITS) constitute one of the most 
widely used experimental techniques to obtain in vivo data about the dynamic behaviour of 
bacteria in the host (Abel et al., 2015). ITS-based data have been historically paired with 
mathematical models to maximise the biological insight they can offer (Vlazaki, Huber and 
Restif, 2019; Rossi et al., 2020). By complementing experimental data with mechanistic 
mathematical models, we go beyond the mere characterisation of statistical differences and 
correlations in the data, to formulation of biological hypotheses into mathematical relations 
and inference-making by fitting the models to the experimental observations. Representative 
examples of integrating such models with ITS-based data include studies identifying 
bottlenecks during the colonisation and infection process (Abel et al., 2015; Kaiser et al., 
2014; Kaiser et al., 2013; Grant et al., 2008), mapping out the host immune responses 
underpinning defence at different stages of the infection (Kaiser et al., 2013; Grant et al., 
2008), deciphering the effects of host adaptation in subsequent infections (Dybowski et al., 
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2015; Dybowski et al., 2017), comparing the effects of different vaccine formulations 
(Coward et al., 2014) and antibiotic therapies (Vlazaki et al., 2020; Kaiser et al., 2014) on 
infection control, characterising the within-host dynamics of co-infections (Abel et al., 2015) 
and understanding the directionality of bacterial migration and de novo tissue colonisation 
in vivo (Kaiser et al., 2013; Kaiser et al., 2014).  
 
The aim of statistical inference is to estimate biological parameters as accurately and 
precisely as possible. Precision is typically reported in the form of confidence intervals 
(Vlazaki et al., 2020; Dybowski et al., 2015; Kaiser et al., 2014; Coward et al., 2014),  which 
are instrumental to assess the evidence for or against hypotheses such as whether 
bacteriostatic or bactericidal effects exerted by the host’s immune system or by a therapeutic 
agent dominate different stages in the infection process. Quantifying parameter estimate 
uncertainty is also important when we use a parameterised model for predictive purposes, 
as it allows us to predict the range of the potential future trajectories of the infection. To 
enable predictions and comparisons to be as clear-cut and distinguishable as possible, it is 
desirable to obtain parameter estimates with the narrowest possible confidence intervals.  
 
Although mathematical models have been increasingly used in the study of in vivo bacterial 
population dynamics, their application has until recently remained limited to inference in 
simple biological systems for short time intervals post-inoculation, typically in the range of 
0-12 hours, largely due to computational inefficiencies (Dybowski et al., 2015; Coward et 
al., 2014; Kaiser et al., 2014; Grant et al., 2008). A recently developed statistical inference 
tool custom-made for making inferences based on experimental data from studies using ITS 
(Price et al., 2017) has enabled inference in more complex biological systems, with larger 
inocula, and for the entirety of the infection timeline (Vlazaki et al., 2020). This moments-
based, divergence minimisation approach represents a computationally efficient inference 
tool suitable for complex biological models, where traditional maximum likelihood 
approaches become too computationally expensive.  
 
To this date, there are no published studies providing executable algorithms for extending 
the application of data-based mechanistic models to experimental design. The availability 
of a computationally efficient inference method now paves the way for an early iterative 
integration of mathematical modelling with data collection at the experimental design stage; 
this can optimise the inferential capacity of models and maximise the biological insights 
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they generate (Figure 6.1). Model-driven experimental design can also address the long-
standing challenge of resource allocation, especially with regards to experimental animal 
use. In particular, the “Three Rs” tenet — Replacement, Reduction and Refinement (Russell 
and Burch, 1959) — calls for “Reduction Alternatives” encouraging strategies to reduce the 
number of animals needed to provide answers to scientific questions; maximising the 
information obtained per animal has been recognised as one avenue to achieve this (Fenwick, 
Griffin and Gauthier, 2009). In this paper, we show that with experimental design tools, it 
is possible to evaluate the information content of alternative designs and identify those with 
the maximum information content per animal host. 
 
Figure 6.1: Model-informed experimental design in an integrated framework of experimental 
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In this paper, we extend the inference methodology to improve experimental designs and 
provide a case study as a blueprint for how it can be applied to data from ITS-based studies. 
As ITS remains one of the key experimental techniques in the field of within-host bacterial 
dynamics (reviewed in Vlazaki, Huber and Restif, 2019), the development of dedicated tools 
to facilitate the integration of mathematical modelling along the experimental process can 
maximise the biological insights we gain from the studies by improving the statistical quality 
of inferences for a substantial body of research. A unique feature of ITS-based studies is the 
multiplicity of infections with different tagged strains within each host organism. Under the 
assumptions of independent action for bacteria and homogeneity in dynamics both between 
ITS and host organisms, the number of biological replicates is equal to the number of ITS 
per host multiplied by the number of hosts. Experiments produce measurements of the 
number of copies of each ITS in anatomical compartments of interest at the time that each 
host animal is killed, and inference about the within-host dynamics “fills in” the gap between 
the sampled timepoints. 
 
Taking these features of ITS infections into account, we provide the first application of 
mathematical modelling as a tool to improve experimental design in studies of in vivo 
bacterial population dynamics using ITS. These studies commonly address questions around 
the dynamical composition of bacterial populations jointly shaped by environmental and 
biological processes such as bacterial replication, death, migration, phenotypic switch and 
bacterial-host interactions. We model bacterial kinetics with a continuous time Markovian 
process where the state variables are the number of copies of a single WITS in each 
anatomical compartment. Given an experimental design, the model predicts the dynamics of 
the lower moments (mean, variance and covariance) of the state variables. Parameter 
inference is based on minimising the Kullback-Liebler divergence between the predicted 
and observed moments (the latter being calculated from biological replicates, i.e. all ITS 
from all mice at each time point). First, we formulate a utility function inspired by the 
moments-based, divergence minimisation approach (Price et al., 2017) that represents our 
criterion for optimality; the objective is to maximise this function across the design space. 
As we are interested in maximising global parameter inference precision, we focus on 
optimising the determinant of the parameter variance-covariance matrix. We use synthetic 
data to study its performance against the width of the corresponding 95% confidence 
intervals for a range of parameter sets. Finally, we illustrate its application by considering 
experimental designs for a variety of biological scenarios reflecting different phases of 
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bacterial dynamics including exponential growth and decay as well as cases dominated by 
unidirectional inter-tissue bacterial migration.  
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6.2.  Methods 
6.2.1. The ITS technique: experimental output and dataset structure  
ITS represent a large class of marker-based techniques, developed over the last decade, in 
order to study the within-host bacterial dynamics at a population level. Libraries of isogenic 
tagged strains are generated by uniquely modifying the non-coding genome of bacteria with 
distinctive, short nucleotide sequences; the resulting ITS are genetically distinguishable, yet 
phenotypically identical. The ITS are mixed in equiproportional inocula and administered 
to the animal host. Animals are culled at predetermined time points to harvest or partly 
sample tissues of interest, and a total bacterial count is obtained per tissue (Abel et al., 2015; 
Grant et al., 2008). The samples are also processed to determine the ITS composition in each 
tissue, originally by qPCR (e.g. in Coward et al., 2014) and more recently by next-generation 
sequencing (e.g. in Rossi et al., 2017; Lim et al., 2014) The final structure of the dataset 
consists of number of copies per ITS in each tissue of interest per time point.  
 
By obtaining snapshots of spatiotemporal data recapitulating the changing ITS composition 
of bacteria in different tissues, it is possible to characterise the unobserved processes that 
underpin the dynamics of the infection in vivo. Supplementing these data with 
compartmental mechanistic models, the rates at which these unobserved dynamical 
processes evolve can be quantified with optimisable precision. We proceed to show how the 
inference precision can be optimised for this type of experimental data, by quantifying the 
impact of a range of design factors that we intuitively expect to affect inference precision.  
 
6.2.2. Conceptual Model Structure  
Mechanistic models applied to ITS data typically have a compartmental structure, with each 
compartment representing a tissue of interest, and model parameters corresponding to the 
rates at which the unobserved biological processes change with time. In this paper, we use 
a radial model structure with three compartments, inspired by the model used in Salmonella 
Typhimurium infections (Price et al., 2017; Coward et al., 2014; Grant et al., 2008), and 
shown as an example in Figure 6.2. Linear compartmental model structures or a combination 
are also possible, and the model can be generalised to include 𝑛 compartments (Price et al., 
2017). 





Figure 6.2: Conceptual structure of the compartmental model detailing the intra- and inter-
tissue dynamics in a model of systemic salmonellosis. In each organ i, bacteria replicate and 
are killed at rates ri and ki, respectively, and bacteria migrate to organ j according to rates mi,j. 
 
6.2.3. A likelihood-free inference framework for complex dynamical systems 
As we are usually interested in tracking the evolution of infections over a period of days, 
and as bacterial infections are typically multi-organ, data collected from ITS-based 
experiments are often complex. Their complexity lies in: (1) the length of observational time 
for the biological system in question, (2) the number of tissues of interest, and (3) the 
multiple organ-organ interactions. The ITS composition across all tissues of interest is 
summarised in a vector of moments (means, variances, and covariances) corresponding to 
each observation time. Assuming first-order dynamics for each time interval between 
sequential points of data collection, a simple mathematical expression that derives the 
moments at a future time point can be obtained and solved analytically. The moments of the 
experimental dataset and the calculated moments for the same time point are compared via 
the Kullback-Leibler divergence. Minimisation of this divergence via standard optimisation 
routines allows us to quantify processes underpinning the change in bacterial numbers and 
composition during a time interval of interest. A full set of computational tools and examples 
on how to use this inference framework can be freely accessed at: 
https://github.com/orestif/SPEEDI.R.  
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6.2.4. Parametric bootstrap to evaluate inference precision  
Parameter inference would not be complete without a measure of its precision. 
Quantification of precision in this framework is carried out using a parametric bootstrap 
approach previously described in Price et al. (Price et al., 2017). Having identified the best 
parameter estimate by minimising the KL-divergence between the experimental and 
calculated moments for a range of parameter sets, we use it to simulate 200 synthetic datasets 
of the same size and structure as the experimental data. The choice of 200 bootstrapped 
samples was motivated by our priority to maximise the computational efficiency of the 
suggested tool, and is in line with previous findings on the minimum adequate number of 
bootstrapped samples (Pattengale et al., 2010). The corresponding moments are calculated, 
and the best parameters inferred via the same divergence-minimisation method. This process 
results in a range of parameter estimates, which provides us with a measure of precision 
regarding the inference for each parameter. 
 
6.2.5. Deriving optimality criteria in a likelihood-free inference framework 
We now turn to formulating an optimality criterion in this likelihood-free framework, 
inspired by the gold-standard alphabetical optimality criteria in the maximum likelihood 
framework (Box, 1982).  
In the maximum likelihood estimation (MLE) context, the Fisher Information Matrix (FIM) 
plays a key role in assessing parameter inference precision (Chaloner and Verdinelli, 1995). 
It summarises the amount of information contained in the experimentally observed dataset 
with regards to the parameter set 𝜃 = {θ1, θ2, θ3, ..., θn}. The FIM can be analytically derived 
from the Hessian matrix (𝐻(𝜃)), a matrix of 2nd order derivatives of the likelihood 𝐿(𝜃) 
with respect to the parameters: 
 
 





For a given MLE, the FIM contains information about the curvature of the likelihood. A 
higher value in the corresponding entry in the FIM matrix, indicates that the estimate for 
that is more precise (which can be expressed as a shorter confidence interval). Furthermore, 
by assessing different functions of the FIM (e.g., the determinant or trace) it is possible to 
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derive information about different aspects of the inference quality provided by each 
experimental design; these ways of assessing different aspects of the inference quality of a 
model given an experimental design are known as alphabetical optimality criteria (Box, 
1982). For example, the determinant of the FIM provides an index of average size (e.g., 
width, area, volume) of the confidence interval for the parameters of interest (D-optimality 
criterion), while the trace of the FIM summarises the average variance of each parameter of 
interest (A-optimality criterion) (Box, 1982). Other composite functions of the FIM lead to 
the full range of the alphabetical optimality criteria.  
An important property of the FIM is its inverse relationship with the variance-covariance 
matrix of 𝜃, via the Cramer-Rao lower bound (Casella, 2002). In 2.3. we used a parametric 
bootstrap approach to estimate the variance-covariance matrix of the parameter estimates; 
let that be M. As the inverse of M is proportional to the FIM, we can define equivalent 
optimality criteria by minimising functions of M, rather than maximising functions of the 
FIM. Analytical evaluation of the FIM is often difficult or impossible (Spall, 2005), but 
instead typically approximated numerically as we propose to do with the minimum-
divergence inference method. Here, we focus on minimising the determinant of M, which 
serves as the global measure of inference precision.  
 
6.2.6. Identifying experimental designs with higher information content  
The FIM summarises the information content of an experiment as a function of both the 
model parameters 𝜃, and the design conditions under which the experiment is conducted. 
As such, it can be used to identify experimental designs that yield data with a higher 
information content. To achieve this, we first identify which aspects of the experimental 
process we are interested in optimising. Here, we focus on the number of biological 
replicates, the initial number of copies per ITS and the choice of sampling timepoints.  
 
Next, we place sensible bounds on the parameter space to be explored. This can be done 
through expert elicitation, based on prior literature or understanding of the system, or by 
using inferences made on previous experiments on the same or a similar system.  
 
For the scenarios we consider in Sections 6.3.1, 6.3.2.1 and 6.3.2.2, we randomly draw 
parameters from a uniform distribution 𝜃~𝑈(0,1) . In 6.3.2.3, we explore 6 biological 
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patterns of within-host dynamics commonly occurring in in-vivo bacterial infections, which 
we list below. For each of the scenarios A1, A2, B1, B2, C1, C2 and keeping the total number 
of replicates fixed at 500, we consider 10 parameter sets, and for each parameter set 3 
numbers of copies per ITS in {10,100,1000} and 8 sampling time points reflecting early, 




To provide an example of how these sampling strategies would be implemented for a time 
interval of 24 hours, a group of animal hosts would be euthanised at 1 hour and a separate 
group at 4 hours post-inoculation (1,4). In the next experimental design, a group of animal 
hosts would be euthanised at 2 hours and a separate group at 5 hours post-inoculation (2,5). 
 
A. Exponential growth (net growth = +0.2, minimal inter-tissue migration)  
A1. Exponential growth with high killing and high replication rates (higher variance in data)  
𝑘𝑖~𝑈(2,2.5), 𝑟𝑖 = 𝑘𝑖 + 0.2 
A2. Exponential growth with low killing and low replication rates (lower variance in data) 
𝑘𝑖~𝑈(0.1,0.6), 𝑟𝑖 = 𝑘𝑖 + 0.2 
 
B. Exponential decay (net growth = -0.2, minimal inter-tissue migration) 
B1. Exponential decay with high killing and high replication rates (higher variance in data) 
𝑘𝑖~𝑈(2,2.5), 𝑟𝑖 = 𝑘𝑖 − 0.2 
B2. Exponential decay with low killing and low replication rates (lower variance in data) 
𝑘𝑖~𝑈(0.3,0.8), 𝑟𝑖 = 𝑘𝑖 − 0.2 
 
C. Source-sink unidirectional bacterial transfer with near-zero intra-organ growth  
C1. Source-sink with high killing and high replication rates (higher variance in data) 
𝑘𝑖 , 𝑟𝑖~𝑈(2,2.5), ⁡𝑚1𝑗~𝑈(1.5,2) 
C2. Source-sink with low killing and low replication rates (lower variance in data) 
𝑘𝑖 , 𝑟𝑖~𝑈(0.1,0.6), ⁡𝑚1𝑗~𝑈(1.5,2) 
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6.3.  Results  
6.3.1. A simulation study to correlate the determinant of the parameter variance-
covariance matrix with precision in parameter inference 
In this section we perform a simulation study to demonstrate that the magnitude of the 
determinant of the parameter variance-covariance matrix is a reliable summary statistic for 
the precision of inference across the entire parameter set. We start with the model structure 
outlined in 6.2.2 and generate 10 random parameter sets. We then simulate 10 synthetic 
datasets for each parameter set (10x10 = 100 in total); the synthetic datasets serve as 
surrogates for experimentally observed ITS-based data. For each of the 100 virtual datasets, 
we obtain 200 bootstrapped samples and proceed to obtain 200 sets of parameter estimates. 
For each set of parameter estimates, we calculate the variance-covariance matrix and obtain 
its determinant, which is taken to be a global measure of inference precision.  Next, we 
obtain the 95% confidence interval for each of the 12 parameters across the 10 synthetic 
datasets generated for each parameter set index and report the mean of their widths across 
each parameter set relative to the maximum one, as a function of the corresponding 































95% Confidence Interval Width (% of the widest interval) 
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Figure 6.3: Mapping the determinant of the variance-covariance matrix to the range of 95% 
confidence intervals. 
Each dot represents the mean width of the 95% confidence intervals across the 12 parameters in each 
synthetic dataset. A three-compartmental model is used (section 6.2.2) and parameters are drawn at 
random from a uniform distribution between 0 and 1, 𝜃~𝑈(0,1). For each of the randomly generated 
parameter sets (parameter set index 1-10), there are 10 dots representing 10 synthetic datasets 
simulated from that parameter set. The mean width of the 95% confidence intervals is plotted against 
the mean logarithm of the determinant across the 10 synthetic datasets generated by each of the 




6.3.2. Determinants of precision inference in experimental design 
Having established the determinant of the parameter variance-covariance matrix as a reliable 
correlate to inference precision in 6.3.1, here we study the effect of 3 design factors on the 
quality of inference precision in ITS-based experiments, namely: the number of biological 
replicates, the number of copies per ITS and the choice of sampling time points. First, in 
6.3.2.1, we focus on the number of biological replicates (𝑅); under the assumption of 
homogeneous inter-host immunological responses (Grant et al., 2008; Kaiser et al., 2013; 
Coward et al., 2014; Rossi et al., 2017) 𝑅 is equal to the number of animal hosts multiplied 
by the number of ITS per host. In 6.3.2.2, we introduce the biological limitation of a 
constraint on the total inoculum size (𝐼) per host; 𝐼 is equal to the number of ITS per host 
multiplied by the number of copies per ITS. Finally, in 6.3.2.3, we study the mixed effect of 
experimental designs with different numbers of copies per ITS and different sampling 
timepoints.  
 
6.3.2.1. Number of biological replicates (𝑹) 
In 6.3.2.1, we use the same simulation-based approach and parameter sets as in 6.3.1. to 
evaluate the effect of the number of biological replicates on the magnitude of the determinant 
of the parameter variance-covariance matrix. At this stage, the number of biological 
replicates (𝑅) is equal to the animal hosts multiplied by any number of ITS per host, without 
constraint on the total inoculum size per animal host. As shown in Figure 6.4, there is a 
directional effect between the determinant of the parameter variance-covariance matrix 
generated by parametric bootstrap and the total number of replicates. As the number of total 
replicates increases (x-axis), the quality of parametric inference increases (reflected by lower 





























Figure 6.4: Inference precision as a function of total number of replicates. 
For each parameter set, 8 experimental designs are considered with number of biological replicates 
𝑅 ∈ {5,10,20,50,100,200,500,10000}. The log10 of the determinant of the parameter variance-
covariance matrix is plotted against log10 (R) to yield a consistent pattern of exponential decay across 
the 10 parameter sets. A three-compartmental model is used (section 6.2.2) and parameters are drawn 






6.3.2.2. Distribution of replicates in animal hosts with a constraint on total inoculum 
size per host (𝑰) 
 
Here, we move a step further from 6.3.2.1 and introduce the biological constraint of total 
inoculum size per host (𝐼). In ITS-based experimental infections, there is a target total 
inoculum 𝐼 achieved by multiplying the number of different ITS used by the number of 
copies per ITS. As detailed in Table 6.1, we consider experimental designs with the total 
inoculum size fixed at 10,000 CFU; this is consistent with the orders of magnitude of inocula 
used in previous ITS studies (Rossi et al., 2017; Coward et al., 2014; Kaiser et al., 2013; 
Grant et al., 2008). We also keep the number of biological replicates fixed at 1000 biological 
replicates to minimise the stochastic noise in experiments with small replicate sizes, and 
consider 8 possible combinations between the total number of host animals per sampling 























Table 6.1: A matrix tabulating the 8 experimental designs arising from different combinations 
of total number of host animals per sampling time point and total number of ITS per host 
animal, with fixed total number of replicates and fixed total inoculum size. Fixed variables are 
highlighted in grey, and variable design factors in yellow.   
 
In Figure 6.5, we plot the determinant of the parameter variance-covariance matrix as a 
function of the total number of ITS per host animal. There is a consistent positive 
relationship between the two variables, indicating that lower numbers of ITS per host yield 
lower determinant values, which reflect higher quality inference in terms of precision. Our 
analysis shows that given a fixed number of biological replicates and total inoculum size per 
host, experimental designs with higher numbers of hosts and lower numbers of ITS per host 
















Figure 6.5: Inference precision as a function of number of ITS per host. 
For each parameter set, 8 experimental designs are considered with number of ITS per host in 
{5,10,20,50,100,200,500,10000} . The log10 of the determinant of the parameter variance-
covariance matrix is plotted against the number of ITS per host to yield a consistent pattern of 
exponential growth across the 10 parameter sets. A three-compartmental model is used (section 2.2) 
and parameters are drawn at random from a uniform distribution between 0 and 1, 𝜃~𝑈(0,1). 




































1 200 5 2000 1 1 1000 10000 
2 100 10 1000 1 1 1000 10000 
3 50 20 500 1 1 1000 10000 
4 20 50 200 1 1 1000 10000 
5 10 100 100 1 1 1000 10000 
6 5 200 50 1 1 1000 10000 
7 2 500 20 1 1 1000 10000 
8 1 1000 10 1 1 1000 10000 














Parameter Set Index 
Number of ITS per host 
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6.3.2.3. The choice of sampling time points in designs with different numbers of copies 
per ITS 
In 6.3.2.2. we found that given the presence of biologically realistic constraints on total 
inoculum size per host and total number of replicates, infections with fewer ITS at higher 
copy number per ITS consistently perform better in terms of precision inference. As a result, 
achieving high precision comes with the cost of using more animal hosts. In this section, we 
introduce a third design factor, the choice of sampling time points during the infection 
process. We seek to address the question: can we choose sampling time points that maximise 
the precision inference, allowing us to discount on the number of copies per ITS and, by 
extension, the number of animal hosts we need to inoculate? 
 
To answer this question, we consider 6 biological scenarios that encompass common 
patterns in within-host dynamics of bacterial disease, described in 6.2.6. In particular, we 
look at scenarios of exponential decay and growth with either high or low variance, as well 
as cases with unidirectional bacterial migration from one organ to the other. 
 
We start with sampling at a single observation point. In the likelihood-free inference 
framework, inference using a single observation time point is only possible for models 
whose number of parameters is smaller than or equal to the number of moments that 
summarise the ITS distributions.  We first consider a simple, two-compartment model 
structure with unidirectional bacterial flow from the first to the second compartment, and 
bacterial death and replication in both (5 parameters in total). Figure 6.6 shows that unlike 
in the scenarios of exponential growth, in the scenarios of exponential decay intermediate 
sampling times (12- and 13-hours post-inoculation) yield higher-precision inference, 
whereas early or late sampling times provide less information on average. This is likely due 
to either minute changes in the bacterial population in the very early stages (1-2 hours), or 
bacterial populations having died out during the later stages (23-24 hours), at which point 
we can only get bounds on the parameter estimates that are consistent with extinction "up 
to" that time (Figure 6.6A). This pattern differs in the growth example (Figure 6.6B), where 
early time points will be subject to greater variation in the population sizes. Later time points 
will have allowed sufficient time for the populations to establish/replicate whereby the 
variation between subpopulations will be less impactful on the inference. 
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In Figure 6.7, we present the results of the same analysis performed using a combination of 
sampling time points for a three-compartment model. The precision across all experimental 
designs considered in Figure 6.7 is consistently higher than in Figure 6.6, as combining data 
two observation times increases the information content overall. Finally, experimental 
infections with higher number of copies per ITS perform consistently better in terms of 
inference precision (Figures 6.6 and 6.7). Assuming a constraint on the total inoculum size 


















Figure 6.6: Scatter plots showing the mean log10(determinant) across 10 parameter sets 
under 4 biological scenarios with single sampling time points for a three-compartment 
model. 
For the exponential growth scenarios, later sampling yields the highest-precision inference 
(Panel A). For the exponential decay scenarios, there is a U-shaped relationship between the 
time of sampling and inference precision, with intermediate sampling time points being the most 
informative. A two-compartmental model with intra-organ bacterial growth and death, and 
bidirectional bacterial migration is used. Parameters are drawn at random from a uniform 
distribution between 0 and 1, 𝜃~𝑈(0,1). 
 





Figure 6.7: Heatmap plots showing the mean log10(determinant) across 10 parameter sets 
under 6 biological scenarios for a range of experimental designs with variable sampling time 
points and starting number of copies per ITS for a four-compartment model. 
The first column of panels (A1, B1, C1) illustrates biological scenarios with high killing and 
replication rates, while the second column (A2, B2, C2) corresponds to biological scenarios with 
low killing and replication rates. Darker blue shades represent experimental designs yielding higher 
inference precision, while lighter blue shades represent designs with lower inference precision. For 
all experimental designs across all scenarios (A1-C2), higher numbers of copies per ITS improve the 
precision inference. For low-variance scenarios (low replication, low killing), the inference precision 
is globally better and the number of high precision experimental designs is larger than for high-
variance scenarios. A three-compartmental model is used (section 6.2.2) and parameters are drawn 
at random from distributions specified in section 6.2.5.   
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6.3.3. Strategies to reduce the number of animal hosts 
In 6.3.2.3, we showed that infections with higher numbers of copies of ITS per host tend to 
correlate with higher inference precision consistently across the sampling time points we 
considered. Under a fixed inoculum size per host, this translates into the cost of requiring 
more animal hosts, which incurs primarily ethical, but also financial costs. The analysis in 
6.3.2.3 assumed a fixed number of biological replicates of 500.  
Here, we consider the interaction between the total number of biological replicates (number 
of animal hosts multiplied by number of ITS per host) and the number of ITS per host, the 
latter being inversely correlated with the initial number of copies per ITS. Taking the case 
of a system with exponential growth dynamics and high variance as an example, we consider 
the experimental designs tabulated in Table 6.2. Each of A to C include experimental designs 
with a decreasing number of animal hosts per timepoint. From our previous analysis, the 
first design in each category A-C is expected to yield the highest precision, as it requires a 
high number of animal hosts and a high number of initial copies per ITS. In alternative 
designs 2 and 3 there is a ten-fold decrease in the number of animal hosts, with design #2 
having a higher number of biological replicates combined with a low number of copies per 
ITS and design #3 having a low number of biological replicates combined with a high 
number of copies per ITS.  
 
Table 6.2: Experimental designs to evaluate the relative effects of two design factors (total 
number of replicates and initial number of copies per ITS) on inference precision. 
 












































A1 200 5 2000 1 1 1000 10000 
A2 20 50 200 1 1 1000 10000 
A3 20 5 2000 1 1 100 10000 
B1 100 5 2000 1 1 500 10000 
B2 10 50 200 1 1 500 10000 
B3 10 5 2000 1 1 50 10000 
C1 50 10 1000 1 1 500 10000 
C2 5 100 100 1 1 500 10000 
C3 5 10 1000 1 1 50 10000 
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In Figure 6.8, we comparatively plot the mean log10(determinant) for the 3 classes of 
experimental designs outlined in Table 6.2, across a range of sampling time points. While 
experimental design index 2 and 3 use the same number of animal hosts, the latter performs 
significantly better and very close to experimental design index 1, which involves 10 times 
more animal hosts. Overall, our analysis shows, that given a constraint on the number of 
animal hosts, higher inference precision is achieved by using experimental infections with 
large initial numbers of ITS even at lower number of biological replicates; the effect of the 
initial number of ITS is stronger than that of number of biological replicates in determining 




































































Figure 6.8: Heatmap plots showing the mean log10(determinant) across 10 parameter sets for 
experimental designs 1-3 in classes A-C with variable number of biological replicates and 
initial number of copies per ITS.  
log10(determinant) 
A1 A2 A3 
log10(determinant) 
B1 B2 B3 
C1 C2 C3 
log10(determinant) 
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6.4.  Discussion  
We have presented a novel, computationally efficient approach to information-based 
experimental design for ITS-based data, with the aim of maximising inference precision for 
the within-host dynamics of bacterial infections. Inspired by the canonical D-optimality 
criterion, we chose the determinant of the parameter variance-covariance matrix, obtained 
via a parametric bootstrap, as a criterion for global parameter inference precision in a 
likelihood-free inference framework previously developed by Price et al. (Price et al., 2017). 
We used a simulation study to illustrate that the magnitude of the determinant effectively 
captures the mean width of confidence intervals across parameter sets. As the determinant 
is a global measure of variance, we correlated it with the mean width of the confidence 
interval across the entire parameter set (12 parameters in our model) and demonstrated the 
strong correlation between the value of the determinant and the average width of the 
confidence interval.  
 
We proceeded to show that the replicate size, initial number of copies per ITS and sampling 
timepoint selection all have an impact on inference precision in range of general biological 
cases representative of bacterial dynamics typically observed during experimental infections. 
Biological scenarios with low replication and killing rates are characterised by low variance 
in the distribution of copies per ITS (Price et al., 2017); for the entirety of experimental 
designs considered for these low-variance scenarios, the inference precision is globally 
higher than for higher-variance scenarios. Furthermore, there is greater redundancy in 
experimental designs yielding similar levels of high-precision inference for lower-variance 
scenarios, entailing that prior intuitive knowledge about the dynamics of a system can inform 
experimental microbiologists about how much focus they should place on identifying unique 
experimental designs with the highest information content. Finally, we found that for a fixed 
total number of replicates and assuming inter-host immunological homogeneity, infections 
with lower numbers of ITS per host at higher initial copies per ITS tend to give higher-level 
inference precision for both high- and low-variance scenarios.  
 
The benefit of our approach is that it can be used not only to identify a single optimal 
experimental design, but also to rank experimental designs, thus providing flexibility to 
experimentalists to choose those that reflect their own priorities. For example, assuming that 
the reduction in the number of animal hosts is a priority, one can dismiss the globally optimal 
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experimental design that requires using a 10-fold higher number of animal hosts and can 
choose the design with the second highest precision, which can be achieved by strategically 
choosing the sampling time points while keeping the number of animal hosts low. Finally, 
we looked at the interaction between two design factors (total number of replicates and initial 
copies per ITS) under a constraint on number of animal hosts, which is one of the key 
priorities in terms of animal welfare, logistical and financial considerations alike. We show 
that in this scenario, favouring an experimental design with lower number of biological 
replicates and fewer ITS per host yields consistently higher inference precision than the 
alternative allocation of resources with high number of biological replicates and more ITS 
per host. This consideration becomes particularly relevant as individual ITS detection in a 
multi-ITS sample has become more advanced, moving away from qPCR with a detection 
threshold of a <10 ITS per host tissue (Kaiser et al., 2013; Grant et al., 2008) to next 
generation sequencing able to detect tens or hundreds of ITS per host tissue sample (Zhang 
et al., 2017; Abel et al., 2015).  
 
Discussing the assumptions and limitations of the likelihood-free inference framework used 
as the basis for the experimental design tool presented here, the moments-based, divergence-
minimisation inference framework makes the simplifying assumption that these 
distributions are multivariate normal across all tissues of interest and sampling time points; 
this assumption facilitates the derivation of the expressions for the moments. Given that the 
shape of the true distribution is different for every tissue and sampling time point, and that 
one would need to approximate each of those individually, the simplifying choice of a 
multivariate normal distribution seems sensible. Furthermore, the first- and second- order 
moments of these distributions were used as sufficient summary statistics. Although it could 
be argued that higher order moments would capture additional features of the distributions, 
the added complexity is not justified by the resolution of the available data and the previous 
simplifying assumption about the structure of the distributions. As shown by Price et al., 
2017, there is excellent agreement between both the inferences and the width of the 
confidence intervals obtained when using the maximum-likelihood framework and the 
likelihood-free framework used here; as a result, the use of summary statistics and the 
assumption of multivariate normal distributions do not affect the quality of inference.  
 
In terms of the bootstrapped samples, we limited their number to 200 per experimental 
design considered in this study, striking a balance between reducing inter-simulation 
Mathematical Modelling in Optimal Experimental Design          Discussion 
192 
 
variation (Monte Carlo error) and limiting the applicability of the tool due to long running 
times. Earlier work by Price et al., 2017 shows that even at 100 experiments (or bootstrapped 
samples), the Gillespie and moments-based approaches both lead to more and more precise 
estimates as the number of biological replicates increases, while at 500-1000 biological 
samples, the variance in the parameter estimates converges to 0. Hence, by large, the source 
of the Monte Carlo error is not the number of bootstrapped samples, but the number of 
biological replicates, which is one of the design factors considered in this study.  
Furthermore, our choice of 200 bootstrapped samples was further motivated by Pattengale 
et al., 2010, who developed a computationally efficient bootstrapping algorithm in the field 
of phylogenetics and used it to formulate testing criteria for determining the minimum 
number of bootstrapped samples needed to infer confidence values; in most cases, a size of 
100-500 bootstrapped samples was adequate. Finally, we considered at least 10 parameter 
sets for each experimental design, obtaining consistent results in terms of how the 
experimental designs ranked relative to each other across the 10 individual datasets; this 
consistent pattern further confirms that our choice of bootstrapped sample size is not a major 
source of Monte Carlo error. 
 
As exploratory research is gaining momentum and the competition for funding is increasing, 
optimal resource allocation is emerging as a first step in the process of experimental setup 
conceptualisation (O’Malley, 2007), while also affecting the welfare of animal hosts which 
is further reflected in the principle of the 3Rs – replacement, reduction and refinement 
(Russell and Burch, 1959;  Sneddon, Halsey and Bury, 2017). In vivo studies in population 
dynamics microbiology have typically not used experimental design tools until now. For 
example, despite the sustained wide application of the ITS technique, questions around 
optimising experimental design and resource allocation have remained formally 
unaddressed, with the exception of past studies having used small-scale simulation-based 
approaches to determine a suitable inoculum size (Coward et al., 2014) or distribution of 
ITS per host (Coward et al., 2014; Kaiser et al., 2013). Limited examples of efforts to 
develop experimental design tools for population-level data in dynamical systems can be 
found in other microbiological fields like systems biology (Braniff, Richards and Ingalls, 
2019; Sinkoe and Hahn, 2017; White et al., 2016; Mdluli, Buzzard and Rundell, 2015; Liepe 
et al., 2013, Steiert et al., 2012), ecology (Moffat et al., 2020; Zhang et al., 2018), and food 
science (Garre et al., 2019; Price et al., 2018).  
Mathematical Modelling in Optimal Experimental Design         Discussion 
193 
 
The apparent under-representation of optimal design algorithms in population dynamics 
microbiology is largely attributable to the lack of computationally efficient inference 
methods that cater for mathematical models with intractable likelihoods. Such models are 
often necessary to capture even simplified representations of biological systems which 
become increasingly more complex, as infections progress (Price et al., 2017). Here, we 
have provided a blueprint for the use of experimental design tools in complex systems in 
population dynamics microbiology. We addressed replicate size, sampling time point 
selection, and the initial number of copies per ITS in the inoculum as design factors 
commonly considered by experimentalists when trying to optimise multifactorial resource 
allocation to achieve a desired level of inference precision. Our framework for optimising 
experimental design can be further extended to serve a wider range of experimentalists’ 
goals beyond maximising inference precision. Other common goals include improving 
experimental designs to enable model discrimination, which can aid in assessing competing 
biological hypotheses (Vanlier et al., 2014). In this paper, we focused on improving the 
overall inference precision and focused on the determinant of the parameter variance-
covariance matrix as the utility function of choice. However, since our likelihood-free 
experimental design tool is based on an approximation of the FIM, it could accommodate 
other utility functions such as the trace or the eigenvalue of the parameter variance-
covariance matrix, which correspond to the A- (Chernoff, 1953) and E- (Ehrenfeld, 1955) 









Discussion and Future Directions 
7.1. Synthetic Overview 
Overall, the present thesis constitutes an interdisciplinary effort to explore both the applied 
and methodological aspects of mechanistic mathematical models when applied to data from 
ITS studies at the level of the bacterial population in host tissues. On the one hand, 
mathematical models were applied to generate biological insights, and, on the other, 
methodological tools were developed to further improve the inferential process. First, I 
developed and used mechanistic mathematical models in conjunction with experimental data 
to address questions regarding the within-host dynamics of S. Typhimurium infection in the 
naïve (Chapter 3), immunised (Chapter 4) and antibiotic-treated (Chapter 5) murine host. 
Second, on a methodological level, I used mathematical models for inference (Chapters 3-
5), model selection (Chapters 3, 5) and experimental design (Chapter 6). To the best of my 
knowledge, this is the first time that data-based mechanistic models have been used so 
extensively in the field of bacterial dynamics and applied to complex biological systems 
over a longer infection time period (> 24 hours). 
 
To summarise the key findings presented in this thesis, the use of mathematical models has 
enabled the characterisation of the unobserved within-host dynamics in the naïve, 
immunised and antibiotic-treated host. In Chapter 3, I showed that inter-organ bacterial 
mixing already occurs in the first 6 hours post-inoculation, much earlier than previously 
thought. The early dynamics in the liver and spleen differ; bacteria preferentially migrate to 
the liver where they are subject to high bactericidal activity, while the spleen 
microenvironment is permissive to bacterial growth. A balance between bacterial killing and 
replication is reached by 24 hours post-infection in both the liver and spleen. In Chapter 4, 
I compared the effect of a live-attenuated and whole-cell killed vaccine and showed that the 
superior performance of the former in preventing bacteraemia is largely attributable to its 
early inactivation of the secondary challenge. I then discussed the differential effects that 
the killed and live vaccine exerted on the within-host dynamics of S. Typhimurium in the 
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context of the significant difference in IgG2 levels induced by the two formulations. In 
Chapter 5, comparing the effect of ciprofloxacin and ampicillin on the within-host dynamics 
of S. Typhimurium both during treatment and after antibiotic withdrawal revealed that 
bacteria surviving treatment in the spleen and mesenteric lymph nodes of ampicillin-treated 
mice were non-replicating, while there was no evidence for the presence of the non-
replicating phenotype in ciprofloxacin-treated mice. Following bacterial relapse after 
antibiotic withdrawal, mathematical inference suggests that previously non-replicating 
bacterial subpopulations grow faster than the progeny of previously replicating bacteria. 
Finally, in Chapter 6, I developed a computationally efficient tool for optimising 
experimental design in ITS-based studies, and showed that decisions on best resource 
allocation under constraints can be greatly aided prior to performing the experiment, leading 
to optimised use of animal hosts, choice of sampling points and distribution of bacterial 
copies per ITS.  
 
7.2. Implications of my research: new insights, new questions 
The Discussion section at the end of each chapter provides a focused contextualisation of 
the implications of the findings presented at the chapter in question. Rather than 
summarising these discussion points, in this section, I have chosen to discuss the broader 
implications of my research on a methodological level and in terms of the generated 
biological insights. 
 
On a methodological level, the work presented here provides a blueprint for the extensive 
use of an integrated modelling-data approach, not only as a tool for a posteriori data analysis 
(Chapters 3-5), but also for a priori experimental design (Chapter 6). Showcasing the merits 
of this dual role of mathematical modelling has the potential to suggest a new paradigm in 
which microbiological research is carried out under conditions that maximise the 
information content of the generated output, in line with the priorities set by the 
experimentalists. Of course, this new field of vision comes with its own unchartered 
philosophical questions and challenges: is there a danger that an a priori optimisation of 
experimental design introduces bias in the generated output? what are the implications of 
sequential experimental design, and can experimental design be used iteratively to enrich 
existing datasets in sequential experimental designs? 
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At the interface between mathematical modelling and biology, inferences made on the basis 
of mechanistic models characterise fine-resolution mechanisms that have not yet been 
experimentally observed. These inferences can lead to the rejection of previous conjectures, 
the generation of new hypotheses and the suggestion of appropriate experimental procedures 
to obtain the missing insight. For example, the analysis in Chapter 2 shows that the 
experimentally observed patterns of bacterial distribution per ITS can only be explained by 
a model that includes early organ-to-blood migration; this challenges the idea that 
Salmonella populations in the systemic organs are segregated in the first phase of the 
infection. Greater inter-tissue bacterial mobility raises more questions as to whether these 
bacteria migrate as single bacteria, host cell-bound or host cell-internalised. To address this 
question, real-time tracking in vivo studies of single Salmonellae migrating between tissues 
would be required. Another example of how insights generated through an integrated data-
driven modelling approach can guide further experimental work is seen in Chapter 5, which 
adds evidence to the hypothesis that the emergence of bacterial persisters depends on the 
dose, frequency and route of antibiotic administration, as well as the class of the chosen 
antibiotic. A growing body of knowledge around the wide range of factors affecting 
antibiotic persistence could lead to experimental setups that can study chosen putative 
determinants of interest in isolation, while carefully controlling for the rest; this could 
address the incongruence in conclusions reached by different studies. 
 
Finally, the work presented in Chapters 4 and 5, which identifies bactericidal and 
bacteriostatic effects of therapeutic and prophylactic interventions, can inspire a new way of 
defining bactericidal and bacteriostatic agents. Currently, the definition of bactericidal and 
bacteriostatic agents is based on a combination of in vitro microbiological activity assays 
that determine the minimum inhibitory concentration (MIC), time-kill curve and serum 
bactericidal titre (SBT), whose results differ depending on the conditions under which they 
were carried out, and whose clinical interpretation is problematic (Pankey and Sabath, 2004; 
Vosti, 1989). Quantification of the bacterial in vivo replication and killing rates in the 
antibiotic-treated host and comparison against a naïve control group may give an alternative 
and more clinically relevant indication of the cidal and static effects of a given antibiotic.   
  
In summary, the various thematic areas explored with the aid data-driven mechanistic 
mathematic models in the present thesis showcase that this approach can provide evidence 
either for or against a biological hypothesis, guide further experimental work, and provide 
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additional tools to characterise and benchmark the mode of action of therapeutic and 
prophylactic agents. Finally, developing a tool for experimental design in microbiological 
studies will allow for more minimal and more effective resource allocation to generate 
maximally informative experimental outputs.  
 
7.3. Limitations of my research  
As detailed in 7.1 and 7.2, mathematical models, especially when applied to experimental 
data, can generate insights which would, otherwise, go unrecognised. It is, however, 
imperative to summarise and highlight the limitations mathematical models are subject to, 
because their explicit recognition can inspire solutions, and determine their merit on realistic 
grounds. I will discuss the limitations of my research in terms of the modelling approach, 
model selection, and interpretation of the inference results.  
 
With regards to whether the data used were fit for purpose, it is important to highlight the 
assumptions behind the modelling approach and how well they reflect the data structure. As 
noted in the Methods section, ITS-based data provide a static snapshot of the distribution of 
bacterial copies per ITS in each tissue of interest. The moments-based, divergence-
minimisation inference framework used here makes the simplifying assumption that these 
distributions are multivariate normal across all tissues of interest and sampling time points; 
this assumption facilitates the derivation of the expressions for the moments. Given that the 
shape of the true distribution is different for every tissue and sampling time point, and that 
one would need to approximate each of those individually, the simplifying choice of a 
multivariate normal distribution seems sensible. Furthermore, in this thesis and in line with 
work by Price et al. (Price et al., 2017), the first- and second- order moments of these 
distributions were used as sufficient summary statistics. Although it could be argued that 
higher order moments would capture additional features of the distributions, the added 
complexity is not justified by the resolution of the available data and the previous 
simplifying assumption about the structure of the distributions. An additional assumption 
made here is that bacteria behave as independent entities in vivo, and thus the probability of 
a demographic event taking place is modelled as uniform across the entire bacterial 
population in that tissue (Cornforth et al., 2015). However, it is known that bacteria 
coordinate their in vivo behaviour population-wide via a range of quorum sensing systems, 
which control bacterial migration and replication in response to environmental cues such as 
food abundance or depletion, crowded conditions and other. 
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Regarding model selection (Chapters 3, 4 and 5), there are no gold-standard criteria like 
those in the likelihood framework (e.g. BIC and AIC). For the purposes of this thesis, I 
developed a conservative algorithm based on the law of parsimony, to enable selection of 
the model that not only fits the average global patterns in the data (lowest overall KL 
divergence), but also adequately approximates all individual summary statistics (moments) 
by evaluating the proximity of the experimentally observed value to the mean value of each 
moment, as determined by stochastic simulations of that model. Model selection between 
nested models (Chapters 3 and 5) is challenging and the marginal “value” a modeller 
attaches to an additional gained unit of goodness-of-fit is largely up to debate (Kuha, 2004). 
In this work, model selection was guided by the rule of parsimony; the simplest model that 
adequately aligns with the pre-chosen summary statistics was chosen as the best model.  
 
In terms of interpreting the inferences made using this framework and the ITS-based data, 
the first limitation to highlight is that the reported rates represent average rates across the 
entire bacterial population in a tissue of interest. Heterogeneity in bacterial phenotypes is a 
well-documented phenomenon (Helaine and Holden, 2013) which is, nonetheless, not 
reflected in this analysis. Another source of heterogeneity that goes largely undiscussed in 
microbiological studies is the inter-host heterogeneity in immunological responses. ITS-
based data reflect bacterial numbers in a pool of murine hosts, which although breed-, age- 
and sex-matched are, nonetheless, different organisms with potential differences in their 
immunological responses. Finally, the inter-sampling time intervals in the datasets used in 
the present thesis range from 0.5 to 24 hours. In my analysis, I assumed the simplest case of 
linear rates to capture the unobservable dynamics of the experimental system during these 
time intervals. Although it is a convenient choice because it results in much simpler 
mathematical expressions, it is also justified by the fact that only average rates are estimated, 
and that for a small time interval, more complex rate expressions may introduce the risk of 
overfitting.   
 
In summary, this section highlighted the assumptions and limitations behind the modelling 
work presented in this thesis, in terms of the modelling approach, model selection and 
inference interpretation. As noted in the next section, cataloguing these limitations can be 
an invaluable guide for future experimental and modelling work.  
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7.4. Future Directions  
As discussed earlier, data-driven mathematical modelling in microbiology is an 
interdisciplinary nascent field, whose evolution depends both on the advent of higher-
resolution bacterial tracking techniques in vivo, and on the development of appropriate, 
computationally efficient modelling tools. As developments on both fronts are underway, I 
would like to conclude this thesis by providing suggestions for further work both in terms 
of methodological tools and in terms of new experiments.  
 
With regards to methodological tools and improvements to the current inference framework, 
there is scope to address the challenge of inter-host immunological heterogeneity by  
incorporating a hierarchical modelling approach within the existing inference framework. In 
this approach, the within-host dynamics are allowed to differ between each host animal, are 
simulated under different sets of parameters, are combined, and summarised by a single set 
of summary statistics. The second line of work would involve developing a tool to assess 
model mimicry, which can be simply explained as the degree of overlap between the 
predictions made by two different models. To give a brief outline, this would involve two 
datasets (1 and 2) and two rival models (M1 and M2). M1 and M2 would be fitted to both 
datasets 1 and 2, resulting in four best parameter estimates. Using a parametric bootstrap 
approach, each of these four parameter sets would be used to simulate a large number of 
datasets, and the models would be fitted to all bootstrapped datasets using the KL-divergence 
minimisation approach, resulting in four distributions of KL-divergence values. It is, then, 
possible to quantify the degree of overlap between the divergence distribution of the correct 
model M1 applied to dataset 1, and the wrong model M2 applied to dataset 1, and similar 
for dataset 2. Taking the ratio of these areas of overlap, it is possible to quantify the extent 
of model mimicry for M1 and M2. 
 
With regards to suggestions for further experiments, this work by large inspires more 
experimental work at the level of the single bacterium. As noted earlier (section 7.3), 
heterogeneity in bacterial behaviour has been largely unaccounted for when using data at 
the level of the entire bacterial population. Individual host cell-bacterial interactions are an 
important area to investigate when trying to understand the in vivo effect of antibiotics or 
vaccines. Furthermore, with a well-established legacy of ITS experiments relating biological 
mechanisms to immunological components, it would be good to see future experiments 
integrating the two in a single experimental setup, by e.g. sampling the blood serum for the 
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presence of immunological markers that may be of interest. Finally, follow-up experiments 
with genetically-engineered hosts can both externally validate and enrich the understanding 
provided by mechanistic mathematical models as shown by Grant et al. (Grant et al., 2008) 
and Kaiser et al. (Kaiser et al., 2013).  
 
7.5. Conclusion  
In conclusion, the present thesis highlights the merits of mechanistic mathematical models 
when combined with experimental data before, during and after experimentation in the lab. 
As a new interdisciplinary field, modelling in microbiology needs to be fostered and gain 
visibility by showcasing successful examples of how it can maximise the insight produced 
by wet-lab experiments. Besides gaining visibility, it is also critical to encourage the 
dialogue between modellers and microbiologists, to fund interdisciplinary projects and to 
promote cross-disciplinary expertise in both life sciences and applied mathematics.  
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KV group – 72 hours p.i. 
Boxplots of moment values from simulated data (n=500) with red dots corresponding to the 
experimentally observed moments.  
 
The x-axis refers to the moments and the numbers 1-3 refer to the tissues as follows:  
1 – blood 
2 – liver 




9.2. Sample Code Implementation 
 
















































1. For the three-compartment model with a single phenotype (Chapters 3 and 4):  
https://github.com/orestif/SPEEDI.R 
 
2. For the four-compartment model with single and dual phenotypes (Chapter 5):  
https://github.com/myrtovlazaki/DP_SP_model 
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